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ABSTRACT

The mechanism of action of 2-thiotriazone (TTZ) was evaluated in adult and
im m ature rats of both sexes. TTZ produced m arked pulmonary toxicity in
rats th a t was both age and sex-dependent. It was highly toxic in male rats
(oral LD50 of 4.6 mg/kg and ip LD50 of 1.4 mg/kg). Female rats were more
resistant than males and im m ature ra ts (30-40 days of age) were totally
resistant to TTZ toxicity. Gross and histological examination of lung tissue
from rats exposed to TTZ showed severe
mottling of the lungs.

pulmonary edema, effusion and

Significant increases in lung weights were also

observed.

Diethlymaleate (DEM) pretreatm ent potentiated the toxicity of TTZ in
male, female, and im m ature rats, but L-buthionine-(SR)-sulfoxamine (BSO)
did not affect TTZ toxicity. Lung weights in DEM-TTZ treated rats were
twice as heavy as anim als treated with TTZ alone.

Resistance to TTZ could be produced in adult male rats by adm inistration
of a sublethal dose of TTZ (lmg/kg).

Survival from a toxic dose also

induced resistance which lasted up to 8 weeks in orally dosed rats and 6
weeks in ip dosed rats.

p-Napthoflavone (BNF) induction of microsomal

mixed function monooxygenase enzymes and N-acetyl-L-cysteine (NAC)
produced resistance to TTZ in male rats.

Diethylmaleate abolished both

TTZ and BNF induced resistance to TTZ; however, BSO had no affect. Phenobarbital (PB) induction and treatm ent of rats with P-estradiol or
xx

testosterone did not affect TTZ toxicity.

Also, toxicity could not be

correlated with the stage of estrus.

Cytochrome P-450 specific content was increased in female rats, and UDPglucuronosyltransferase activity was decreased in both female and im m ature
male rats treated with TTZ.

Cytochrome P-450 specific content was

decreased in male rats and PB induced male rats adm inistered DEM-TTZ.
All other specific contents and activities were unaffected.

2-Thiotriazone produced a dose-dependent decrease in lung glutathione
(GSH) concentration in adult male rats.

It also decreased GSH

concentration in the lungs of female rats in a dose-independent manner.
Diethylmaleate-TTZ depleted glutathione stores in the liver and lung of
male and female rats.

This study indicates th at TTZ is probably

metabolized to a short-lived reactive metabolite in the lungs by the
cytochrome P-448 isozyme, although the involvement of the non-cytochrome
containing flavin monooxygenase system can not be ruled out.

CHAPTER 1
INTRODUCTION
2-Thiotriazone (TTZ) is a thiourea derivative developed by Triazone
Corporation for use as a potential fertilizer. Acute toxicity testing performed
with TTZ showed detrim ental effects on mammalian species, specifically rats
(Sprague Dawley).

TTZ was found to be an acute pulmonary toxicant in

adult male rats, producing severe pulmonary edema and effusion with death
occurring within 2-3 hrs.

Interest in this compound developed because of

the striking pulmonary toxicity observed in rats a t very low doses.

The

toxic action of TTZ closely resembles th a t of alpha-napthylthiourea (ANTU),
which is also a thiourea derivative (rodenticide) th a t produces pulmonary
toxicity in rats (Richter, 1945).

Thiourea (NH2CSNH2) and several of its

derivatives, especially the N-monosubstituted compounds containing the
thioredo moiety (-NHCSNH-), produced m arked pulmonary toxicity in many
animal species (Mackenzie and Mackenzie, 1943, Dieke and Richter, 1945,
Dieke,

et al., 1947).

Alpha-napthylthiourea (ANTU) is one of the most

potent of these derivatives. Because of it’s selective pulmonary toxicity at
very low doses, ANTU has been widely used as a model toxin for investigat
ing the pathophysiology of pulmonary edema (Richter, 1952).

Previous studies have shown th a t repeated adm inistration of sublethal doses
of ANTU and other thiono-sulfur containing compounds to experimental
animals produces a state of prolonged resistance or "tolerance" to the
pulmonary effects of a subsequent challenge with normal lethal doses (Bond
and Neal, 1976). Although this tolerance has been studied, its biochemical

or molecular basis has not been established.

Marked age and species

differences in susceptibility have also been dem onstrated with thiourea
compounds.

Rodents are highly susceptible to thiourea toxicity, whereas

other mammals such as cats and rabbits are not (Dieke and Richter, 1945,
Richter, 1952). Young and im m ature rats are highly resistant to thioureainduced lung toxicity indicating th a t toxicity increases with age (Dieke and
Richter, 1945, 1946). Marked resistance to ANTU toxicity was induced by
pretreatm ent of rats with toxic and nontoxic antithyroid drugs (Saunders
and Spaulding, 1951; Van Den Brink et al., 1976) or with iodine or iodide
(Byerrum, 1946; Van Den Brink et al., 1976).

Sulfhydryl compounds,

including cysteine, glutathione and 2-aminoethylisothiouronium bromide
protected ra ts against the lethal effects of thiourea derivatives (Dubois et
al., 1946; Giri and Combs, 1970; Karel and Meyer, 1948). Pretreatm ent of
rats with 3, 4-benzpyrene resulted in m arked tolerance to the pulmonary
toxicity of ANTU, but sim ilar pretreatm ent with phenobarbital had little
effect. Pretreatm ents with SKF-525A or piperonyl butoxide did not appear
to modify ANTU toxicity consistently (Van Den Brink et al., 1976).
Treatm ent of rats with ANTU intraperitoneally decreased pulmonary mixed
function oxidase enzymes (Boyd and Neal 1976), suggesting th a t a toxic
metabolite of ANTU was formed in vivo. Pretreatm ent of ra ts with a nonlethal dose of ANTU daily for 5 days decreased the activity of the lung
mixed function oxidase enzyme systems th a t metabolize parathion and
ANTU in vivo. The pretreatm ent with ANTU also caused a decrease in
both the covalent binding and pulmonary toxicity of “ S-ANTU in vivo (Boyd
and Neal, 1974).

This suggested th a t a decreased rate of activation of

ANTU in ANTU pretreated rats m ight have been a t least partially
responsible for the development of tolerance.

At least two enzymes systems are known to play a role in activating toxic
thioureas.

Cytochrome P-450-dependent oxidases th a t activate some

thionosulfur compounds (H unter and Neal, 1974; Bond and Dematteis, 1969)
and the flavoprotein mixed function oxidase enzyme system described by
Poulsen et al., (1974), for which ANTU has been shown to be a substrate.
Previous studies have also shown th a t depletion of glutathione concentra
tions in the lung and liver of rats caused increases in both pulmonary
toxicity and in vivo covalent binding of ANTU (Boyd and Neal, 1976). Thus
it seems reasonable to assum e th a t glutathione may detoxify reactive species
involved in the toxicities of thioureas, possibly by forming non-target
conjugates (Hollinger et al., 1976). Despite the extensive research th a t has
been conducted on thioureas, the mechanism by which these compounds
specifically damage lung tissue is not known.

Many pharmacological and toxicological aspects previously observed in rats
administered thiourea-like compounds are quite sim ilar to those observed in
animals exposed to atmospheric pollutants such as ozone and nitrogen
dioxide (Farchild et al., 1959; Stokinger, 1965). These agents also exhibit
differential toxicity in im m ature and m ature anim als and induce tolerance.
Cross-tolerance between several gaseous pulmonary irritan ts (ozone, nitrogen
dioxide, phosgene, hydrogen disulfide) and thiourea-like compounds has been
shown (Farchild, et al., 1959; Farchild, 1963; Stokinger, 1965).

Thus

gaseous pulmonary irritants and thiourea-like compounds may share a
common pathophysiological effect and a common toxicologic mechanism of
action.

Although the prospects for the use of TTZ as a fertilizer has been dampened
because of its pulmonary toxicity in rats, research on this compound is
warranted since chemical compounds th a t produce selective acute pulmonary
toxicities are rare. Therefore valuable insight into the biochemical basis for
this specificity leading to an understanding of both normal and abnormal
pulmonary physiology may be gained. 2-Thiotriazone could also be used as
a model for investigating the pathophysiology of pulmonary edema since its
toxic effects are specifically directed a t the lung, causing m arked pulmonary
edema in and around blood vessels, and because it produces toxicity a t
relatively low doses. The objectives of this study were to characterize the
acute toxicity of TTZ in rats; to determine if toxicity is age or sex
dependent; to characterize both innate and drug induced resistance to TTZ
in rats; to determine the effects of TTZ on hepatic microsomal and cytosolic
enzymes and enzyme activities; to determine the effect of TTZ on hepatic
and pulmonary glutathione concentrations in rats, and to determine the
effect of glutathione depletion on TTZ toxicity in rats.

CHAPTER 2
LITERATURE REVIEW

An increasing num ber of drugs and chemicals have been shown to produce
pulmonary toxicity via systemic administration.

These chemicals produce

specific lung damage and they also produce damage to other tissues. The
exact mechanisms by which pulmonary toxicants may cause lung damage
includes:

concentration of the agent within the lung, the absence of

adequate pulmonary detoxification systems and bioactivation to a toxic
species within specific lung cells or within the liver or other metabolic sites.
The biochemical and pathological changes associated with lung edema, the
responses of individual lung cells, pulmonary repair processes to toxic
agents, and species and age differences in susceptibility to lung damage
have not been determined for most pulmonary toxins. Previous studies by
Boyd (1980; 1982) and Minchin and Boyd (1983), have shown th a t some
pulmonary toxicants require metabolic activation prior to producing lung
damage, while some do not require activation.

Even though no previous toxicological research has been performed on 2thiotriazone (TTZ), a new compound developed for use as a potential
fertilizer, acute toxicity testing has shown it to be an acute selective
pulmonary toxicant in rats. Its selective pulmonary toxicity has been found
to be very similar to th a t of a-napthylthiourea (ANTU).

Due to the fact

th a t chemical compounds th a t produce selective pulmonary toxicity are rare,
related acute selective pulmonary toxicants such as 4-ipomeanol and other

furans, paraquat, pyrrolizidine alkaloids and thioureas (specifically ANTU)
along with their proposed mechanisms of toxicity will be reviewed in this
study.

4-IPOMEANOL AND O TH ER FURANS

At least 13 furan derivatives have been found to produce acute lung damage
in rats via inhalation or systemic adm inistration, (Boyd, 1980). Some occur
naturally in the environment, others are used in industry and research, and
some are found in food and drugs (Kehrer and Kareu, 1985). 4-Ipomeanol,
a furanterpenoid which is the major component of the "lung edema factor"
produced in mold (Fusarium solani), damages sweet potatoes (Ipomea
batatas) (Boyd, 1980) and is the most extensively studied of the furan
derivatives.

4-Ipomeanol produces m arked pulmonary toxicity (William et al., 1971; Boyd
et al., 1974; Dutcher and Boyd, 1978; 1979) in several laboratory animal
species (rats, rabbits and guinea pigs). Lethal doses after oral, intravenous
or intraperitoneal adm inistration are between 10-60 mg/kg.

Typical

pathological findings in the lung included massive alveolar (interstitial)
edema, congestion, pleural effusion and hemorrhage (Perkham et al., 1972)
within 6-24 h r after adm inistration (Boyd, 1976). Sabo et al., (1983) found
th a t functional changes in the lungs may be attributed to swelling and
necrosis of non-ciliated bronchiolar (Clara) cells, which is the characteristic
pulmonary cellular lesion.

This appeared to be the prim ary site of lung

damage produced by 4-ipomeanol (Boyd, 1982; 1980; 1976; 1977).

This

damage was restricted to the smaller airways a t low doses, but a t higher
doses the cells of the larger airways were also affected.

There are some

species differences in pathological alterations produced by 4-ipomeanol.
For example, liver damage is produced in ham sters (Dutcher and Boyd,
1979; Boyd and Dutcher, 1981) and in birds, which lack non-ciliated
bronchiolar cells (Clara cells) and alveolar Type II cells (Buckpitt et al.,
1982).

Tolerance to 4-ipomeanol, like thioureas, can be produced in rats by
adm inistration of sublethal doses of the toxin itself (Boyd et al., 1972; 1967).
Pretreatm ent of rats with 4-ipomeanol (7 mg/kg) for 7 days triples the LD^.
Protection against the toxicity of 4-ipomeanol is provided by pulmonary GSH
and other sulfhydryl compounds which can react with a metabolite and
prevent covalent binding and lung damage (Boyd et al., 1978; 1972).
Studies both in vitro and in vivo indicated th a t the reactive metabolite
formed by metabolism of 4-ipomeanol is a highly electrophillic species (Boyd
and Burke, 1978; Boyd et al., 1978; 1979).

Addition of the nucleophilic

tripeptide, glutathione (GSH), or "soluble fraction" (which contains GSH and
GSH-transferases) markedly inhibited the covalent binding of 4-ipomeanol
in vitro (Boyd et al., 1978). Glutathione did not inhibit the formation of the
reactive metabolite, but inhibited its covalent binding by acting as an
alternate nucleophile (Boyd et al., 1978; Buckpitt and Boyd, 1979; Statham
and Boyd, 1979). In vivo studies by Boyd and B urka (1978); Boyd et al.,
(1979); and Statham and Boyd, (1979), have likewise implicated an

electrophillic metabolite in 4-ipomeanol toxicity and these authors also
suggested th a t GSH may modulate susceptibility to the pulmonary damage,
as it does with certain

hepatotoxins,

such as acetaminophen and

bromobenzene (Mitchell et al., 1973; Mitchell and Boyd, 1978). Toxic doses
of 4-ipomeanol selectively depleted lung GSH; this effect was prevented by
pretreatm ent of the anim als with piperonyl butoxide (Boyd et al., 1979).
Prior depletion of tissue GSH by diethylmaleate (DEM) pretreatm ent
markedly increased both covalent binding and the toxicity of 4-ipomeanol,
although it did not alter the tissue distribution of the parent compound
(Statham and Boyd, 1979).

Adm inistration of exogenous sulfhydryl

compounds such as cysteine or cysteamine, decreased both covalent binding
and the toxicity of the compound (Boyd et al., 1979).

These studies

suggested th a t endogenous GSH m ight play a protective role in 4-ipomeanol
toxicity by reacting with the toxic metabolite(s) to form a nontoxic
conjugate(s).

However, GSH seemed to be acting only as an alternative

nucleophile; there was no indication th a t it was preferentially depleted prior
to alkylation of tissue nucleophiles.

Extensive research with 4-ipomeanol revealed th a t its toxicity is due to
bioactivation by cytochrome P-450 (Boyd, 1982; 1976; 1977; Dutcher and
Boyd, 1979).

Pulmonary alveolar Type II cells have been found to

metabolize 4-ipomeanol to an electrophillic species (Devereux, et al., 1981).
This metabolite is highly reactive, and has been shown to covalently bind
to lung tissue in vivo (Boyd et al., 1975; Boyd and Burka, 1978), and to
microsomal proteins in vitro (Boyd et al., 1978) when
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C-ipomeanol was

incubated in the presence of NADPH with various subcellular fractions of
ra t lung and liver homogenates. Radioactive m aterial became predominately
bound to the microsomal fractions (Boyd et al., 1978). The maximal rates
of covalent binding of the toxin occurred only in the presence of NADPH
and oxygen.

Several inhibitors of monooxygenase enzymes decreased the

covalent binding of 4-ipomeanol in ra t lung and liver microsomes in vitro.
Pyrazole, piperonyl butoxide, and SKF-525A all inhibited the covalent
binding, with piperonyl butoxide being the most effective (Boyd et al., 1978).
Covalent binding of 4-ipomeanol was also m arkedly decreased in lung and
liver microsomes from rats pretreated with cobaltous chloride, which causes
a decrease in both pulmonary and hepatic cytochrome P-450 (Sesame and
Boyd, 1978).

The activation of 4-ipomeanol was examined in lung and liver microsomes
from rats pretreated with 3-methylcholanthrene or phenobarbital (Boyd et
al., 1978).

Both pretreatm ents produced the expected increase in liver

cytochrome P-450 and also increased the in vitro hepatic microsomal
covalent binding of 4-ipomeanol, indicating th a t 4-ipomeanol could be
metabolized by forms of hepatic cytochrome P-450 induced by either
phenobarbital or 3-methylcholanthrene. However, phenobarbital treatm ent
did not alter in vivo covalent binding or the toxicity of 4-ipomeanol in the
lungs, although it did significantly increase the LD5 0 value (Boyd and Burka,
1978).

Covalent binding of the toxin was decreased in vivo in both lung

and liver in phenobarbital treated anim als compared to controls (Boyd and
Burka, 1978). Thus, phenobarbital induction probably affected detoxifying
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pathways in vivo more than toxifying ones (Boyd, 1981; Boyd and Burke,
1978). In 3-methylcholanthrene pretreated animals, liver necrosis resulted
from metabolic activation of 4-ipomeanol by hepatic enzymes. The in vitro
formation of an alkylating metabolite of 4-ipomeanol was greatly increased
in liver microsomes but not in renal or pulmonary microsomes, from
C57BL/6J mice pretreated with 3-methylcholanthrene (Boyd and Dutcher,
1978). in vivo covalent binding of 4-ipomeanol was markedly elevated in
livers of the induced mice, while covalent binding of the toxin was markedly
decreased in the lungs and kidneys.

4-Ipomeanol caused striking

centrilobular hepatic necrosis in the induced mice, but much less intense
renal and pulmonary necrosis, as compared to non-induced controls.

In

contrast, 3-methylcholanthrene pretreatm ent had no significant effect on
target organ alkylation and toxicity by 4-ipomeanol in "non-inducible"
DBA/2J mice.

The furan moiety is clearly necessary for both binding and subsequent lung
toxicity induced by 4-ipomeanol and related chemicals. Analogs in which
the furan is replaced by methyl or phenyl substitutes do not covalently bind
to lung tissue and are not toxic to the lung (Boyd and Burka, 1978; Boyd
et al., 1978).

Clara cells have the greatest metabolic capacity for 4-

ipomeanol in mammalian systems indicating th a t its pulmonary toxicity is
directly related to its site of metabolism.

Altering the metabolism of 4-

ipomeanol through the use of drug metabolism inducers shifts the toxicity
from lung to liver (Boyd et al., 1980; Jones et ah, 1983).

Many other furan derivatives, such as
Statham

et al.,

1978), furan

3

-methylfuran (Boyd et al., 1978;

carbonates (analogues of 4-ipomeanol)

(Seawright and Mattocks, 1973; Boyd et al., 1974), perilla (mint plant)
ketone (Wilson et al., 1977), and sulfur and nitrogen containing analogues
of furans (Franklin and Boyd, 1978), have been shown to produce
bronchiolar cell necrosis (both ciliated and non-ciliated) and hepatic and/or
renal damage following systemic adm inistration (Boyd, 1982; 1980).

3-

Methylfuran was also converted by a cytochrome P-450 dependent pathway
in mouse lung microsomes to a highly reactive metabolite th a t became
covalently bound to microsomal protein in the same m anner as 4-ipomeanol.
Microsomal alkylation of 3-methylfuran required NADPH and air, and it
was strongly inhibited by a carbon monoxide enriched atmosphere or by
addition of piperonyl butoxide (Boyd et al., 1978; Statham et al., 1978).

Other furans and related compounds such as the furan carbam ates, perilla
ketone, furan derivatives, thiophenes and pyrolles also require metabolic
activation like 4-ipomeanol and

3

-methylfuran (McMurty et al., 1977;

Franklin and Boyd, 1978; Boyd, 1980).

Nitrofurantoin, another furan

derivative, is widely used as a urinary tract antiseptic and produces a
unique lung lesion different from bronchiolar, hepatic or renal necrosis seen
with other furans (Israel et al., 1973). Although the pulmonary toxicity of
nitrofurantoin is rare, it has potentially serious side effects in patients
treated with standard doses of the drug (Koch-Weser et al., 1971). Acute
signs of nitrofurantoin induced lung damage begin a t

2

hour to

2

weeks

after adm inistration of the drug and include fever, cough, dyspnea, and
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cyanosis. Pulmonary infiltrates and pleural effusion also occur. This acute
toxicity may develop into a chronic reaction resulting in pulmonary fibrosis
(Rosenow, 1976). The mechanisms by which nitrofurantoin damages lung
tissue are not known, but they appear to be significantly different from
those of

other furan derivatives.

mechanism (Rosenow, 1976).

E arlier studies supported an allergic

Recent studies have shown th a t cyclic

reduction and reoxidation of nitrofurantoin, like paraquat, may occur in
vitro under aerobic conditions.

This could lead to the production of

superoxide radicals, the depletion of NADPH, and lung damage (Mason and
Holtzman, 1975). Nitrofurantoin stim ulates hydrogen peroxide production
in lung microsomes (Sesame and Boyd, 1979). It is also more toxic to lungs
of rats deficient in vitam in E or exposed to high concentrations of oxygen
(Boyd et al., 1979). Several antioxidants, including superoxide dismutase
and catalase, have protected lung explants from nitrofurantoin toxicity while
hyperoxia enhanced it’s toxicity (Martin, 1983). Nitrofurantoin will oxidize
GSH in an isolated perfused lung preparation (Dunbar et al., 1981). It also
has the ability to inhibit glutathione reductase (Buzzard, 1960) which is
involved in the glutathione antioxidant system of the lung.

Inhibition of

this enzyme has been postulated as a factor in the lung toxicity of the
anticancer drug carm ustine, 1,3 bis (2 chloroethyl)-l-nitrosurea (BCNU)
(Kehrer and Paraidathathu, 1984).
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THIOUREAS (SPECIFICALLY ANTU)

Thiourea (NH 2 CSNH2) and several of its derivatives, especially the Nmonosubstituted ones containing the thioredo moiety (-NH CS NH-), produce
marked pulmonary toxicity in m any animal species (Mackenzie and
Mackenzie,

1943;

Dieke

and

Richter,

1945;

Dieke

et

al.,

1947).

Phenylthiourea and ANTU produced massive pulmonary edema and effusion
in rats (Mackenzie and Mackenzie, 1943; Dieke and Richter, 1945; Dieke et
al., 1947). The rodenticide, ANTU, has been shown to be one of the most
potent of these derivatives.

Because of its selective pulmonary toxicity,

ANTU is a widely used model for investigating the pathophysiology of
pulmonary edema (Richter, 1952).

Alpha-napthylthiourea and other toxic thioureas produce a fibrin rich
pulmonary edema (usually nonhemorrhagic) and, frequently, massive pleural
effusion in susceptible anim als (Mackenzie and Mackenzie, 1943); Dieke and
Richter, 1945; Dieke et al., 1947; Richter, 1945; McClosky and Smith, 1945;
Dieke and Richter, 1946; Richter, 1952; Bohm, 1966; Cunningham and
Hurley, 1972; Meyrick et al., 1972). Oral LDa, values for ANTU range from
7 mg/kg in some ra t strains to 4,250 mg/kg in monkeys and chickens (Dieke
and Richter, 1946). Rodents such as rats and mice were found to be highly
susceptible to thiourea toxicity, whereas other species such as cats and
rabbits were much more resistant (Dieke and Richter, 1945; Richter, 1945;
Dieke and Richter, 1946).

ANTU has also been shown to produce fatal
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pulmonary edema in dogs (Michel et al., 1984) and sheep (Havill et al.,
1982).

Detailed descriptions of ANTU toxicity in rats by Cunningham and Hurley
(1972) and Ven Den Brink et al., (1976), showed th a t a dose of 5 mg/kg
given intraperitoneally (ip) produced evidence of pulmonary edema and
effusion within 2 hr, which reached a maximum 4.5 hr. after injection. The
damage was lethal to some anim als a t 8-10 hr. post-injection.

ANTU

administered ip to rats a t doses of 3,10, and 50 mg/kg produced capillary
endothelial damage (blebbing and scalloping) and pulmonary edema (Meyrick
et al., 1972; Brun-Pascaud et al., 1983).

The morphologic changes

associated with thiourea-induced lung toxicity are prim arily found in the
endothelium of pulmonary capillaries and venules of rats (Cunningham and
Hurley, 1972).

Some damage to Type 1 alveolar epithelial cells has also

been reported (Meyrick et al., 1972) although it is not clear whether this
was a direct effect of ANTU or secondary to the endothelial cell lesion.
Light and electron microscopic studies have shown gaps in the endothelium
and occasional blebs protruding into the capillary lumen.

These gaps

appear to allow the leakage of fibrin rich fluid resulting in pulmonary
edema and, often, massive pleural effusions (Cunningham and Hurley,
1972). Hemorrhage is rare, and in surviving animals, edema resolves itself
within 48 hr. and there is no evidence of an inflammatory response. Gaps
a t the endothelial cell junction disappear when fluid leakage ceases and
there is no evidence of perm anent damage to any lung cell (Cunningham
and Hurley, 1972).
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Other thiourea and thiono-sulfur compounds cause other toxicities i.e.,
thioacetamide causes centrilobular hepatic necrosis (H unter et al., 1977).
It impairs the synthesis of messenger and transfer RNA or their transfer
from the nucleus (Stocker and Yokyaman, 1966).

Hanzlik et al., (1980)

found th a t both thiobenzamide and thiobenzamide-S-oxide, a metabolite,
produced a

dose-related liver injury in

rats.

Dithioburet caused

neurotoxicity in rats (William et al., 1987), characterized by delayed onset
of skeletal muscle weakness and depressed nerve stim ulated release of
acetylcholine (Astwood et al., 1945; Atchison et al., 1981; Weiler et al., 1984,
1986 and Atchison, 1984).

Ethylenethiourea, a fungicide (Ludwig et al.,

1954; Czegkedijenka, 1967) produced tumors in mice (Innes et al., 1969),
thyroid cancer in rats (Ulland et al., 1977), and was teratogenic in mice and
rabbits (Khera, 1973). Tetam ethylthiourea has also been found to be a weak
embryotixic and teratogenic agent (Stula et al., 1979).

Some thiourea derivatives also have antithyroid activity.

However, their

pulmonary toxicity is not correlated with this activity (Mackenzie and
Mackenzie, 1943; Dieke et al., 1947).

Lethal doses of propylthiourea,

thiouracil, and certain other related compounds having potent antithyroid
activity did not cause significant lung damage. However, m arked resistance
to ANTU toxicity has been induced by pretreatm ent of rats with toxic and
non-toxic antithyroid drugs (Saunders and Spaulding, 1951; Van Den Brink,
et al., 1976) or with iodide or iodine (Beyerum, 1946; Van Den Brink, et al.,
1976).
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Young and im m ature anim als, compared to adult animals, were generally
highly resistant to the lung toxicity of thioureas (Dieke and Richter, 1945;
1946.

The prior treatm ent of susceptible older anim als with small non-

lethal doses of ANTU produced striking tolerance to subsequent large
challenge doses of ANTU (McClosky and Smith, 1945; Van Den Brink, et
al.,

1976; Richter,

1946; Mayer and Saunders,

1949; Sabonya and

Kleinerman, 1973). This tachyphylaxis was dose-related and occurred, even
if rats were pretreated a t an early age with ANTU (or with other toxic and
non-toxic antithyroid drugs, or with iodine or iodide) before susceptibility to
thiourea had developed (Van Den Brink et al., 1976).

Previous investigations with thiourea indicated th a t sulfhydryl compounds,
including cysteine, (Dubois et al., 1946; Karel and Mayer, 1948) glutathione,
(Giri

and

Combs,

1970;

Karel

and

Mayer,

1948),

and

2

-

aminoethylisothiouronium bromide protected rats against the lethal effects
of thiourea derivatives (Van Den Brink et al., 1976). Giri and Combs (1970)
found th a t cysteine and reduced glutathione inhibited both the pulmonary
edematogenic effect and the hyperglycemic effect of phenylthiourea in rats.
Several experiments have suggested th a t sulfhydryl compounds could
modulate susceptibility to the toxicity of thioureas.

Because of this, the

effect of diethylmaleate (DEM) pretreatm ent on the toxicity and covalent
binding of “ S ANTU was studied by Boyd and Neal (1976).

DEM

pretreatm ent depleted liver and lung glutathione (GSH) levels by 80%.
Both pulmonary toxicity and in vivo covalent binding were strikingly
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increased after ANTU pretreatm ent. These findings showed th a t GSH could
possibly detoxify reactive species involved in the toxicities of thiourea by
forming non-toxic conjugates (Hollinger et al., 1976).

Pretreatm ents of rats with 3,4-benzpyrene resulted in m arked tolerance to
the pulmonary toxicity of ANTU, but phenobarbital (PB) pretreatm ent had
little effect.

Pretreatm ent with SKF-525A or piperonyl butoxide did not

appear to modify ANTU toxicity consistently (Van Den Brink et al., 1976).
Treatm ent with aminophilline, nicotine, or atropine had no significant effect
on ANTU toxicity.

Actinomycin D has also been shown to potentiate

thiourea toxicity (Giri et al., 1974).

Recent studies have shown th a t hyperoxia enhanced the toxicity of thiourea
and th a t hydroxyl radicals may be the ultim ate m ediator responsible for
lung injury (Fox et al., 1981). This highly reactive species could directly
damage the lung or indirectly induce destructive reactions such as lipid
peroxidation.

Endotoxin

pretreatm ent,

which protects

rats

against

pulmonary oxygen toxicity, also prevent pulmonary edema produced by
thioureas (Hollinger et al., 1981). The mechanisms involved in endotoxin
protection against thioureas are not clear, but may be related to the
increased activity of pulmonary antioxidant defense systems induced by
endotoxin (Frank et al., 1980). The beta-adrenergic system may also play
a role in thiourea induced lung damage.

Isoproterenol increased and

propranolol decreased the endematogenic response (Combs and Jam es, 1975).
These effects may be related to changes in cardiac output which could alter
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the formation of edema fluid.

Prostaglandin E treatm ent, which could

increase ANTU uptake as well as produce platelet depletion, potentiated
ANTU-induced lung injury, while neutrophil depletion had no apparent
effect (Fantone et al., 1984). These factors suggest th a t ANTU induced lung
toxicity may have a very complex mechanism.

Alpha-napthylthiourea

and

other

thioureas

caused

disturbances

in

carbohydrate metabolism in ra ts and dogs. Thiourea-induced hyperglycemia
could be antagonized by insulin, ergotamine, or adrenal demedullation, but
none of these treatm ents prevented the pulmonary toxicity (Dubois et al.,
1946). Giri and Combs (1970) established th a t the degree of hyperglycemia
induced by phenylthiourea in rats varied directly with age, as did
susceptibility to pulmonary edema.

Treatm ent of rats with ANTU ip decreased pulmonary mixed function
oxygenase enzymes (Boyd and Neal, 1976), suggesting th a t a toxic
metabolite of ANTU was formed in vivo. Pretreatm ent of rats with a nonlethal dose of ANTU daily for 5 days decreased the activity of the lung
mixed function oxygenasee enzyme systems th a t metabolized parathione and
ANTU in vitro. A similar effect has been previously shown with CSa (Bond
and DeMatteis, 1969) and other thiono-sulfur containing compounds (Hunter
and Neal, 1975) on ra t liver mixed function monooxygenase activity. The
pretreatm ent with ANTU also caused a decrease in both covalent binding
and the pulmonary toxicity of “ S ANTU in vivo (Boyd and Neal, 1976).
This suggested th a t a decreased rate of activation of ANTU in ANTU-
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pretreated rats might have been a t least partially responsible for the
development of tolerance (Hollinger et al., 1976).

Boyd and Neal (1976)

have shown th a t on incubation of 14C lung and liver microsomes two types
of binding occurred.
NADPH independent.

One was NADPH dependent and the other was
Boiling of microsomes abolished the NADPH

dependent covalent binding activity, suggesting th a t the binding in the
absence of NADPH was nonenzymatic.

The NADPH dependent covalent

binding presumably reflected the metabolic conversion of the parent
compound to a more reactive species capable of interacting covalently with
tissue macromolecules.

However, NADPH independent binding may have

reflected nonenzymatic mixed disulfide formation between ANTU and tissue
protein sulfhydryl groups (suggesting th a t the postulated mixed disulfide
bond was cleaved in a m anner which left the sulfur atom of ANTU bound
to the protein). Furtherm ore, the binding th a t occurred in the presence of
NADPH led to decreases in

cytochrome P-450 and

mixed-function

monooxygenase activities in vitro, whereas th a t which occurred in the
absence of NADPH had no effect on cytochrome P-450 or mixed function
monooxygenase activities in vitro.

Hollinger et al., (1976) also observed two types of binding of radioactivity
from

14

C-thiourea incubated in vitro with ra t lung slices.

One form of

binding was low affinity, high capacity, and the other was characterized as
high affinity/low capacity. It may be possible th a t these were analogues to
the nonenzymatic and enzymatic binding, respectively, th a t had been
observed with ANTU in lung microsomes (Boyd and Neal, 1976).
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At least two enzyme systems are known th a t might play a role in activating
toxic thioureas:

cytochrome P-450 dependent monooxygenases (which are

known to activate some thionosulfur compounds) (Dalvi et al.„ 1974; H unter
and Neal, 1975; Bond and Dematteis, 1969), and the flavoprotein mixed
function oxidase system (Poulsen et al.„ 1974). The flavoprotein enzyme is
capable

to

NADPH-dependent

desulfuration

of some

thionocarbonyl

compounds, and it is reasonable to suspect th a t a chemically reactive, toxic
interm ediate could also be formed by this route. ANTU has been shown to
be a substrate for this enzyme system. According to Hollinger et al., (1976),
the pulmonary toxicity of thioureas is quite different from 4-ipomeanol
toxicity (reversible lesions of endothelial cells and no bronchiolar necrosis).
This suggested that, if metabolic activation is involved in thiourea toxicity,
the metabolism of thioureas m ay occur by different pathways and/or
different pulmonary cell types th an 4-ipomeanol.

Despite the extensive research th a t has been performed with thiourea, the
mechanisms by which these compounds specifically damage lung tissue are
not known. The presence of specific binding sites is one mechanism proposed
to explain the toxicity of various lung toxins including thioureas (Gregory,
1970). Differences in the num ber of binding sites might explain the age
and species variation in thiourea induced pulmonary toxicity (Gregory,
1970).
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Metabolic activation may be a necessary step in the pulmonary toxicity of
the thioureas (Cunningham and Hurley, 1972; Meyrick et al., 1972; Gregory,
1970; Van Den Brink et al., 1976).

Previous studies have shown th at

ANTU and thioureas covalently bind to lung protein (Hollinger et al., 1974;
Boyd and Neal, 1976; Hollinger et al., 1976), while a non-toxic analogue,
alphanapthylurea does not (Boyd and Neal, 1976). Binding occurred in vitro
under both aerobic and anaerobic conditions. This binding was associated
with a reduction in glutathione and was tem perature dependent (Hollinger
and Giri, 1979), suggesting th a t it was mediated by a reactive metabolite
(Boyd and Neal, 1976; Lee et al., 1980).

While the greatest amount of

evidence supports the hypothesis th a t thioureas are activated metabolically
to a lung toxic oxidative species, the issue has not been completely resolved.

PARAQUAT

Paraquat ( l , l ’-dimethyl-4,4’-bipyridylium dichloride) is another specific lung
toxicant in mammals. It is known as methyl viologen and is a quaternary
bipyridyl compound once widely used as a broad spectrum herbicide (Pasi,
1978). P araquat has become one of the most extensively studied pulmonary
toxins because of its lethal toxicity in m an (suicide attem pts) and in
domestic anim als after accidental ingestion (Bullivant, 1966; Smith and
Heath, 1976; and Haley, 1979).

P araquat is highly w ater soluble and

aqueous solutions are irritating to most biological systems. Oral ingestion
usually results in lesions of the mucosal lining of the m outh and throat and
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results in nausea and vomiting (Fairshter et al., 1976).

Acute signs of

toxicity include diarrhea and decreased kidney function, both of which
disappear in a day or two with apparent recovery. This is deceiving,
however, because, severe lung damage gradually develops and the mortality
rate is high.

Twelve to 36 hrs. after receiving toxic doses of paraquat (10-60 mg/kg iv or
ip in the rat), the lungs frequently appear edematous and plum colored.
They are generally much heavier than normal, and light microscopic
examination usually reveals extensive edema and hemorrhage.

Lung

damage caused by paraquat is characterized by a destructive phase, followed
by a proliferative phase (Smith et al., 1974; Sykes et al., 1977).

The

destructive phase is the first morphologic change observed and includes
damage to Type I and Type II alveolar epithelial cells.

Damage to

pulmonary capillaries can be seen within 48 hours but is much less
extensive th an damage to Type I and Type II alveolar cells (Dearden et al.,
1982) and there is some early necrosis of term inal bronchiolar cells
(Etherton and Gershom, 1979).

The destructive stage is also associated

with interstitial edema and the collapse of lung parenchyma.

This is

followed by a proliferative phase where fibroblasts m igrate into alveolar
spaces and m ature into fibroblasts. They then synthesize excessive amounts
of an abnormal collagen characteristic of intraalveolar fibrosis. Interstitial
fibrosis is not commonly seen in rats (Panpenoe, 1979) and the proliferation
phase of paraquat induced lung damage is independent of, and not always
preceded by, the destructive phase.
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A

num ber

of

endogenous

amines,

including

norepinephrine,

5-

hydroxytryptamine, histam ine, and several drugs such as imipramine,
propranolol, burimomide and betazole, were found to inhibit paraquat
uptake by lung slices in vitro (Rose et al., 1977; 1974; 1976; Locke et al.,
1973; Smith et al., 1976). Studies conducted on the relationship between
lung uptake processes for paraquat and 5-hydroxytryptamine (5HT)
suggested some cellular specificity for paraquat accumulation and toxicity
in the lung.

Both paraquat and 5HT uptake were energy dependent but

the process or rate of accumulation was different for both compounds.

Paraquat, unlike 4-ipomeanol, 3-methylfuran, other furans and ANTU, does
not become covalently bound to lung tissue in vivo (Ilette et al.„ 1974).
Rose and Smith (1977) reported th a t the accumulation and retention of
paraquat by lung tissue was not related to any binding phenomenon. It is
highly unlikely th a t the pulmonary toxicity of paraquat involves the
irreversible binding of the parent compound or its metabolites to lung
tissue.

Phenobarbital pretreatm ent partially protected anim als from paraquat
toxicity (Bus et al., 1976).

However, phenobarbital pretreatm ent was

effective only when tissue levels were relatively high, suggesting th a t the
protective effect was not due to induction of drug metabolizing enzymes.
Ilette and co-workers (1974) also found no evidence of N-demethylation of
paraquat by 9000xg supernatants of liver or lung from either rats or
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rabbits, although those tissues possessed measurable N-demethylase activity
when codeine or ethylmorphine were used as substrates.

A stable free radical metabolite was produced when paraquat was incubated
under anaerobic conditions with fresh ra t liver homogenates (Gage, 1968).
Formation of the radical was prevented by heating the homogenate or by
dialyzing it.

NADH was a required cofactor for the mitochondrial

preparation, whereas NADPH was required for the reduction of paraquat to
a free radical by the microsomes. P araquat will readily accept an electron
from NADPH in pulmonary microsomal preparations (Bus et al., 1975), and
under aerobic conditions will rapidly be metabolized with the resultant
formation of superoxide or other oxygen radicals (Farrington et al., 1973).
This reaction could lead to cell damage from NADPH depletion (Witschi et
al.„ 1977; Ilette et al.„ 1974; Rose et al., 1976), free radical generation and
lipid peroxidation (Bus gt al.„ 1976; Ilette et al., 1974).

The lethality of paraquat was m arkedly increased in ra ts exposed to an
oxygen-enriched atmosphere (Fischer et al., 1973; Bus and Gibson, 1975;
Witchi et al., 1977). Additionally, its toxicity was diminished in animals
exposed to atmospheres deficient of oxygen. G reater lethality and histologic
change in lungs occurred in mice given a lethal dose of paraquat and keep
in room air, compared to those kept in a 10% oxygen atmosphere (Rhodes
et al., 1976). Animals surviving the hypoxic atmosphere quickly died when
exposed to air. Smith and Rose (1977) found the opposite effect of paraquat
in rats.

Rats placed in 10% oxygen after a lethal dose of paraquat died
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faster th an comparable controls left in room air.

Even though several mechanisms of oxygen toxicity have been proposed, the
superoxide radical might be the species responsible for the lung lesions
produced by exposure to oxygen (Carpo and Tierney, 1974).

Exogenous

superoxide dismutose (SOD) adm inistered iv provided partial protection
against paraquat toxicity (Autor, 1974; W asserman and Block, 1975). The
conversion of superoxide to H 2 0 2 is catalyzed by SOD. Superoxide dismutase
activity in lung microsomes is low compared to other tissues, and this may
be a significant factor in the pulmonary specificity of paraquat (Montgomery,
1976). Derivatives of SOD with longer circulating half-lives may be more
effective.

Pretreatm ent with endotoxin and hyperoxia, which stim ulate

endogenous antioxidant systems, provided significant protection (Frank,
1981). O ther studies suggest ascorbic acid might be an effective protective
agent (Matkovics et al.„ 1980), but this could not be verified (Sullivan and
Montgomery, 1984). in vitro work performed by Montgomery et al., (1982)
suggested th a t ascorbic acid m ight increase paraquat toxicity. The singlet
oxygen, derived from spontaneous dism utation of superoxide, could cause the
peroxidative decomposition of lipids in vitro (Pederson and Aust, 1973).
F urther studies performed by Bus et al., (1974;

1977; 1978) and

Montgomery (1976) suggested th a t paraquat caused lung lesions by
stim ulating lipid peroxidation. Sim ilar mechanisms have also been proposed
for paraquat induced damage in plants (Dodge and H arris, 1970; Dodge,
1971).
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Vitamin E deficient mice were sensitized to paraquat toxicity as measured
by a single dose 7 day LDgo (Bus et al., 1975).

Mice fed a selenium

deficient diet were also sensitized to paraquat (Bus et al., 1975). This is
supportive of an oxidative mechanism of paraquat toxicity because selenium
is required for glutathione peroxidase activity (Gram, 1973) and glutathione
peroxidase

is

thought

to

be

a

modulator

of

lipid

peroxidation

(Christopherson, 1969).

Pretreatm ent of mice with diethylmaleate (DEM), which depletes stores of
reduced glutathione (GSH), and tri-o-cresylphosphate (an inhibitor of GSHperoxidase) significantly enhanced paraquat toxicity (Bus et al., 1975).

It

has been speculated th at the enhancem ent of paraquat toxicity by DEM was
caused by removal of reducing equivalents necessary for GSH-peroxidase
activity or possibly by the loss of the intrinsic antioxidant activity of GSH
(Bus et al., 1975; 1976).

P araq u at caused significant decreases in the

concentration of GSH in the liver, b u t not in the lung (Bus et al., 1976).
In contrast to its effects on lung and liver levels of GSH, paraquat
decreased the level of lipid soluble antioxidants (primarily vitam in E) in the
lung, but not in the liver. The paraquat-induced depression in lung lipid
soluble antioxidants was very prolonged, recovery to control levels requiring
nearly 200 hrs. (Bus et al., 1976). This m ight indicate possible differences
in the cellular sites of paraquat toxicity or available pools of antioxidant in
the liver and lung tissue.

Pretreatm ent of rats with 85% oxygen for 7 days induced tolerance to
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subsequent exposure to

1 0 0

% oxygen, and caused elevations in the lung

activities of G-6 -P dehydrogenase (Bus et al., 1976), superoxide dismutase
(Rose and Smith, 1977), and GSH-peroxidase (Bus et al., 1976). The survival
time after a toxic dose of paraquat was increased in oxygen-tolerant rats as
compared to control rats (Bus et al., 1976).

The mechanism involved in

lung damage appeared to be related to its specific uptake into this tissue
and the redox capacity of paraquat, which may lead to depletion of NADPH
and/or the generation of oxygen free radicals.

Treatm ent of paraquat

toxicity has focused on preventing active lung uptake and scavenging the
potential oxygen radicals th a t are formed.

Unfortunately, none of the

previously mentioned treatm ents were effective against paraquat poisoning.

PYRROLIZIDINE ALKALOIDS (PA)

These chemicals are found in a variety of plant species. Toxic responses to
these alkaloids vary between species and may be neurologic, hematologic,
gastrointestinal, hepatic or pulmonary (McLean, 1970).

Lung lesions are

observed in most species several days after systemic treatm ent with a PA
such as monocrotaline. The major initial sites of lung damage are the cells
lining the arteries, capillaries, and veins. Thrombi appear on the surface
of these

cells (Huxtable,

1979), which then

develop an

increased

permeability resulting in intraavleolar and interstitial edema and pleural
effusion (Plestina and Stoner, 1972). This is followed by focal necrosis of
the alveolar walls, changes in interstitial cells, endothelia and alveolar cell
proliferation, medial thickening and intim al hyalinosis of arteries and
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pulmonary arterial hypertension (McLean, 1970; Valdina et al.„ 1967;
Hayashi et al., 1984). There is a positive correlation between progressive
pulmonary hypertension, increased thickness of the wall of pulmonary
vessels and right ventricular hypertrophy (Ghodsi and Will, 1981).
The liver is the most prom inent target organ of pyrrolizidine alkaloids,
causing both acute and chronic liver toxicities. However, the lung is also
an im portant target organ, and the toxicity may result from activation at
a distant site, i.e., in the liver (Mattocks, 1972; 1973). The lung itself is
not capable of activating PA’s (Mattocks and White, 1971; Guengerich,
1977). Previous studies have shown th a t a toxic metabolite is produced in
the liver which may be responsible for the damage seen in both tissues
(Culvenor et al., 1976).

Toxic pyrrolizidine alkaloids are metabolized both in vivo and in vitro to
pyrrole derivatives which bind to macromolecular tissue constituents. The
pyrrole derivatives are potent alkylating agents, and their reactivity is
greatly enhanced by the presence of ester groups (Mattocks, 1972). These
ester groups are the most reactive sites, due to conjugation with the ring
nitrogen atom. The ester groups could be lost, leaving a positively charged
dihydropyrrolizine moiety which could react with nucleophilic groups such
as amines or thiols to form relatively stable alkylation products.

The in vitro characteristics of pyrrolic metabolite production m ediated by ra t
liver microsomes were studied by Mattocks and White (1970).

Pyrrole

formation required oxygen and NADPH, was inhibited by carbon monoxide
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and SKF-525A, and was increased in microsomes from phenobarbital
pretreated rats. This reaction was typical of a microsomal mixed function
oxidation.

This study showed th a t pyrrolic formation from pyrrolizidines

can be mediated by a cytochrome P-450 dependent microsomal activity.
Allen et al., (1972) showed th a t chronic phenobarbital treatm ent of rats
prior to adm inistration of monocrotaline considerably enhanced the pyrrolic
metabolite in the liver and lungs and potentiated acute pulmonary toxicity.
Phenobarbital did not induce ra t lung cytochrome P-450 enzymes, but it
greatly enhanced the in vitro production of pyrrolic derivatives from
monocrotoline in liver microsomes (Chesney et al., 1974). Chloramphenicol
treatm ent prior to adm inistration of monocrotalline markedly decreased both
tissue pyrrole concentrations and the acute pulmonary toxicity (Chesney et
al., 1974). Studies performed by Chesney et al., (1974), Allen et al., (1972),
and Huxtable et al., (1978) collectively provide good metabolic evidence th a t
pyrrolic metabolites are involved in causing acute monocrotaline-induced
lung toxicity in vivo and they also support the view th a t toxic metabolites
are produced primarily in the liver.

MECHANISMS OF TOXICITY OF PULMONARY TOXICANTS

According to previous studies by Boyd (1980), all of the acute specific
pulmonary toxicants in this review are affected by GSH concentration
(modulates toxicity).

GSH could possibly play a role in the metabolism of

these compounds. According to the review by Boyd (1980) there are three
potential mechanisms of lung toxicity by which metabolic activation could
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play an im portant role in their toxicity.

Mechanism I is comprised of a

reaction in which an "inert" parent compound is metabolized to a highly
reactive ultim ate toxin in situ in the lung. In mechanism II, the ultim ate
toxin is also a highly reactive metabolite of the parent compound, but
formed primarily in the liver and is transported to the lung by the
circulation. In mechanism III, the activated parent compound would only
participate indirectly in the toxic reaction. Presumably the activated oxygen
species (such as superoxide radicals and derivatives thereof) could act as the
ultim ate toxin(s) and/or the deficits in cellular energy metabolism and
defense mechanisms resulting from depletion of essential cofactors could lead
to pulmonary damage. The relatively high oxygen tensions in pulmonary
tissue could possibly contribute to preferential damage to lungs by agents
acting through mechanism III.

The pulmonary toxicities of 4-ipomeanol and 3-methylfuran are best
described by mechanism I. Lung damage (particularly bronchiolar necrosis)
by other furan derivatives and related compounds also occur by mechanism
I. Toxic thioureas may also cause lung damage by mechanism I. However,
because these compounds damage primarily the pulmonary vascular
endothelium and not bronchiilar cells or Type II pneumocytes, other
mechanisms of lung injury (such as mechanism II or possibly a mechanism
not involving metabolic activation) m ust be considered for the toxic
thioureas. The pyrrolizidine alkaloids appear to best exemplify compounds
causing lung damage by mechanism II.

The available evidence strongly

suggests th at the ultim ate toxic metabolites of these agents, which severely
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damage piolmonary vascular endothelium, are formed prim arily in the liver
and reach the lungs via the blood stream. P araquat is capable of causing
lung injury by redox cycling of paraquat in certain lung cells, which leads
to the consumption of cellular NADPH, and the "activation" of molecular
oxygen. The toxicological consequences of these effects are not certain, but
there

is

considerable

circum stantial

evidence

to

suggest

th a t

the

intracellular generation of superoxide and its derivatives (such as singlet
oxygen, H 2 0 2 and OH.) leads to cell damage by stim ulating the peroxidative
decomposition of cellular lipids. Nitrofurantoin (antibacterial drug) is also
capable of causing lung injury by mechanism III.

In conclusion, despite

decades of intensive research on specific pulmonary toxicants, the actual
mechanisms by which they produce lung toxicity are not known.

CHAPTER 3
EXPERIMENTAL GOALS AND DESIGN

The ultim ate goal of this study was to characterize the toxicity of 2thiotriazone (TTZ) and to determine the mechanism of toxic action of TTZ
in Spraque Dawley rats. This study included 5 experiments:

(1) EXPERIMENT 1 - ACUTE TOXICITY OF TTZ IN RATS.

The purpose of this study was to determine if TTZ was acutely toxic in
m ature and im m ature male and female rats. This study was designed to
determine both oral and intraperitoneal (ip) LDgo’s, to document all clinical
signs of intoxication, to determine if TTZ toxicity was age and sex
dependent, and to characterize changes in the lung (target organ) of treated
animals by macroscopic and histological examination.
(2)

EXPERIMENT 2 - INNATE AND DRUG INDUCED RESISTANCE
TO TTZ IN RATS.

To better understand variations in response to TTZ based on age and sex
differences in rats, both innate and drug induced resistance to TTZ was
studied.

This study was designed to characterize both innate and drug

induced resistance in m ature and im m ature rats (both sexes).

This was

accomplished by determ ining the age a t which susceptibility to TTZ
develops, if resistance was dose-dependent, how long resistance lasts, effect
of enzyme induction with (3-napthoflavone and phenobarbital on TTZ
32

33
toxicity, effect of enzyme inhibition with a-napthoflavone and SKF525A on
TTZ toxicity, effect of adm inistration of hormones (^-estradiol and tes
tosterone) on TTZ toxicity, if changes in estrous cycle affected TTZ toxicity
in female rats and the effects of N-acetyl-L-cysteine (glutathione precursor)
on TTZ toxicity in male rats.
(3)

EXPERIMENT 3 - EFFECT OF TTZ ON HEPATIC MICROSOMAL
AND CYTOSOLIC ENZYMES AND ENZYME ACTIVITIES IN RATS.

The purpose of this study was to determine if TTZ caused decreases or
increases in hepatic microsomal mixed function monooxygenase enzyme
systems and activities in m ature (male and female) and im m ature (male)
rats.

This study was designed to determine the effect of TTZ on:

cytochromes P-450 and b5, NADH cytochrome-b5 and NADPH cytochromeC-reductases, glutathione-S-transferase and UDP-glucuronosyltransferase.
Enzyme activities analyzed were aldrin epoxidase,

7

-ethoxycoumarin-O-

deethylase (ECOD) and 7-ethoxyresorufin-O-deethylase (EROD). The effect
of TTZ on P-napthoflavone and phenobarbital induced enzyme systems in
rats was also determined.
(4)

EXPERIMENT 4 - EFFECT OF TTZ ON HEPATIC AND PUL
MONARY GLUTATHIONE LEVELS IN RATS.

The purpose of this study was to determine if glutathione was involved in
the metabolism of TTZ. This was accomplished by dosing m ature male and
female rats with increasing concentrations of TTZ and determining if there
was a dose-dependent decrease in glutathione levels in liver and lungs of
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rats. Rats were administered diethylmaleate (DEM) which is a glutathione
depletor to determine if glutathione levels were actually depleted. Animals
were pretreated with diethylmaleate (DEM) and dosed with TTZ to
determine if glutathione levels were depleted more th an in animals
administered DEM alone. R ats pretreated with N-acetyl-L-cysteine (NAC),
which is a glutathione precursor and subsequently dosed with TTZ were
used to determine if glutathione levels were m aintained.
(5)

EXPERIMENT 5 - EFFECT OF GLUTATHIONE DEPLETION BY
DIETHYLMALEATE
(DEM)
AND
l-BUTHIONINE-(SR)-SULFOXAMINE (BSO) ON TTZ TOXICITY IN RATS.

The purpose of this study was to determine if DEM potentiates the toxicity
of TTZ in adult and im m ature ra ts (both sexes).

The effects of BSO

(specific inhibitor of GSH synthesis) on TTZ toxicity was also studied. This
study was designed to determine if toxicity was potentiated by pretreatm ent
with DEM or BSO, to document all clinical signs of intoxication, to
determine the effects of DEM pretreatm ent on age and sex dependent
variations in TTZ toxicity, and to characterize changes in the lung of
treated anim als by macroscopic and histological examination.

The effect

of DEM pretreatm ent on hepatic microsomal mixed function monooxygenase
enzyme systems (cytochromes P-450 and b6, NADH cytochrome-b5 and
NADPH cytochrome-C-reductases), glutathione-S-transferase, UDP-glucuronosyltransferase and enzyme activities (aldrin epoxidase, ECOD and EROD)
were also studied.

CHAPTER 4
SPECIFIC OBJECTIVES AND MATERIALS AND METHODS

EXPERIMENT 1 - ACUTE TOXICITY OF TTZ IN RATS
OBJECTIVES:
1.

To determine oral and intraperitoneal LDgo’s.

2.

To determine clinical signs of toxicity.

3.

To determine if toxicity is age or sex dependent.

4.

To determine the site of action or target organ.

MATERIALS AND METHODS:
A.

Chemical:

2-Thiotriazone (Fig.

1

) is a thiourea derivative with a molecular weight of

110 and 10% solubility in water.

It was obtained as a white crystalline

solid (97% pure) from the Triazone Corporation (Geismar, LA).

B.

Animals:

Adult (250-500g) and im m ature (60-180g) Sprague Dawley albino rats (male
and female) were obtained from Hilltop Lab Animals, Inc. (Scottdale, PA).
Food (Purina R at Chow) and w ater were allowed ad libitum . Rats were
housed in groups of three (3) in wire m esh bottom cages. The room where
the rats were kept was environmentally controlled a t 20-22 degrees C with
a 12 h r light/dark cycle. After seven (7) days of acclimatization, the rats
were randomly assigned to control and treatm ent groups.
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FIGURE 1: STRUCTURE OF 2-THIOTRIAZONE (TTZ)
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C.

LDm Studies:
1.

Oral Treatm ent:

A lOmg/ml solution of TTZ was prepared by adding O.lg of TTZ to 10ml of
distilled water. 2-Thiotriazone was administered via gavage with increasing
doses of 1.25, 2.5, 5 and 10 mg TTZ/kg body weight (bw) to adult male rats
(10 rats per group). Adult female rats were adm inistered doses of 2.5, 5,
10, 62.5, 100, 125, 250 and 1000 mg TTZ/kg bw.

A total of 10 rats per

treatm ent group were used except where noted. Im m ature rats (both sexes)
were administered doses of 10, 100 and 1000 mg TTZ/kg bw (10 rats per
group). Control rats (5 rats per group) were dosed with distilled w ater (10
ml/kg). Rats were observed closely for
24 hr. post-treatment.

6

hrs. a t 15 min. intervals and at

Clinical signs were documented as they occurred.

The total mortality within a 24 hr. period was documented and recorded for
LD5 0 determination. Surviving anim als were observed over a 7-day period
to document any delayed effects. Results were evaluated and LD,*, values
were calculated according to the method of Weil (1952).

Postmortem

examination

heart,

of liver,

kidney,

lung,

intestine,

stomach,

and

reproductive organs in affected anim als was conducted to determine the
toxic effects of TTZ and to establish the principle target organ.

2.

Intraneritoneal T reatm ent:

Acute toxicity was also studied following single ip injections of 1.25, 2.5 and
5 mg TTZ/kg bw to adult male rats

( 6

ra ts per group). Adult female rats

(5 rats per group) were adm inistered doses of 5, 10 and 100 mg TTZ/kg bw.
Im m ature rats (both sexes) were adm inistered doses of 10, 100 and 1000 mg
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TTZ/kg bw (10 rats each group).
m anner as for oral studies.

Responses were monitored in the same

Postmortem examination of affected animals

was also performed.

D.

Histological Exam ination:

Development of the onset of TTZ toxicity in the lung was monitored in adult
male and female rats (6 rats per group) by histological examination of lungs
taken from rats (adult male and female) exposed to TTZ (10 mg/kg ip) at
1 and 2 hrs. Control rats were dosed with distilled w ater (10 ml/kg bw)
and sacrificed 1 and 2 h rs later by a lethal injection of pentobarbital
(O.lml/kg bw ip). T reatm ent anim als were sacrificed in the same manner.
The lungs of both control and treated rats were perfused with fixative prior
to tissue collection. The trachea was intubated and the intratracheal tube
was sutured into place.

A m ixture of 1.25% glutaraldehyde and 2%

formaldehyde in 0.1M sodium cacodylate buffer pH 7.4 was infused slowly
through the tube via syringe (50 ml) into the trachea until the lungs
completely filled the thoracic cavity. After 5-10 min. the chest cavity was
opened and the lungs were removed, cut into small pieces (O.lg) and
immersed in the fixative solution.

Specimens were dehydrated in ethyl

alcohol, infiltrated with LKB basic resin (glycol m ethacrylate monomer,
polyethylene glycol 400 and hydroquinone) and activator (benzoyl peroxide
with 50% plasticizer) overnight or until the specimens sank to the bottom
of the vial.

They were then embedded in Historesin (LKB products AB,

Brommar, Sweden) which consists of basic resin, activator and hardener
(derivative of barbituric acid and DMSO) and sections were cut a t a
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thickness of 3-5pm with a microtome (LKB Brommar 2218 Historange).
Sections were then stained with hematoxylin and eosin, examined under a
Zeiss Photomicroscope III equipped with a MC63 photomicrographic camera
and photographed.

Tissue samples (liver, kidney, spleen, lungs, intestine and stomach) were
removed from anim als used in oral and ip LD5 0 studies for histological
examination.
for 24 hrs.

Samples were immersed in fixative ( 1 0 % buffered formalin)
After fixation the organs were dehydrated in ethyl alcohol,

embedded in paraffin, and sections were cut a t a thickness of 5-7um with
a microtome. Sections were then stained with hematoxylin and eosin and
examined with a photomicroscope.

E.

Organ weights and organ to body weight ratios:

The effect of TTZ on liver and lung weights was monitored as follows:
Adult (male and female) and im m ature (male) rats were randomly assigned
to control and treatm ent groups

( 6

rats per group).

The anim als were

administered a lethal dose of TTZ (10 mg/kg ip) and sacrificed after 1 hr.
The lungs and livers (possible sites of metabolism) were removed and
weighed to determine if TTZ caused a change (decrease and increase) in
the weights of these organs.
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EXPERIMENT 2 - INNATE AND DRUG INDUCED RESISTANCE TO TTZ
TOXICITY IN RATS:
OBJECTIVES:
1.

To determine the age a t which TTZ becomes toxic in male rats.

2.

To determine if resistance to TTZ is dose dependent.

3.

To determine how long rats rem ain resistant to TTZ after a
single exposure.

4.

To determine the effect of N-acetyl-L-cysteine (glutathione replenisher)
on TTZ toxicity.

5.

To determine the effect of p-napthoflavone (BNF) induction on TTZ
toxicity.

6.

To determine the effects of phenobarbital induction on TTZ toxicity.

7.

To determine the effect of BNF induction and a-napthaflavone (ANF)
inhibition on TTZ toxicity.

8.

To determine the effect of phenobarbital induction and SKF-525A
inhibition on TTZ toxicity.

9.

To determine the effect of hormones (p-estradiol and testosterone) on
TTZ toxicity.

10.

To determine the effect of changes in the estrous cycle on TTZ
toxicity.

MATERIALS AND METHODS:
A.

Chemicals:

p-Napthoflavone (BNF), P-estradiol and testosterone (4-androsten-17P-ol-3one) were

purchased

from

Sigma

Chemical

Co.

(St.

Louis,

MO).

Phenobarbital (sterile phenobarbital sodium, USP, 120 mg/vial) (Eli Lilly &
Co., Indianapolis, IN) was purchased from the Louisiana State University
School of V eterinary Medicine Pharmacy.

SKF-525A was a generous gift

of Smith, Klein, and French Laboratories, (Philadelphia, PA).

B.

Innate Resistance:

Im m ature rats (both sexes) were weighed and randomly assigned to control
and treatm ent groups (10 rats per group).

The control anim als were

administered distilled w ater (10 mg/kg ip) and treatm ent anim als were
administered TTZ (10 mg/kg ip) a t 30, 40, 45, 50 and 55 days of age.
Clinical signs and m ortality were observed and documented over a 24 hour
period.

C.

2-Thiotriazone Induced Resistance:

Adult male rats were weighed and randomly assigned to control and
treatm ent groups (3 ra ts per group except where noted). Control anim als
were administered distilled w ater (10 ml/kg ip) and treated anim als (12
groups) were administered a sublethal dose of TTZ (1 mg/kg ip). Animals
in treatm ent groups were subsequently reweighed and adm inistered a toxic
dose of TTZ (10 or 100 mg/kg) either orally or intraperitoneally (ip) a t 1, 2,
or 3 days, or 1, 2, 3, 4, 5, 6, 7, 8 or 9 weeks after adm inistration of the
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sublethal dose (1 group per time interval).

D.

Effect of N-acetvl-L-cvsteine on TTZ Toxicity:

Adult male control anim als (6 rats per group) were dosed with N-acetyl-Lcysteine (150 mg/kg ip) alone while treated anim als (6 ra ts per group) were
dosed with N-acetyl-L-cysteine (150 mg/kg ip) 30 minutes prior to
adm inistration of TTZ (10 mg/kg ip).

Clinical signs and mortality were

observed and documented over a 24 hour period. Postmortem examinations
were performed and tissue samples (lung and liver) were taken for
histological examination.

E.

Enzyme Induction:
1.

B-Napthoflavone (BNF) and Phenobarbital:

The cytochrome P-450 monooxygenase system of adult male rats (10 rats per
group) was induced by ip adm inistration of BNF (50 mg/kg/day in com oil)
or rats were induced by ip adm inistration of phenobarbital (60 mg/kg/day
in sterile water) for three (3) consecutive days.

Rats were administered

TTZ (10 mg/kg bw orally) 24 hours after the third dose.

Phenobarbital

control rats (3 per group) were adm inistered sterile w ater (60 mg/kg ip) and
BNF control ra ts (3 per group) were adm inistered com oil (50 mg/kg/day ip)
for three consecutive days. Clinical signs and m ortality were observed and
documented for 24 hours after adm inistration of TTZ.
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F.

Enzyme Inhibition:
1.

oc-Napthoflavone (ANF) and SKF-525A Inhibition:

Adult male rats (10 rats per group) were induced with BNF (50 mg/kg/day
in com oil); 24 hours later they were administered ANF (50 mg/kg in com
oil ip), 1 hour before dosing with TTZ (10 mg/kg orally). A separate group
of adult male rats (10 rats per group) were induced with phenobarbital (60
mg/kg in sterile w ater ip).

Twenty-four hours after the last dose of

phenobarbital, the rats were adm inistered SKF-525A (50 mg/kg in sterile
w ater ip), 1 hour before dosing with TTZ (10 mg/kg orally). Clinical signs
and

mortality

were

observed

and

documented for 24 hours

after

adm inistration of TTZ.

G.

B-Estradiol and Testosterone:

p-Estradiol (2 mg/kg) was adm inistered to adult male, female and im m ature
(both sexes) rats for 7 consecutive days. The rats were administered TTZ
(10 mg/kg ip) on the 8th day and were observed over a 24 hour period for
clinical signs and mortality. Testosterone (10 mg/kg ip) was administered
to adult female and im m ature of both sexes rats for 7 consecutive days and
TTZ (10 mg/kg ip) was administered on the 8th day. These anim als were
also observed for 24 hrs for abnorm al clinical signs or mortality.
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H.

Effect of Changes in the Estrous Cycle on TTZ Toxicity in Female
Rats:

Five groups of female rats (5 rats per group) were administered a lethal
dose of TTZ (62.5 mg/kg ip).

One group per day was administered the

compound for five consecutive days to determine if changes in response
(mortality) could possibly be related to changes in the estrous cycle
(hormone levels on different days).

In another experiment adult female

rats were assigned to E strus, M etestrus, Proestrus and Diestrus groups
based on a vaginal sm ear taken w ith a cotton swab moistened with distilled
water. A total of 10 anim als were analyzed for each group except where
noted. The anim als were adm inistered TTZ (10-2000 mg/kg) orally. Clinical
signs and mortality were observed and documented over a 24 hour period.
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EXPERIMENT 3 - EFFECT OF TTZ ON HEPATIC MICROSOMAL AND
CYTOSOLIC ENZYMES AND ENZYME ACTIVITIES:
OBJECTIVES:
1.

To determine the effect of TTZ on cytochromes P-450 and b5,
NADH

cytochrome-b5

and

NADPH

cytochrome-C-reductases,

glutathione-S-transferase, and UDP-glucuronosyltransferase in rats.
2.

To determine the effect of TTZ on aldrin epoxidase, 7ethoxyresorufin and 7-ethoxycoumarin-0-deethylase activities in rats.

MATERIALS AND METHODS:

A.

Chemicals:

Umbelliferone (99% pure) and 7-ethoxycoumarin (99% pure) were purchased
from Sigma Chemical Co. (St. Lotus, MO).

7-Ethoxyresorufin (98% pure)

was purchased from Molecular Probes, Inc. (Junction City, OR). Resorufin
(75% dye content) was obtained from Aldrich Chemical Co., Inc. (Milwaukee,
WI). Aldrin (99.4% pure) and dieldrin (99.8% pure) were obtained from the
EPA (Research Triangle Park, NC). All other chemicals were of analytical
grade or better and were obtained from commercial sources.

B.

Animals:

Adult (male and female) and im m ature (male) rats were weighed and
randomly assigned to control and treatm ent groups (3 rats per group).
Control animals were adm inistered distilled w ater (10 ml/kg ip) and
sacrificed by decapitation at 1 hour post-dosing. Corresponding groups of
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adult (male and female) and im m ature (male) anim als were administered
TTZ (10 mg/kg ip) and sacrificed a t 1 hour post-dosing. In a separate set
of experiments adult male rats were induced either by adm inistration of
BNF (50 mg/kg in com oil ip) or adm inistration of phenobarbital (60 mg/kg
in sterile w ater ip) for 3 consecutive days and sacrificed 24 hours later
(controls n=3). Similarly induced anim als were adm inistered TTZ (10 mg/kg
ip) 24 hours after the last dose of BNF or phenobarbital and sacrificed at
1 hour post-dosing of TTZ (treatm ent groups n=3).

C.

Preparation of Hepatic Microsomes:

Animals were weighed and sacrificed by decapitation.

Their lives were

removed, weighed and placed on ice in 1.15% KCI (buffered with 0.1M
potassium phosphate buffer to pH 7.4).

Microsomes were prepared from

pooled livers of 3 anim als per group (treated and control). The livers were
minced, rinsed in phosphate buffer and homogenized in 4 volumes of icecold Tris buffer (10 mM Tris; 0.25M sucrose, and 1.0M disodium EDTA, pH
7.4). Homogenization was accomplished by using 4 to 5 passes of a motor
driver Potter-Elvehjem type homogenizer w ith teflon tip. The homogenate
was centrifuged a t 600g for 10 m in and the supernatant was saved. This
supernatant was then centrifuged a t 8,000 g for 10 m inutes and the
supernatant was decanted and saved. This supernatant was then centrifuged
a t 14,500 g for 10 m inutes and the resulting supernatant, containing the
microsomal fraction, was retained. The microsomes were pelleted by
centrifugation a t 105,000 g for 60 minutes. All centrifugation steps were
conducted a t 4 degrees C. This final supernatant was saved for glutathione-
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S-transferase

analysis.

The

microsomal

pellet

was

washed

by

homogenization in 1 volume of 0.125M KC1 (buffered with 0.1M potassium
phosphate buffer to pH 7.4). Homogenization was carried out by using 23 passes of a hand held glass pestle and tube homogenizer. The homogenate
was brought to the original volume with 0.125M KC1 (pH 7.4) and
centrifuged again a t 105,000g for 60 minutes a t 4 degrees C.

The

microsomal pellet was resuspended by homogenization with a glass pestle
and tube homogenizer in 1 volume 0.125M KC1 in 20% glycerol to give a
protein concentration of 20-50 mg protein/ml.

The final suspension was

stored a t -70°C until used. This microsomal suspension was used for assays
of cytochromes P-450 and b5, NADH cytochrome b5 and NADPH cytochromeC-reductases,

UDP-glucuronosyltransferase,

glutathione-S-transferase,

aminopyrine-N-demethylase, aldrin epoxidase, 7-ethoxyresorufin-0-deethylase
and 7-ethoxycoumarin-0-deethylase.

D.

Protein Determ ination:

Microsomal protein concentration was determined according to the method
of Lowry et al., (1951). Protein standards were prepared in duplicate from
stock bovine serum albumin (1 mg/ml) a t concentrations of 0, 10, 20, 30, 40,
50 and 60 ug/ml, pipetted into clean glass test tubes and brought to a
volume of 0.1 ml. Microsomal samples (duplicate) were diluted 1:100 and
0.1 ml pipetted into clean glass test tubes. To both standard and sample
tubes was added 2.0 ml of buffer (2% sodium potassium ta rtrate (1.0 part)
+ 1% CuSo4 - 7H20 (1.0 part), 100 parts Na2C 0 3 (2%) + NaOH (0.4%). Each
tube was mixed by vortexing and incubated for 10 m inutes a t room
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tem perature. To each tube 0.2ml of Folin reagent (2N phenol solution) was
added with mixing.

After incubating for 30 m inutes the absorbance was

measured a t 750 nm in a Shimadzu UV-visible spectrophotometer (UV 160, Kyoto, Japan). A standard curve was constructed from the standards
and the concentration of protein in the samples were determined from the
standard curve.

E.

Cytochrome P-450:

The microsomal content of cytochrome P-450 was determined by the method
of Omura and Sato (1964). Microsomes (125ul) were added to 2.375 ml of
0.1M

potassium

phosphate

buffer

(pH

7.4)

in

glass

test

tubes.

Approximately O.lg (tip of small spatula) of sodium dithionite was added to
the tubes and mixed by inverting. The m ixture was divided into two 1.0
ml plastic cuvettes (10 mm path length).

The cuvettes were placed into

the spectrophotometer and a baseline was recorded between 350-490 nm.
The sample was saturated with 30-40 bubbles of carbon monoxide (CO) a t
a rate of about 1 bubble/second. The sample cuvette was returned to the
spectrophotometer and the difference spectra was recorded a t 350-490nm.
A peak usually occurred between 447-450nm. The microsomal content of
cytochrome P-450 was determined from the difference in absorbance of the
carbon monoxide complex of reduced cytochrome P-450 and the spectral
contribution of reduced cytochrome P-450.

The change in absorbance at

450nm relative to 490nm was then converted to specific content of
cytochrome P-450 using a molar extinction coefficient of Olm M 1 cm'1
(Haugen and Coon, 1976; Ryan et al., 1975). Cytochrome P-450 content was
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determined utilizing the following formula:

[(A450-490) observed - (A450-

490) baseline]/9 ImM'1 cm'1 = nmole P-450/volume of microsomes used
[protein concentration (mg/ml)]. The final concentration was expressed as
nmole cytochrome P-450/mg microsomal protein.

F.

Cytochrome Be:

The microsomal content of cytochrome b5 was also determined by the
method of Omura and Sato (1964). Microsomes (125ul) were added to 2.375
ml of potassium phosphate buffer (0.1M, pH 7.4) in glass test tubes.
Samples were mixed and divided into two 1.0 ml plastic cuvettes (10 mm
path length) and the cuvettes were placed into the spectrophotometer
(Shimadzu UV-visible) and a baseline recorded between 350 and 490 nm.
The sample cuvette was removed and 5 ul of freshly prepared NADH (30
mg/ml)

was

added,

mixed

by

inversion,

placed

back

into

the

spectrophotometer, and scanned from 350-490 nm. A peak usually appeared
a t 426 nm and a valley a t 409 nm. The concentration of cytochrome b5 in
the microsomal suspension was determined from the NADH-reduced
difference spectrum by using the millimolar extinction coefficient of 185 mM
1 cm'1 for the absorbance difference between 426-409 nm.

Cytochrome b5

content was determined utilizing the following formula: [(A426-409) observed
- (A426-409) baselinej/lSSmM'1 cm'1 = nmole cytochrome bs/volume of
microsomes used [protein concentration (mg/ml)]. The final concentration
was expressed as nmole cytochrome h jxa g microsomal protein.
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G.

NADH cvtochrome-h. and NADPH Cvtochrome-C-Reductases:

Reductase activities were assayed using the method of Phillips and Langdon
(1962) as modified by Yasukochi and M asters (1976).

The rate of

cytochrome C reduction was followed spectrophotometrically a t 550 nM. The
reaction mixture consisted of 2.5 ml of cytochrome C solution (31 mg
cytochrome C; 17 ml of 1M potassium phosphate buffer (pH 7.4) diluted to
50 ml with triple distilled water). The cytochrome C solution was brought
to room tem perature before use.

The microsomal suspension was diluted

1:10 with 0.125M KC1 and 5 ul was delivered into 4.0 ml plastic cuvettes
containing 2.5 ml of cytochrome C solution. Reference and sample cuvettes
were placed into the spectrophotometer and automatically balanced a t zero.
The sample cuvette was removed and 10 ul of NADH (10 mg/ml) was
added,

the

solution

mixed

by

inversion,

and

returned

to

the

spectrophotometer. The spectrophotometer was programmed in the kinetic
mode and the reaction was monitored at 550 nm for 195 seconds.

The

specific activity of NADH cytochrome-b5-reductase was determined from
AA/min using the millimolar extinction coefficient 29.5 mM'1 cm'1 for
cytochrome C. Reductase activity = [AA/min] [2.5] [1000]/29.5 [0.005]: where
2.5 = volume in cuvette, 1000 = conversion factor to nmoles, 29.5 =
millimolar extinction coefficient and 0.0005 = vol. of microsomes. Final units
were

expressed

as

nmoles

cytochrome-C/min/mg

protein.

NADPH

cytochrome-C-reductase activity was determined in the same m anner, except,
NADPH was used instead of NADH.
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H.

UDP-Glucuronos vltransferase:

UDP-glucuronosyltransferase (UDPGT) was assayed according to the method
of Burchell and WeatheriU (1981). The reaction mixture consisted of 20mM
UDP-glucuronic acid (UDPGA), pH7.4 (75ul); Tris m aleate buffer/4nitrophenol pH 7.4 which consists of: ImM 4-nitrophenol; 9.5M tris-m aleate
and

10 mM MgCl2 (125ul); distilled w ater (25ul); and microsomal

preparation (25ul). The reaction m ixture was added to both blank (0 min.)
and reaction (10 min.) tubes. The reaction tubes were placed into a w ater
bath a t 37 degrees C to equilibrate for 5 minutes. The reaction was then
initiated by the addition of 75 ul of UDPGA. After incubation a t 37 degrees
C for 10 m inutes the reaction was term inated by the addition of 0.5 ml of
ice-cold 0.5M trichloroacetic acid (TCA).

The reaction tubes were then

placed on ice for 5 minutes. The blank tubes were placed on ice and 75 ul
of UDPGA was added to the tubes after precipitation of proteins by the
addition of 0.5M TCA (0.5ml). All tubes were centrifuged a t 2000xg for 10
minutes. A 400ul aliquot of the supernatant was removed from each tube
and added to a second tube containing 400 ul of 2M NaOH, followed by the
addition of 2.2 ml of distilled water. The tubes were centrifuged again a t
2000g for 10 minutes and the absorbance of the supernatant was m easured
a t 405 nm against a distilled w ater blank in order to assess the reduction
in color (4-nitrophenol) caused by the formation of colorless product (4nitrophenolglucuronide). The molar extinction coefficient of 4-nitrophenol a t
pH > 10 is 18.1 x 103/mol-cm.

Final units were expressed as nmole p-

nitrophenol conjugated/min/mg microsomal protein.
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I.

Glutathione-S-Transferase:

Glutathione-S-transferase was determined by the method of Habig et al.,
(1974). Microsomal supernatant was diluted 1:50 with 0.125M KC1 and 50
ul was delivered into 4.0 ml plastic cuvettes containing a m ixture of
potassium phosphate buffer (0.2 M monobasic pH 6.5) 1.5ml, 1.34ml of triple
distilled w ater and lOOul of reduced glutathione (30mM).

Reference and

sample cuvettes were placed into the spectrophotometer and automatically
balanced a t zero. The sample cuvette was removed and 10 ul of substrate
(300 mM l-chloro-2, 4-dinitrobenzene dissolved in ethanol) was added, mixed
by inversion and placed into the spectrophotometer which was programed
in the kinetic mode. Changes in absorbance were monitored a t 340 nm for
32 seconds and the specific activity of glutathione-S-transferase was
calculated from AA/min using the millimolar extinction coefficient 9f 9.6
m M 1 cm'1 for the formation of the glutathione conjugate.
transferase activity was calculated using the formula:

Glutathione-S-

activity = AA/min

[3.0][1000]/9.6 [0.05]: where, 3.0 = volume in cuvette, 1000 = conversion
factor to nmoles, 9.6 = millimolar extinction coefficient and 0.05 = volume
of microsomes.

Final units were expressed as nmoles l-chloro-2, 4-

dinitrobenzene conjugated/min/mg microsomal protein.

J.

Aldrin Epoxidase:

Aldrin epoxidase activity was determined from the am ount of dieldrin
produced as described by Riviere (1985) with modifications. The reaction
mixture contained 50mM potassium phosphate buffer (pH 6.8), 0.25 mM
NADP + 2.5mM glucose-6-phosphate, 1 I.U/ml of glucose-6-phosphate
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dehydrogenase, 50uM aldrin, 2 mg/ml microsomal protein and triple distilled
w ater to a final volume of 1 ml in glass screw cap test tubes (13 x 100
mm).

Microsomes were usually diluted 1:10 (female rats) or 1:20 (male

rats).

Incubation was carried out under air in a constant tem perature

shaker bath a t 37° C for 15 m inutes.

The reaction was initiated by the

addition of aldrin (0.1 ml) and stopped by the addition of acetone (0.2 ml).
Five milliliters of iso-octane (2,2,4-trimethylpentane) were added to the
tubes. The tubes were then capped and vortexed for 45 seconds. Dieldrin
standards (0.01, 0.05, 0.1, 0.5 and 1.0 ppm) were prepared in iso-octane.
Aliquots (1.0ml) were removed from the sample and standard tubes and
pipetted into sample vials.

The samples were then subjected to gas

chromatography. Dieldrin was quantified using a Hewlett Packard 5880A
chromatograph equipped with an ECD detector (63Ni) using a Quadrex
column (15m long, 0.53mm ID, phase 007-17) (Quadux Corp. New Haven,
CT). The column detector and injector port tem peratures were 220-240°C
(10 °/min), 300°, and 180 °C, respectively.

The injection of samples was

made in the splittess mode using a direct flask injection liner. The carrier
gas was 5% m ethane in argon a t a flow rate of 11 ml/min. C arrier gas was
also used for detector make-up to a total flow of approximately 30 ml/min.
The amount of dieldrin in the extract was quantitated by peak area from
the standard curve.
formula:

Aldrin epoxidase activity was calculated using the

activity = [ppm dieldrin formed] [.005]/380,100 mg/ 15 m in/ mg

protein/ml, where .005 = molar concentration of aldrin; 380,100 mg = 1
mole of dieldrin.

Final units

formed/min/mg protein.

were expressed as nmoles dieldrin
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K.

7-Ethoxvcoumarin (ECOD):

The deethylation of 7-ethoxycoumarin was m easured fluorometrically by the
method of Lake (1987), using an Aminco Bowman spectrofluorometer, model
J4-896 1A (Silver Springs, Maryland). This assay was carried out a t 37°C
for 10 m inutes under air. The reaction m ixture contained 50 mM Tris HC1
buffer pH 7.8 (1.0 ml); 5 mM MgS04 (0.1 ml); 0.5 mM NADH (0.1 ml);
5mM NADPH generating system which consisted of 10 ul glucose-6phosphate dehydrogenase (2000 I.U.) and 1.0 ml of glucose-6-phosphate
(lOOuM) (0.1 ml); 0.5 mM 7-ethoxycoumarin (0.5ml), microsomal preparation
(equivalent to 2-3 mg protein ) (10 ul); and triple distilled w ater (0.1 ml)
in a final volume of 2 ml. This reaction was initiated w ith the addition of
substrate and term inated by the addition of 1 ml of zinc sulfate solution (5
% w/v) followed by the addition of 1 ml of barium hydroxide solution. The

tubes were centrifuged a t 2000g to remove precipitate. A 1.5 ml aliquot of
the supernatant was removed and added to 3 ml of 0.5M glycine sodium
hydroxide buffer pH 10.5.

7-Ethoxycoumarin-O-deethylase activity was

m easured by fluorescent emission (380 nm excitation, 452 nm emission) and
compared to an umbelliferone (7-hydroxycoumarin) standard (4.0 nM).
ECOD activity was calculated according to the formula: activity = standard
concentration (nmole) / standard AOD [1/10 min] [sample AOD]/mg
protein/ml.

Final units were expressed as nmoles 7-hydroxycoumarin

formed/min/mg microsomal protein.
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L.

7-Ethoxvresorufin-O-deethvlase (EROD):

The EROD assay was also carried out a t 37° C for 10 m inutes under air
and contained all of the above components in the reaction m ixture except
th a t 5mM 7-ethoxyresorufin (0.2ml) was used for the substrate and
microsomal protein concentration was 0.3-0.5 mg/ml.

The reaction was

initiated by the addition of substrate and term inated in the same m anner
as ECOD. The tubes were centrifuged a t 2000g to remove precipitate. A
1.5 ml aliquot of the supernatant was removed and added to 3 ml of 0.5M
glycine sodium hydroxide buffer (pH 8.5). EROD activity was m easured by
fluorescent emission (535 nm excitation, 582 nm emission) and quantitated
with 7-hydroxyresorufin as a standard (1000 pmoles). EROD activity was
calculated using the formula:

activity = standard concentration (pmole) /

standard AOD [1/10 min] [sample AOD]/mg protein/ml.

Final units were

expressed as pmoles resorufin formed/min/mg microsomal protein.
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EXPERIMENT 4 - EFFECT OF TTZ ON HEPATIC AND PULMONARY
GLUTATHIONE CONCENTRATIONS IN RATS

OBJECTIVE:
1.

To determine the effect of TTZ on glutathione concentration in the
liver and lung of male and female rats.

MATERIALS AND METHODS:

A.

Chemicals:

Glutathione (reduced form), maleic acid dimethyl ester (dimethyl maleate)
and N-acetyl-L-cysteine were purchased from Sigma Chemical Co. (St. Louis,
MO).

All other chemical were of analytical grade or better and were

obtained from commercial sources.

B.

Glutathione Determ ination:

Glutathione was determined according to the method of Mitchell et al (1973)
as modified by Droy (1987).

Glutathione content was analyzed in adult

male and female ra ts (3 ra ts per group).

All anim als were dosed

intraperitoneally and sacrificed by decapitation a t 1 hour post-dosing.
Control animals were administered distilled w ater (10 ml/kg) and treated
anim als were administered TTZ a t doses of 1.25, 2.5, 5 and 10 mg/kg.
Diethylmaleate (DEM) control anim als were administered DEM (485 mg/kg)
alone, and DEM-TTZ treated anim als were administered DEM (485 mg/kg)
30 minutes prior to dosing with TTZ (10 mg/kg). N-Acetyl-L-cysteine control
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animals were administered N-acetyl-L-cysteine (150 mg/kg) and N-acetyl-Lcysteine + TTZ treated anim als were administered N-acetyl-L-cysteine (150
mg/kg) minutes prior to dosing with TTZ (10 mg/kg).

Livers and lungs were removed from each of the anim als and quick frozen
in liquid nitrogen.

Duplicate sample pieces weighing approximately O.lg

were broken off from frozen liver and lung tissues, placed on ice in 2ml of
2% sulfosalicylic acid and homogenized using a Tekm ar tissue homogenizer.
The homogenate was centrifuged a t 10,000g for 15 m inutes. Fifty microliter
aliquots of the supernatant were added to cuvettes containing 1 ml of 0.1M
phosphate buffer (pH 7.4; 10 ml 0.2M monobasic sodium phosphate, 81 ml
0.2M dibasic sodium phosphate, diluted to 200 ml with distilled water).
Standards were prepared by adding 1ml of 2mM reduced glutathione stock
to 1 ml of distilled w ater (1000 uM standard).

O ther standards were

prepared by diluting the stock glutathione (lOOuM and 500uM). A 20 ul
aliquot of 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) (0.4M in phosphate
buffer pH 7.4), was added to each tube, mixed and incubated for 15 m inutes
a t room tem perature (22-25 degrees C).

Absorbances of samples and

standards were m easured a t a wavelength of 400 nm on a Shimadzu UV
visible spectrophotometer and the date recorded.
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EXPERIMENT 5 - EFFECT OF GLUTATHIONE DEPLETION BY
DIETHYLMALEATE (DEM) AND L-BUTHIONINE-(SR)SULFOXAMINE (BSO) ON TTZ TOXICITY IN
RATS

OBJECTIVES:
1.

To determine the effect of DEM and BSO on TTZ toxicity in rats.

2.

To determine the effects of DEM and BSO on resistance to TTZ in
rats.

3.

To determine the effect of DEM on microsomal mixed function
monooxygenase enzyme systems and enzyme activities in rats.

MATERIALS AND METHODS:

A.

Effect of Diethvlmaleate (DEM) and L-buthionine(SR)-sulfoxamine (BSO) on TTZ Toxicity in Rats:

Male rats were administered DEM (485 mg/kg ip) 30 m inutes prior to
adm inistration of TTZ a t doses of 1 and 5 mg/kg ip (10 anim als per group).
Control anim als were adm inistered DEM (485 mg/kg ip) only. A separate
group of male rats was also adm inistered BSO (1,786 mg/kg ip) 30 minutes
prior to adm inistration of TTZ a t doses of 1-5 mg/kg ip (3 rats per group).
Female ra ts were adm inistered DEM in the same m anner as male rats
except th at TTZ was adm inistered a t concentrations of 0.5, 1, 1.25, 2.5, 5,
and 10 mg/kg ip (6 rats per group). Im m ature ra ts (both sexes) were also
administered DEM (485 mg/kg ip) 30 m inutes prior to adm inistration of

TTZ a t concentrations of 1 and 10 mg/kg ip a t 30 and 40 days of age (10
rats per group).

The anim als were observed over a 24 hour period and

clinical signs and m ortality were documented.

Postmortem examinations

were performed and samples of lung and liver were taken for histological
examination.

In a separate treatm ent, adult (male and female) and

im m ature (male) rats (6 per group) were administered DEM (485 mg/kg ip)
30 m inutes prior to dosing TTZ (10 mg/kg ip) and sacrificed 1 hour postdosing with TTZ. Livers and lungs were removed and weighed to determine
if TTZ had an effect on organ weights.

B.

Diethvlmaleate (DEM) and L-Buthionine-(SR)Sulfoxamine (BSO) effects on Resistance in Adult
Male R ats:

Male rats (6 per group) were adm inistered a sublethal dose of TTZ (1
mg/kg). Twenty-four hours later the same anim als were adm inistered DEM
(485 mg/kg ip), 30 m inutes prior to adm inistration of TTZ (10 mg/kg ip).
A separate group of m ature male ra ts (3 rats per group) received a
sublethal dose of TTZ (1 mg/kg) and 24 hours later they were administered
BSO (1,786 mg/kg), 30 m inutes prior to dosing them w ith TTZ (10 mg/kg
ip). The anim als were observed over a 24 hour period and clinical signs
and m ortality were documented,

p-napthoflavone induced resistant male

rats had been administered BNF (50 mg/kg in com oil ip) for three
consecutive days and 24 horn’s after the last dose of BNF they were
administered DEM (485 mg/kg) or BSO (1,786 mg/kg ip) 30 m inutes prior
to dosing with TTZ (10 mg/kg ip). The anim als were observed in the same

60
m anner as for TTZ resistant animals.

Postmortem examinations were

performed on all animals.

C.

Effect of Diethvlmaleate (DEM) and 2-Thiotriazone
(TTZ) on Hepatic Microsomal and Cytosolic Enzymes

Adult (male and female) and im m ature (male) rats were administered DEM
(485 mg/kg) 30 m inutes prior to adm inistration of a lethal dose of TTZ (10
mg/kg ip).

The anim als were sacrificed by decapitation 1 hour after

exposure of TTZ.

Their livers were removed, weighed and placed on ice

in ice-cold 1.15% KC1 buffered to pH 7.4 with 0.1M potassium phosphate
buffer.

Microsomes were isolated from the livers according to methods

described previously. Control anim als were dosed with DEM (485 mg/kg ip)
and sacrificed after 1 hour. Animals induced with (3-napthoflavone (BNF)
or phenobarbital (PB) were administered DEM (485 mg/kg ip) and 24 hours
following the last dose of BNF or PB and sacrificed 1 hour after dosing of
DEM. Microsomes were again prepared as previously described. All groups
contained three animals and livers were pooled from all three animals. The
following enzyme systems were analyzed in male, female and im m ature
(male) rats:

cytochromes P450 and b5, NADH cytochrome-b5 and NADPH

cytochrom e-C -reductases,

g lu tath io n e-S -tran sferase,

and

UDP-

glucuronosyltransferase. Enzyme activities analyzed were aldrin epoxidase,
EROD and ECOD.

D.

STATISTICAL ANALYSIS:

Analysis of variance (general linear model) and Duncan’s multiple range
post test was used to determine the differences due to treatm ents with TTZ
and DEM-TTZ in combination on ra t liver and lung weights, liver to body
weight ratios, and lung to body weight ratios; to compare the effects of TTZ
and DEM-TTZ in combination on enzymes (cytochromes P-450 and
reductases, UDP-glucuronosyltansferases, and glutathione-S-transferase) and
enzyme activities (aldrin epoxidase, EROD and ECOD) in rats; and to
compare the effects of TTZ and DEM-TTZ in connection on hepatic and
pulmonary glutathione (GSH) concentrations (including diethylmaleate and
N-acetyl-L-cysteine effects) in rats. Differences were considered significant
a t the p < 0.05 level (Steel and Torrie, 1980).
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TABLE 1
DESCRIPTION OF GROUPS AND TREATMENTS FOR LD50 STUDIES.
Group
No.
1

Description

Route
of exposure

TTZa
(mg/kg)

Male

Oral

Number
per group

1.25

10

(i

it

ii

2.5

10

ii

ii

ii

5

10

II

ii

ti

10

10

ii

2.5

5

5
10

5
10

2

Female

it

it

ii

•i

it

it

ll

ti

it

62.5

10

li

it

it

100

10

ii

it

n

125

10

ii

ii

n

250

10

tl

ii

ii

1000

10

10

10

3

n

Im mature
(Male and Female)

it

ii

ii

100

10

ii

ii

ii

1000

10

4

1.25

6

ll

ii

ii

2.5

6

it

ii

it

5

6

Male

Intraperitoneal

5

Female

ii

5

6

ii

ii

ii

10

5

it

ii

it

100

Im m ature

it

10

5
10

6

(Male and Female)
ii

ii

ii

100

10

it

ii

ii

1000

10

All anim als were observed over a 24 h r period.
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TABLE 2
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF
EFFECT OF AGE ON TTZ TOXICITY IN RATS.
Group No.
la

Description

TTZ0 (mg/kg)

Age (days)

Im m ature Male

10

30

2a

ii

ll

40

3a

it

ti

45

4a

it

ti

50

5a

it

ll

55

6a

Im m ature Female

n

30

7a

ii

it

40

8a

ti

ii

45

9a

it

ll

50

10a

it

it

55

“ Administered via ip injection in distilled water.

TABLE 3
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF TTZ
INDUCED RESISTANCE IN RATS8.
Group
No.
lb

Redosing time
(days,weeks)
1 day

Route of exposure
Subgroup b
Subgroup c
Oral

Intraperitoneal

Second dose
TTZ (mer/k£?)b
10

it

tt

100

tt

tt

10

ti

n

100

tt

it

10

tt

it

100

tt

ti

tt

tt

10
100

tt

ti

10

5c

it

tt

100

6b

tt

tt

10

tt

ti

100

tt

tt

10

7c

tt

tt

100

8b
8c

5"

tt

tt

10

tt

tt

100

9b

6”

tt

ti

10

9c

it

tt

100

10b

tt

tt

10

ti

100

tt

it

10

11c

tt

tt

100

12b

tt

tt

tt

it

10
100

lc
2b

2"

2c
3b

3"

3c
4b
4c

1 week

5b

2"
3"

6c
7b

4"

7"

tt

10c
lib

12c

8"
9"

'

8 All rats received TTZ a t a dose (sublethal) of 1 mg/kg (ip) on day 1.
b Lethal dose administered in distilled w ater a t redosing time shown.
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TABLE 4
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF
EFFECT OF N-ACETYL-L-CYSTEINE (NAC) ON TTZ TOXICITY.

Group No.

Group Name

NAC8 (mg/kg)

Id

NAC-Control

150

_

2d

NAC - TTZ

150

10

8 Administered via ip injection in distilled water.

TTZ8 (mg/kg)

TABLE 5
DESCRIPTION

OF

GROUPS

AND

TREATMENTS

FOR

ENZYME

INDUCTION AND INHIBITION STUDY.

Group

Group

TTZa

No.

Name

(mg/kg)

Enzvme modifiers(mg/kg/dav)
PBb

BNFC

le

BNF-Control

2e

PB-Control

-

60

-

3e

BNF-TTZ

10

-

50

4e

PB-TTZ

10

60

-

5e

BNF-ANF-TTZ

10

-

50

6e

PB-SKF-TTZ

10

60

ANFd

SKFe

50

_

50
50

a Administered via gavage in distilled water.
b Phenobarbital sodium administered via ip injection in sterile water.
' J3-Napthoflavone administered via ip injection in corn oil.
d a-Napthoflavone administered via ip injection in com oil 1 h r prior to
oral gavage with TTZ.
e SKF-525A administered via ip injection in distilled w ater 1 h r prior to
oral gavage with TTZ.
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TABLE 6
DESCRIPTION OF GROUPS AND TREATMENTS FOR 13-ESTRADIOL AND
TESTOSTERONE STUDY.

Group

Group

TTZfl

13-Estradiolb

Testosterone"

No.

Name

(mg/kg)

(mg/kg)

If

Male

10

2

_

2f

Female

10

2

-

3f

Im mature

10

2

-

4f

Male

10

-

10

5f

Female

10

-

10

6f

Im mature

10

-

10

(mg/kg)

a All rats were administered TTZ in distilled w ater via ip injection on day
8.
b 13-Estradiol (2mg/kg) adm inistered in distilled w ater via ip injection for
days 1-7.
c Testosterone (10 mg/kg) adm inistered in distilled water via ip injection
for days 1-7.
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TABLE 7
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF THE
EFFECT OF CHANGES IN THE ESTROUS CYCLE ON TTZ TOXICITY IN
RATS.
Group

Group

No.

Name

lg

E strus

10

62.5

100

1000

2000

2g

M etestrus

10

62.5

100

1000

2000

3g

Proestrus

10

62.5

100

1000

2000

4g

Diestrus

10

62.5

100

1000

2000

TTZa (mg/kg)

a Administered via ip injection in distilled water.

TABLE 8
DESCRIPTION OF GROUPS AND TREATMENTS FOR ENZYME STUDY.

Group

Group

TTZa

No.

Name

(mg/kg)

Enzvme modifiers (mer/kg/dav)
BNFb

PBC

lh

Male-Control

_

_

lh

Male-TTZ

10

-

2h

Male-BNF-Control

-

50

2h

Male-BNF-TTZ

10

50

3h

Male-PB-Control

-

60

3h

Male-PB-TTZ

10

60

4h

Female-Control

-

-

4h

Female-TTZ

10

-

5h

Immature-Male-Control

-

-

5h

Immature-Male-TTZ

10

-

a Administered via ip injection in distilled water.
b 13-Napthoflavone administered via ip injection in corn oil
c Phenobarbital sodium adm inistered via ip injection in sterile water.

TABLE 9
DESCRIPTION OF GROUPS AND TREATMENTS
GLUTATHIONE DETERMINATION STUDY.
Group
No.

Group
Name

TTZ“

DEMb

(mg/kg)

(mg/kg)

FOR

THE

NACC
(mg/kg)

Ii

Male Control

.

.

m

2i

Male TTZ1

1.25

-

-

3i

Male TTZ2

2.5

-

-

4i
5i

Male TTZ3

5

-

-

Male TTZ4

10

-

-

6i

Male DEM Control

-

485

-

7i

Male DEM-TTZ

10

485

-

8i

Male NAC Control

-

-

150

9i

Male NAC-TTZ

10

-

150

lOi

Female Control

-

-

-

Hi

Female TTZ1

1.25

-

-

12i

Female TTZ2

2.5

-

-

13i

Female TTZ3

5

-

-

14i

Female TTZ4

10

-

-

15i

Female DEM Control

-

485

-

16i

Female DEM-TTZ

10

485

-

17i

Female NAC Control

-

-

150

18i

Female NAC-TTZ

10

-

150

a 2-Thiotriazone administered via ip injection in distilled water.
b Diethylmaleate administered via ip injection 0.5 h r prior to ip injection
of TTZ.
0 N-Acetyl-L-cysteine administered via ip injection in distilled w ater 0.5 hr
prior to ip injection of TTZ.
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TABLE 10
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF
DIETHYLMALEATE (DEM) AND L-BUTHIONINE-(SR)-SULFOXAMINE
(BSO) EFFECTS ON TTZ TOXICITY IN RATS.
Group
No.
lj
2j
3j
4j
5j
6j
7j
8j
9j
10j
llj
12j
13j
14j
15j
16j
17j
18j
19j
20j
21j

Group
Name

Test comDounds (mer/ke)
TTZa
DEMb
BSOb

Male

485

.

ti

it

ti

ti

ii

ii

Female
ti

ti

tt

it

ii

Im m ature male
(30 day old)
tt

Im m ature male
(40 day old)
ti

Im m ature female
(30 day old)
ti

Im m ature Female
(40 day old)
tt

-

-

1
5
1
5
1
0.5
1
1.25
2.5
5
10

485
485
-

-

970
485
485

-

-

1,786
1,786
-

-

-

ii

ii

it
ti
-

1
10

485

1
10

tt

1
10

ll

1
10

1,786

ii

-

.

it
-

ti
-

ti

.

ti
-

a 2-Thiotriazone administered via ip injection in distilled water.
b Diethylmaleate and L-buthionine-(SR)-sulfoxamine administered via ip
injection 0.5 h r prior to ip injection of TTZ.

TABLE 11
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF EFFECTS OF DIETHYLMALEATE
(DEM) AND L-BUTHIONINE-(SR)-SULFOXAMINE (BSO) ON RESISTANCE.

Group

Group

No.

Name

Day 1
TTZd(mg/kg)

BNFa

DEMb

DEM-TTZ

1

2k

BSO-TTZ

1

-

3k

BNF-DEM-TTZ

-

50

4k

BNF-BSO-TTZ

-

50

_

TTZd

(mg/kg)

(mg/kg/day)

Ik

BSOc

485

_

10

-

1,786

10

485

-

10

1,786

10

-

a P-napthoflavone administered via ip injection in com oil.
b Diethylmaleate administered via ip injection 24 hr after ip injection of TTZ (sublethal dose) or 24 h r
after the last dose of BNF and 0.5 h r prior to ip injection of a lethal dose of TTZ (10 mg/kg).
c L-Buthionine-(SR)-sulfoxamine administered via ip injection 24 hr after ip injection of TTZ
(sublethal dose)\or 24 hr after the last dose of BNF and 0.5 hr prior to ip injection of a lethal
dose of TTZ (10 mg/kg).
d 2-Thiotriazone administered via ip injection in distilled water (sublethal dose).

TABLE 12
DESCRIPTION OF GROUPS AND TREATMENTS FOR STUDY OF DIETHYLMALEATE (DEM) AND 2THIOTRIAZONE (TTZ) EFFECTS ON HEPATIC MICROSOMAL AND CYTOSOLIC ENZYMES AND
ENZYME ACTIVITIES.

Group
No.
1L
ii

2L
ii

3L
n

4L
ii

5L
it

Group
Name
Male-DEM-Control
Male-DEM-TTZ
Male-BNF-DEM
Male-BNF-DEM-TTZ
Male-PB-DEM
Male-PB-DEM-TTZ
Female-DEM-Control
Female-DEM-TTZ
Im m ature MaleDEM-Control
Im m ature MaleDEM-TTZ

TTZa
(mg/kg)

DEMb
(mg/kg)

Enzvme modifiers (me/ks)
BNFC
PBd

485
10

ii

ii

-

10

ti

50
50

it
-

-

10

ti
-

-

-

60
60

it
-

10

ii

II

ii

10

tt

a 2-Thiotriazone administered via ip injection in distilled water.
b Diethylmaleate administered via ip injection 0.5 hr prior to ip injection of TTZ.
c p-napthoflavone administered via ip injection in com oil.
d Phenobarbital administered via ip injection in sterile water.

-

-

-

-

_

_

CHAPTER 5
RESU LTS

EXPERIMENT 1 - ACUTE TOXICITY OF TTZ IN RATS:

2-Thiotriazone (TTZ) is highly toxic to adult male ra ts causing 100%
mortality when adm inistered as a single oral dose of 10 mg/kg, (Table 13).
The acute single oral dose LD r, was calculated to be 4.6 mg/kg. Maximum
m ortality produced by TTZ in adult female rats was 40% and an LD^ could
not be determined. Im m ature rats showed no toxic response to TTZ a t any
of the concentrations tested. Clinical signs of intoxication observed included
severe respiratory distress, dyspnea, cyanosis, prostration or listlessness and
ruffled fur. In ra ts th a t subsequently died, a white frothy nasal discharge
was observed. These signs reached a maximum within 2-3 hours and death
usually ensued, or the rats recovered.

Clinical signs of intoxication were

similar in female rats but lasted for longer periods of tim e (4-24 hours).
Clinical signs of intoxication were not apparent in im m ature rats.
Macroscopic lesions observed in affected anim als were m ottling of the lungs,
and pulmonary edema and effusion.

Administration of a single dose of TTZ (5 mg/kg) intraperitoneally (ip)
produced 100% m ortality in adult male ra ts (Table 14). Compared to oral
treatm ent, ip adm inistration of TTZ to adult male rats caused twice the
mortality a t the same dose. The acute single dose LDgo was calculated to

74

TABLE 13
ACUTE TOXICITY OF 2-THIOTRIAZONE IN RATS FOLLOWING ORAL GAVAGE.
Group

Sex

Dose
(mg/kg)

No dead
No. tested

%
Mortality

1

Male

1.25
2.5
5.0
10.0

1/10
2/10
6/10
10/10

10
20
60
100

2

Female

2.5
5.0
10.0
62.5
100
125
250
1000

0/5
2/5
4/10
4/10
2/10
3/10
4/10
1/10

0
40
40
40
20
30
40
10

3

Im m ature

10
100
1000

0/10
0/10
0/10

0
0
0

LDsq
(mg/kg)

4.6(3.31-6.39)a

N.D.b
(both sexes)

>1000

a Confidence interval (95%)
b N.D.= not determined

TABLE 14
ACUTE TOXICITY OF 2-THIOTRIAZONE IN RATS FOLLOWING INTRAPERITONEAL INJECTION.

Group

4

Sex

Male

%

Dose

No. Dead/

(mg/kg)

No. Tested

1.25

1/10

10

2.5

5/6

90

5.0

6/6

100

Mortality

LDso
(mg/kg)

1.4(1.008-1.938)“
5

Female

5

0/5

0

10

0/5

0

100

0/5

0
>100

6

Im m ature
(both sexes)

10

0/10

0

100

0/10

0

1000

0/10

0
>1000

a Confidence interval (95%)
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be 1.4 mg/kg.

Adult female and im m ature ra ts did not respond to ip

adm inistration of TTZ (0% mortality). Clinical signs of intoxication observed
in adult male and female ra ts were the same as clinical signs observed in
oral treatm ent, bu t im m a tu re rats did not show any signs of intoxication.
Macroscopic lesions observed in affected anim als were also the same as
lesions observed in male ra ts (mottling of the lungs, and pulmonary edema
and effusion).
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HISTOLOGICAL EXAMINATION

Histopathologic evaluation of rats treated with TTZ showed no hepatic
structural alterations but m arked changes were observed in the lungs of
treated rats. Macroscopic lesions included pulmonary edema, effusion and
mottling of the lungs.

The normal appearance of adult male ra t lung is

shown in Figure 2. Light microscopic examination of adult male ra t lungs
after 1 hour exposure (10 mg/kg ip) showed acute interstitial and
perivascular edema (Figure 3). The edema fluid was largely restricted to
areas around the blood vessels.

Edema was also noted around the

bronchioles with some seepage into the alveoli.

W ithin the perivascular

bundles, there was substantially more fluid in the loose periarterial
interstitium than around airways, and more edema was observed around
larger bundles.

This edema was associated with mild interstitial

inflammatory response with minimal num bers of neutrophils, macrophages
and lymphocytes. Peak response to TTZ occurred within 1 hour and there
were no marked differences in the am ounts of edema observed a t 2 hour
(Figure 4) post-dosing. Animals usually died within 2 to 3 hours, or they
recovered with no noticeable histopathological effects.
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F igure 2 .

P hotom icrograph o f a control m ale rat lu n g , sh ow in g
a connected bronchovascular bundle w ith bronchiole,
a = bronchiole ; b = artery ; c = alveoli. S tain ed
w ith hem otoxylin-eosin ; x 109.

Figure 3 .

P hotom icrograph o f broncho vascu lar bundle o f a m ale
rat after 1 h r exposu re to TTZ (10 mg/kg),
a = b ronchiole ; b = artery ; c = p erivascu lar edema;
d = in terstitia l edem a. N ote preponderance

of

edem a around blood vessels. Stain ed w ith hem otoxylineosin ; x 83.

81

F igu re 4 .

P hotom icrograph o f bronchovascular bu nd le o f a m ale
rat after 2 h r exposu re to TTZ (10 mg/kg),
a = bronchiole ; b = artery ; c = p erivascu lar edema;
d = in terstitial edem a.

N ote preponderance o f edem a

around blood v essels. Stained w ith hem otoxylin -eosin ;
x 83.
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A section of control female ra t lung is shown in Figure 5.

Female rats

exhibited the same response 1 hour after exposure, but the effects were
milder (Figure 6). Female ra t lungs were less edematous, with relatively
smaller quantities of edema in and around blood vessels compared to male
ra t lungs after 1 hour exposure (Figure 3). There was no interstitial edema
or edema around peribronchial spaces.

There was also no inflammatory

response to TTZ observed in female ra t lung. However, perivascular edema
was apparent. Histopathologic findings observed in both male and female
rats were consistent with macroscopic observations and clinical signs of
intoxication.

Results also showed th a t TTZ did not affect liver weights and liver to body
weight ratios in male, female or im m ature male rats following 1 hour
exposure (10 mg/kg ip) (Table 15). However, lung weights and lung to body
weight ratios were significantly increased 1 hour after exposure in male,
female and im m ature male ra ts (Table 16).

In all cases lung weights of

treated animals were significantly increased compared to control groups.
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Figure

5 . P hotom icrograph o f a control fem ale rat lung, sh ow in g
a connected bronchovascu lar bundle w ith a bronchiole,
a = bronchiole ; b = artery ; c = alveoli. Stain ed w ith
hem otoxylin-eosin ; x 109.

F igure

6 . P hotom icrograph o f a bronchovascu lar bu nd le o f a
fem ale rat after lh r exp osu re to TTZ (10 mg/kg),
a = bron ch iole ; b = artery ; c = p erivascu lar edem a.
Stain ed w ith hem otoxylin -eosin ; x 148.
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TABLE 15
LIVER WEIGHTS (g) AND LIVER TO BODY WEIGHT RATIOS FOR
RATS DOSED WITH TTZa.

Group

Sex

Liver Wt.(g)

lh (Control)

Male

13.12 ± 1.15b

3.98 ± 0.23

lh (TTZ)

ft

13.48 ± 1.06b

3.98 ± 0.17

4h (Control)

Female

8.92 ± 1.11

3.47 ± 0.35

4h (TTZ)

ft

8.57 ± 0.83

3.32 + 0.32

5h (Control)

Im m ature

8.46 ± 0.90

4.50 ± 0.44‘

5h (TTZ)

tt

8.34 ± 0.49

4.46 ± 0.41°

Liver to Body Wt. Ratio

a All animals were administered TTZ (10 mg/kg ip). D ata represent Mean
± SD for n=6 animals.
b Significantly different (p<0.05) from female or im m ature male liver
weights (control and treated).
c Significantly different (p<0.05) from male and female liver to body
weight ratios (control and treated).

TABLE 16
LUNG WEIGHTS (g) AND LUNG TO BODY WEIGHT RATIOS FOR
RATS DOSED WITH TTZa.

Group

Sex

Liver Wt.(g)

l h (Control)

Male

1.69 ± 0.27

0.51 + 0.07

l h (TTZ)

it

2.07 + 0.28b

0.61 ± 0.08b

4h (Control)

Female

1.22 + 0.11

0.48 ± 0.05

4h (TTZ)

ii

2.04 + 0.39°

0.78 ± 0.14c

5h (Control)

Im m ature

1.18 + 0.07

0.62 + 0.05

5h (TTZ)

ii

1.46 ± 0.14d

0.78 ± 0.07d

Liver to Body Wt. Ratio

a All anim als were administered TTZ (10 mg/kg ip). D ata represent
Mean ± SD for n=6 animals.
b Significantly greater (p<0.Q5) th an male controls.
c Significantly greater (p<0.05) th an female controls.
d Significantly greater (p<0.05) th an im m ature male controls.

87
EXPERIMENT 2 - INNATE AND DRUG INDUCED RESISTANCE TO TTZ
IN RATS.
Results show th a t im m ature ra ts have a specific innate resistance to TTZ.
All imm ature rats (male and female), tested from 30-45 days of age, were
resistant to TTZ a t concentrations ranging from 10-1000 mg/kg when dosed
either orally or ip. This resistance began to diminish by 45 days of age and
by 50 days of age 20% m ortality was produced (Table 17). In im m ature
male rats th a t were 55 days of age 90% m ortality was also produced by
TTZ (10 mg/kg ip), thus showing th a t there was an age-related effect of
TTZ. Male rats th a t were 50 days of age and older exhibited clinical signs
of intoxication to TTZ while younger anim als did not.

Female im m ature

rats (30-55 days old) did not respond (0% mortality) to TTZ, but clinical
signs of intoxication were also observed in female im m ature rats th a t were
50-55 days of age.

2-Thiotriazone itself produced resistance in adult male rats, after either
prior exposure to a sublethal dose (1 mg/kg) or in anim als th a t survived a
toxic dose of TTZ (10 mg/kg). This resistance lasted for 9-10 weeks in rats
th a t were redosed orally with a toxic dose (10 mg/kg) (Table 18).

2-

Thiotriazone induced resistance was not dose dependent because there were
no differences in response when rats were dosed with 10 or 100 mg TTZ/kg
orally. However, there were differences in response based on the route of
exposure.

When resistant anim als were redosed intraperitoneally with a

toxic dose of TTZ (10 mg/kg) the resistance lasted for only 7 weeks
compared to 9 weeks for resistant anim als redosed orally with a toxic dose.
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TABLE 17
EFFECT OF AGE ON 2-THIOTRIAZONE TOXICITY IN RATSa.

Group

Sex

%

Age

No. Dead/

(days)

No. Tested

Mortality

30

0/10

0

2a

40

0/10

0

3a

45

0/10

0

4a

50

2/10

20

5a

55

9/10

90

30

0/10

0

7a

40

0/10

0

8a

45

0/10

0

9a

50

0/10

0

10a

55

0/10

0

la

6a

Male

Female

All rats were dosed orally with a lethal dose of TTZ (10 mg/kg).

TABLE 18
EXTENT OF TTZ INDUCED RESISTANCE IN MALE RATS8.
Group

Post-treatm ent time

No.

(days and weeks)

ORAL
No. dead/
No. Tested

INTRAPERITONEAL
%

Mortality

No. dead/

%

No.Tested

Mortality

0/6

0

0/3

0

2b,2c

1 day
2 "

0/6

0

0/3

0

3b,3c

3 "

0/3

0

0/3

0

4b,4c

1 week

0/3

0

0/3

0

5b,5c

2 "

0/6

0

0/3

0

6b,6c

3 "

0/6

0

0/3

0

7b,7c

4 "

0/3

0

0/3

0

8b,8c

5 "

0/3

0

0/3

0

9b,9c

6 "

0/3

0

0/3

0

10b,10c

7 "

0/6

0

2/3

67

lib

8 "

0/6

0

12b

9 "

2/3

67

13b

10 "

3/3

100

lb ,lc

8 All rats were administered a sublethal dose of TTZ (1 mg/kg ip) and redosed at a specified time with
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Adult male rats administered N-acetyl-L-cysteine (Glutathione precursor)
prior to adm inistration of TTZ (10 mg/kg) were shown to be resistant to the
toxic effects of TTZ (Table 19). Only 30% mortality was produced in these
animals, but clinical signs of intoxication were apparent in all animals
tested. These signs lasted for longer periods of time and in anim als th at
died, toxicity occurred after 6-8 hours post-dosing.

P-Napthoflavone induction of the microsomal mixed function monooxygenase
enzyme system also produced resistance to TTZ in male ra ts (Table 20). In
fact, no m ortality was observed and none of the typical responses (clinical
signs of intoxication and macroscopic lesions) were observed in BNF-induced
rats administered TTZ (10 mg/kg) either orally or ip. The only symptom
observed was ruffled yellow fur.

Phenobarbital induction did not produce

a noticeable increase or decrease in the toxicity in adult male rats.

2-

Thiotriazone produced 70-100% m ortality in phenobarbital induced rats and
this m ortality was dose-dependent.

The adm inistration of inhibitors such

as a-napthoflavone did not affect BNF induced resistance in male rats (0%
mortality).

SKF-525A (inhibitor) did not increase or decrease the toxic

effects of TTZ when administered to phenobarbital induced anim als (Table
21). There was a slight decrease in m ortality from 70-60% in animals
induced

with

phenobarbital

and

adm inistration of TTZ (10 mg/kg ip).

administered

SKF-525A

prior

to
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TABLE 19
EFFECT OF N-ACETYL-L-CYSTEINE (NAC) ON 2-THIOTRIAZONE
(TTZ) TOXICITY IN ADULT MALE RATS6.

Group

% M ortality

NAC

TTZ

(mg/kg)

(mg/kg)

Id

150

0

0/3

0

2d

150

10

2/6

33

No. dead/No. Tested

a All rats were administered N-acetyl-L-cysteine (NAC) 0.5 h r prior to
adm inistration of TTZ.
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TABLE 20
EFFECT OF BETA-NAPTHOFLAVONE (BNF) AND
PHEONBARBITAL (PB) INDUCTION ON 2-THIOTRIAZONE (TTZ)
TOXICITY IN ADULT MALE RATS.
ENZYME MODIFIERS
TTZa
(mg/kg)

PBC

BNFb
No. dead/No. Tested

No. dead/No. Tested

10

0/10

7/10

100

0/10

8/10

2000

0/10

5/5

8 All animals were administered TTZ orally.
b B-Napthoflavone (50 mg/kg) administered via ip injection in corn oil.
c Phenobarbital (60 mg/kg) administered via ip injection in sterile
water.
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TABLE 21
EFFECT OF ENZYME INDUCTION AND INHIBITION ON 2THIOTRIAZONE (TTZa) TOXICITY IN ADULT MALE RATS.

Group

Treatm ent

le

BNFb Control

0/5

0

2e

PBb Control

0/5

0

3e

BNFb-TTZ

0/10

0

4e

PB-TTZ

7/10

70

5e

BNF-ANFb-TTZ

0/10

0

6e

PB-SKFb-TTZ

3/5

60

No. Dead/No. Tested

% Mortality

° All anim als were administered TTZ (10 mg/kg orally), except groups le
and 2e.
b fi-Napthoflavone (BNF) was administered ip (50 mg/kg); phenobarbital
(PB) was administered ip (60 mg/kg); a-Napthoflavone (ANF) was
administered ip (50 mg/kg); SKF525A (SKF) was administered ip
(50 mg/kg). For dosing protocol see Table 5.

94
The adm inistration of sex steroids (P-estradiol or testosterone) did not affect
the toxicity of TTZ in adult male ra ts (90% mortality) and im m ature rats
(0% mortality). However, 60% m ortality was produced in adult female rats
(Table 22). Female rats responded differently when adm inistered TTZ on
different days of the week. Variation in responses (mortality) ranged from
20% on Wednesday and Friday to 60% on Monday and Tuesday and 100%
on Thursday (Table 23). The effect of changes in the estrous cycle (hormone
levels) on toxicity in adult female rats was monitored (Table 24). Variations
in toxic response were still observed in adult female rats th a t were in the
same stage of estrus, and the responses were not dose-dependent.

The

highest m ortality observed when rats were in estrus was 50% a t 2000
mg/kg.

When they were in m etestrus it was 50% a t 100 mg/kg, in

proestrus it was 60% a t 62.5 mg/kg and, in diestrus it was 30% a t 2000
mg/kg.

TABLE 22
EFFECT OF B-ESTRADIOL AND TESTOSTERONE ON 2-THIOTRIAZONE (TTZa) TOXICITY IN RATS.

B-ESTRADIOL b
Group

Sex

No. Dead/No. Tested

TESTOSTERONE'

% Mortality

No. Dead/No. Tested

% Mortality

If

Male

9/10

90

2f,5f

Female

6/10

60

6/10

60

3f,6f

Im m ature

0/10

0

0/10

0

(Both sexes)

a All rats were administered TTZ ip.
b B-Estradiol was administered ip (2 mg/kg).
c Testosterone was administered ip (10 mg/kg).
For dosing of protocol see Table 6.

VO
CJ

1
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TABLE 23
EFFECT OF DOSING ADULT FEMALE RATS WITH 2-THIOTRIAZONE
(TTZ“) ON DIFFERENT DAYS OF THE WEEK.

Day of Week

No. Dead/No. Tested

% Mortality

MONDAY

3/5

60

TUESDAY

3/5

60

WEDNESDAY

1/5

20

THURSDAY

5/5

100

FRIDAY

1/5

20

• All ra ts were adm inistered TTZ (62.5 mg/kg) orally. Animals th a t died
did so w ithin a 24 h r observation period.
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TABLE 24
VARIATION IN TOXICITY OF 2-THIOTRIAZONE (TTZ) AT
DIFFERENT STAGES OF THE ESTROUS CYCLE IN FEMALE RATS0

Group

Group
Name

TTZ (mer/ke)b
10

62.5

100

1000

2000

No. Dead/No. Tested

lg

E strus

3/10

0/10

1/7

1/10

4/8

2g

M etestrus

1/10

0/10

5/10

1/10

4/10

3g

Proestrus

1/10

6/10

0/7

0/10

1/10

4g

Diestrus

2/10

1/10

2/10

1/10

3/10

0 All rats were administered TTZ orally.
b All anim als th a t died did so within a 24 hr observation period.
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EXPERIMENT 3 - EFFECT OF TTZ ON HEPATIC MICROSOMAL AND
CYTOSOLIC ENZYMES AND ENZYME ACTIVITIES
IN RATS.

2-Thiotriazone did not affect cytochrome P-450 content in adult male,
imm ature male, (J-napthoflavone (BNF) induced or phenobarbital induced
male rats, but it was significantly increased in adult female rats (Table 25).
Cytochrome bs content (Table 26), NADPH cytochrome-C-reductase activities
(Table 27), and glutathione-S-transferase activities (Table 28) were generally
unaffected by TTZ treatm ent in adult (male and female) and im m ature male
rats.

NADH cytochrome b5-reductase activity in im m ature ra ts was

significantly lower th an activity in non-induced male and female rats (Table
29). UDP-glucuronosyltransferase (UDPGT) activity in adult female and
imm ature male rats was significantly decreased, while activity in adult,
BNF and PB induced male rats was not affected (Table 30). Cytochrome
P-450 content in BNF and PB induced male rats was significantly higher
th an in non-induced rats (male, female and im m ature) (Table 25). The P450 content of PB induced rats was also significantly higher than in BNF
induced rats.

The effect of TTZ on cytochrome P-450 in induced and non-induced male
rats is shown in Figure 7. Cytochrome P-450 content in both PB and BNF
induced rats was significantly increased, while cytochrome b5 content was
generally unaffected in PB and BNF induced male rats (Figure 8).
induced control and TTZ treated ra ts had significantly lower NADH

PB
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TABLE 25
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC CYTOCHROME P450 CONTENT IN INDUCED AND NON-INDUCED RATS8.

Cytochrome P-450 (nmoles/mg microsomal protein)

GROUP

CONTROL

TTZ

lh (Male)

0.672 ± 0.049

0.718 ± 0.170

4h (Female)

0.456 ± 0.113

0.585 ± 0.044b

5h (Immature Male)

0.562 ± 0.230

0.487 ± 0.243

2h (Male BNF Induced)

0.934 ± 0.191°

0.899 ± 0.206°

3h (Male PB Induced)

1.534 ± 0.405°d

1.584 ± 0.338°,d

8 D ata represent Mean ± SD for n=5 groups of 3 pooled livers per
group.
b Significantly

different (p<0.05)from

female controls.

c

Significantly

different (p<0.05)from

non-induced animals.

d Significantly

different (p<0.05)from

male BNF induced animals.

For dosing protocol see Table 8.

TABLE 26
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC CYTOCHROME B5
CONTENT IN INDUCED AND NON-INDUCED RATS8.

Cytochrome Bs
(nmoles/mg microsomal protein)

GROUP

CONTROL

TTZ

lh (Male)

0.223 ± 0.049

0.236 ± 0.055

4h (Female)

0.214 ± 0.069

0.228 ± 0.058

5h (Immature Male)

0.174 ± 0.066b

0.160 ± 0.072b

2h (Male BNF Induced)

0.310 ± 0.125

0.268 ± 0.032

3h (Male PB Induced)

0.268 ± 0.059

0.281 ± 0.033

8 D ata represent Mean ± SD for n=5 groups of 3 pooled livers per
group.
b Significantly different (p<0.05) from non-induced (male and female) and
PB and BNF induced rats.
For dosing protocol see Table 8.
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TABLE 27
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL
NADPH CYTOCHROME-C-REDUCTASE ACTIVITY CONTENT IN
INDUCED AND NON-INDUCED RATS8.

NADPH cytochrome-C-reductase
(nmoles reduced/min/mg microsomal protein)

GROUP

CONTROL

TTZ

lh (Male)

119.432 ± 32.687

129.481 ± 50.869

4h (Female)

107.254 ± 38.119

105.605 ± 29.083

5h (Immature Male)

101.884 ± 30.406

94.336 ± 17.163

85.022 ± 30.227

89.224 ± 29.551

2h (Male BNF Induced)
3h (Male PB Induced)

149.046 ± 55.532

210.522 ± 104.363b

8 D ata represent Mean ± SD for n=5 groups of 3 pooled livers per
group.
b Significantly different (p<0.05) from im m ature male and female control
and treated rats.
For dosing protocol see Table 8.
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TABLE 28
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC CYTOSOLIC
GLUTATHIONE-S-TRANSFERASE ACTIVITY IN INDUCED AND NON
INDUCED RATSa.

Glutathione-S-transferase
(nmoles 1 chloro-2,4 dinitrobenzene
conjugated/min/mg microsomal protein)

GROUP

CONTROL

TTZ

lh (Male)

1701.066 ± 502.263

1783.790 ± 493.839

4h (Female)

1480.552 ± 707.729

1368.984 ± 734.334

5h (Immature Male)

1579.632 ± 332.546

1370.162 ± 224.365

2h (Male BNF Induced)

1571.626 ± 386.389

1724.722 ± 323.825

3h (Male PB Induced)

2105.576 ± 468.469

2141.044 ± 702.964

a D ata represent Mean ± SD for n=5 groups of 3 pooled livers per
group.
For dosing protocol see Table 8.

TABLE 29
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL
NADH CYTOCHROME-B5-REDUCTASE ACTIVITY IN INDUCED AND
NON-INDUCED RATSa.
NADH cytochrome-b5-reductase
(nmoles reduced/min/mg microsomal protein)

GROUP

TTZ

CONTROL

lh (Male)

512.030

54.643

526.434 ± 139.828

4h (Female)

533.526

167.126

617.310 ± 91.387

5h (Im mature Male)

373.316

111.214f,B

329.194 ± 85.296fB

2h (Male BNF Induced)

483.310

132.240

499.236 ± 148.890

3h (Male PB Induced)

244.832

59.575bc

271.626 ± 86.491dc

8 D ata represent Mean ± SD for n=5 groups of 3 pooled livers per
group.
b Significantly different (p<0.05) from non-induced male and female
controls.
0

Significantly different (p<0.05) from male BNF controls.

d

Significantly different (p<0.05) from non-induced male and female TTZ
treated animals.

8

Significantly different (p<0.05) from male BNF TTZ treated animals.

f

Significantly different (p<0.05) from male and female controls.

8

Significantly different (p<0.05) from male and female TTZ treated rats.
For dosing protocol see Table 8.

TABLE 30
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL
UDP-GLUCURONOSYL TRANSFERASE ACTIVITY IN INDUCED AND
NON-INDUCED RATS°.

UDP-glucuronosyltransferase
(nmoles p-nitrophenol conjugated
/min/mg microsomal protein)

GROUP

CONTROL

TTZ

lh (Male)

1.309 ± 0.871

0.968 ± 0.542

4h (Female)

3.269 ± 1.118

1.727 ± 0.381b

5h (Immature Male)

1.460 ± 0.543

0.618 ± 0.533c

2h (Male BNF Induced)

1.573 ± 0.847

1.685 ± 0.690

3h (Male PB Induced)

1.080 ± 0.229

1.137 ± 0.304

a D ata represent Mean ± SD for n=5 groups of 3 pooled livers per
group.
b Significantly different (p<0.05) from female control values.
0 Significantly different (p<0.05) from im m ature male control values.
For dosing protocol see Table 8.
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cytochrome-b5-reductase activities than non-induced (male, female and
immature) and BNF induced (control and TTZ treated) ra ts (Table 29;
Figure 9).

Glutathione-S-transferase (Figure 10), NADPH cytochrome-C-

reductase (Figure 11) and UDP-glucuronosyltransferase (Figure 12) activities
were not significantly different (increased and decreased) from non-induced
male rats.

Aldrin epoxidase (Table 31), 7-ethoxyresorufin-0-deethylase (Table 32) and
7-ethoxycoumarin-0-deethylase (Table 33) activities were not affected by TTZ.
However, aldrin epoxidase activity in female rats was significantly lower
than male and im m ature male rats.

Aldrin epoxidase EROD and ECOD

activity in relation to cytochrome P-450 content was increased approximately
two-fold in both control and TTZ treated female and im m ature male rats.
These activities were also slightly higher in male (non-induced), BNF
induced male rats and slightly lower in PB induced male rats in relation
to cytochrome P-450 content. Aldrin epoxidase (AE) and 7-ethoxycoumarin0-deethylase (ECOD) activities in both PB and BNF induced male rats were
significantly higher than those in non-induced anim als (Tables 31 and 32;
Figures 13 and 14).

7-Ethoxyresorufin-O-deethylase (EROD) activity in both BNF and PB induced
rats was also significantly higher than activity in non-induced rats (Table
32; Figure 15).

Also, both EROD and ECOD activities in BNF induced

male rats were higher th an activities in PB induced animals. PB induced

NM

CYT.

b5

REDUCEDflUIIWMG

PROTEIN
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se e F igu re 7 . F or d o sin g p rotocol se e T able 8 .
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F igu re 12 . E ffect o f TTZ on h ep a tic m icrosom al UDPg lu cu ron osyltran sferase a c tiv ity in in d u ced an d nonin d u ced m ale rats. F or id e n tific a tio n o f ab b reviation s,
se e F igu re 7 . F or d o sin g p rotocol se e T able 8 .

TABLE 31
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL
ALDRIN EPOXIDASE ACTIVITY IN INDUCED AND NON-INDUCED
RATS8.
Aldrin epoxidase
nmoles dieldrin formed/min/mg/microsomal protein
(nmoles dieldrin formed/min/nmole P-450)
GROUP

CONTROL

TTZ

l h (Male)

1.609 ± 0.965
(2.609 ± 1.956)

1.414 ± 0.926
(2.261 ± 1.860)

4h (Female)

0.241 ± 0.287b
(0.555 ± 0.574)

0.238 ± 0.234c
(0.421 ± 0.446)

5h (Im mature Male)

1.933 ± 0.352
(4.078 ± 2.233)

1.994 ± 0.819
(5.260 ± 3.923)

2h (Male BNF Induced)

0.674 ± 0.269d
(0.746 ± 0.231)

0.474 ± 0.114e
(0.538 ± 0.122)

3h (Male PB Induced)

5.854 ± 1.399f
(4.297 ± 2.187)

6.308 ± 1.109B
(4.104 ± 1.037)

8 D ata represent Mean ± SD for n=5 groups of 3 pooled livers per
group.
b Significantly lower (p<0.05) th an male, im m ature male and induced
male controls.
c Significantly different (p<0.05) th an male im m ature male and induced
male TTZ treated animals.
d Significantly lower (p<0.05) th an non-induced male and im m ature male
controls.
e Significantly lower (p<0.05) th an non-induced male and im m ature male
TTZ treated animals.
f Significantly higher (p<0.05) th an non-induced male, female, im m ature
male and BNF induced male controls.
g Significantly higher (p<0.05) than non-induced male, female, im m ature
male and BNF induced male TTZ treated animals
For dosing protocol see Table 8.

TABLE 32
EFFECT OF 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL 7-ETHOXYRESORUFIN-ODEETHYLASE (EROD) ACTIVITY IN INDUCED AND NON-INDUCED RATSa.
EROD
pmoles resorufin formed/min/mg/microsomal protein
(pmoles resorufin formed/min/nmole P-450)
GROUP

CONTROL

TTZ

lh (Male)

116.558 ± 63.918
(166.595 ± 76.932)

142.334 ± 87.806
(184.884 ± 74.934)

4h (Female)

72.870 ± 52.751
(148.511 ± 71.547)

60.042 ± 33.922
(107.111 ± 56.903)

5h (Immature Male)

108.158 ± 60.252
(186.668 ± 40.687)

84.022 ± 55.498
(162.257 ± 34.72)

4738.238 ± 770.045b
(5044.185 ± 891.752)

4726.094 ± 392.997°
(5487.357 ± 1429.831)

619.638 ± 464.583bd
(362.608 ± 220.852)

518.750 ± 284.721ce
(318.209 ± 132.954)

2h (Male BNF Induced)
3h (Male PB Induced)

a D ata represent Mean ± SD for n=5 groups of 3 pooled livers per group.
b Significantly different (p<0.05) from all non-induced controls.
c Significantly different (p<0.05) from all non-induced TTZ treated animals.
d Significantly different (p<0.05) from BNF induced controls.
e Significantly different (p<0.05) from BNF induced TTZ treated animals.
For dosing protocol see Table 8.
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TABLE 33
EFFECT OF 2-THIOTRIAZONE (TTZ ON HEPATIC MICROSOMAL 7ETHOXYCOUMARIN-O-DEETHYLASE (ECOD) ACTIVITY IN INDUCED
AND NON-INDUCED RATS'*.
ECOD
nmoles 7-hydroxycoumarin formed/min/mg/microsomal protein
(nmoles 7-hydroxycoumarin formed/min/nmole P-450)
GROUP

CONTROL

TTZ

lh (Male)

1.262 ± 0.234
(1.941 ± 0.596)

1.312 ± 0.317
(1.916 ± 0.713)

4h (Female)

0.949 ± 0.800
(1.890 ± 1.217)

0.953 ± 0.798
(1.619 ± 1.346)

5h (Immature Male)

1.933 ± 0.352
(4.708 ± 2.233)

1.994 ± 0.819
(5.260 ± 3.923)

13.572 ± 1.628b,d
(15.405 ± 3.094)

12.524 ± 2.428°°
(14.289 ± 3.462)

5.158 ± 1.204b
(3.538 ± 1.088)

5.216 ± 0.931°
(3.506 ± 1.327)

2h (Male BNF Induced)
3h (Male PB Induced)

a D ata represent Mean ± SD for n=5
group.
b Significantly different (p<0.05) from
c Significantly different (p<0.05) from
animals.
d Significantly different (p<0.05) from
e Significantly different (p<0.05) from
animals.
For dosing protocol see Table 8.

groups of 3 pooled livers per
all non-induced controls.
all non-induced TTZ treated
male PB induced controls.
male PB induced TTZ treated

CONTROL TTZ

BNFC

BNFT

PBC

PBT

F igu re 13 . E ffect o f TTZ o n h ep a tic m icrosom al ald rin ep oxid ase
a ctiv ity in in d u ced and n on -ind uced m ale rats. F or
id en tifica tio n o f ab b reviation s , se e F igu re 7. F or
d o sin g p rotocol se e T able 8 . * S ig n ifica n tly d ifferen t
(p < 0.05) from con trols.

1

CONTROL TTZ

BNFC

BNFT

PBC

PBT

2

z

F igu re 14 . E ffect o f TTZ o n h ep a tic m icrosom al ECOD
a c tiv ity in in d u ced an d n on -in d u ced m ale rats.
F or id en tifica tio n o f ab b reviation s, se e F igu re 7.
F or d osin g p ro tocol se e T able 8 .
* S ig n ifica n tly d ifferen t (p < 0.05) from con tro ls.
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NM RESORUFIN FORMED/MIN/MG PROTEIN
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5
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3
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1

0
CONTROL TTZ
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BN FT

PBC

PBT

F igu re 15 . E ffect o f TTZ on h ep a tic m icrosom al EROD a c tiv ity in
in d u ced and n on -in d u ced m ale rats. F or id en tifica tio n
o f ab b reviation s, se e F igu re 7 . F or d o sin g p rotocol
se e T able 8 .
con tro ls.

* S ig n ifica n tly d ifferen t (p < 0.05) from
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rats had significantly higher AE activity than BNF induced rats. Female
rats had significantly less AE activity than male and im m ature male rats.
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EXPERIMENT 4 - EFFECT OF TTZ ON HEPATIC AND PULMONARY
GLUTATHIONE CONCENTRATION IN RATS:

2-Thiotriazone produced a dose-dependent decrease in glutathione (GSH)
content in the lung of adult male ra ts (Table 34).

The decrease in GSH

(non-protein sulfhydryl) was observed a t 1 hour following exposure of male
rats to 1.25, 2.5, 5, and 10 mg TTZ/kg (Table 34).

All treatm ent values

were depressed from control values (93.5, 80.1, 62.7 and 22.7% of control
following 1.25, 2.5, 5, and 10 mg TTZ/kg respectively; Figure 16). Activity
of the 1.25 mg/kg group was significantly different from th a t of the 10
mg/kg group; activity of the 2.5 mg/kg group was different from th a t of the
10 mg/kg group; activity of the 5 mg/kg group was different from th a t of the
control, 1.25 and the 10 mg/kg groups; and the activity of the 10 mg/kg
groups was different from th a t of the control, 1.25, and 5 mg/kg groups.
TTZ also decreased non-protein sulfhydryl (NPDH) concentration in the
lungs of adult female rats. Concentrations of GSH in the lungs of female
rats a t 1 hour following exposure to 1.25, 2.5, 5, and 10 mg TTZ/kg were
variable and the values were not significantly different from each other
(Table 34).

However all treatm ent values were depressed from control

values, (24.2, 9.83, 30.7, and 53.8% of controls following 1.25, 2.5, 5 and
10 mg/kg respectively; Figure 17).

Glutathione concentration was not

decreased in the liver of adult male (Figure 18) and female ra ts (Figure 19)
except th a t 1.25 mg TTZ/kg caused a significant decrease in male liver
GSH concentration when compared to controls and 10 mg TTZ/kg caused a
significant decrease in female liver GSH concentration.

TABLE 34
EFFECT OF 2-THIOTRIAZONE (TTZ) ON RAT LIVER AND LUNG GLUTHATHIONE (GSH)
CONCENTRATIONS*.

Group

TTZ
(mg/kg)

Sex

Liver
GSH(um/g)

%
Control

Lung
GSH(um/g)

%
Control

Male

5.806 ± 0.679b

100

2.186 ± 0.363*

100

li

Control

2i

1.25

it

5.166 ± 0.713'

88.9

2.043 ± 0.295f

93.5

3i

2.5

li

6.386 ± 0.806

117.7

1.750 ± 0.298'

80.1

4i

5

i»

6.906 ± 0.360"

118.9

1.370 ± 0.433b

62.7

5i

10

it

5.883 ± 0.003

103.3

0.493 ± 0.144*

22.5

lOi

Control

5.530 ± 0.3831

100

1.790 ± 0.3341

100

lli

1.25

••

5.130 ± 1.508

92.7

0.433 ± 0.647

24.2

12i

2.5

"

13i
14i

Female

4.543 ± 0.965

82.2

0.176 ± 0.280

9.83

5

ti

5.293 ± 0.408

95.7

0.550 ± 0.334

30.7

10

n

3.550 ± 0.175k

64.2

0.963 ± 0.150m

53.8

* Data represent Mean ± SD for n=3 rats.
b Significantly different (p<0.05) from group 4i.
* Significantly different (p<0.05) from groups 3i, 4i, and 5i.
d Significantly different (p<0.05) from groups li and 2i.
* Significantly different (p<0.05) from groups 4i and 5i.
f Significantly different (p<0.05) from group 5i.
1 Significantly different (p<0.05) from groups 4i and 5i.
h Significantly different (p<0.05) from groups 2i and 5i.
1 Significantly different (p<0.05) from groups 2i, 3i, and 4i.
J Significantly different (p<0.05) from group 14i.
k Significantly different (p<0.05) from groups H i and 13i.
1 Significantly different (p<0.05) from groups lli, 12i, 13i, and 14i.
m Significantly different (p<0.05) from group 12i.
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F igu re 16 . E ffect o f TTZ on g lu ta th io n e co n cen tra tion in th e lu n g
o f m ale rats. * = S ig n ifica n tly d ifferen t (p < 0.05) from
con trols.

% CONTROL
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TTZ (MG/KG)

F igu re 17 . E ffect o f TTZ on g lu ta th io n e con cen tratio n in th e lu n g
o f fem ale rats. * = S ig n ifica n tly d ifferen t (p < 0.05)
from con trols.
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F igu re 18 . E ffect o f TTZ on g lu ta th io n e co n cen tratio n in th e liv e r
o f m ale rats. * = S ig n ifica n tly d ifferen t (p < 0.05) from
con trols.
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F igu re 19 . E ffect o f TTZ o n g lu ta th io n e co n cen tra tio n in th e liv er
o f fem ale rats.
from con trols.

* = S ig n ifica n tly d ifferen t (p < 0.05)
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The importance of GSH in TTZ induced pulmonary toxicity was tested by
pretreatm ent of adult male and female rats with diethylmaleate (DEM).
Both liver and lung GSH levels were depleted by DEM (Table 35). DEM
itself depleted liver GSH in male rats to 10.5% of control and 25.9% of
control in female rats; lung GSH levels were depleted to 7.1% of control in
males and 22.1% of control in females. DEM+TTZ treatm ent depleted liver
GSH in male rats to 1.09% of control and 18.3% of control in females; lung
GSH concentration in male ra ts was depleted to 27.1% of control and 43.7%
of control in female rats.

These results provide evidence th a t GSH is

involved in the metabolism and mechanism of action of TTZ.

Experiments with N-acetyl-L-cysteine (NAC), a GSH precursor, were
conducted to determine if maintenance of GSH levels in ra t liver would be
protective

against

TTZ-induced

toxicity

in

male

and

female

rats.

Administration of NAC m aintained liver GSH concentrations significantly
above control values even in the presence of a toxic dose of TTZ (10 mg/kg)
in male rats (158.2% of control for NAC treated rats and 149.5% of control
for NAC-TTZ treated rats). Also, fiver GSH concentrations were m aintained
a t 89.8% of control values for NAC treated female rats (Table 36). Lung
GSH concentrations were m aintained in male rats at 96.9% of controls for
NAC treated rats (NAC controls) and 87% of control for NAC-TTZ treated
rats. However, female lung GSH concentrations were significantly decreased
to 33-43% of control. Both the effects of NAC and DEM on glutathione

TABLE 35
EFFECT OF DIETHYLMALEATE (DEM) ON RAT LIVER AND LUNG GLUTHATHIONE (GSH)
CONCENTRATIONS0.
Liver
GSH(um/g)

Treatm ent
No.

Sex

Control

Male

5.806 ± 0.679b

100

2.186 ± 0.263d

100

6i

DEMC

it

0.610 ± 0.723c

10.5

0.156 ± 0.028°

7.1

7i

DEM-TTZ

ti

0.063 ± 0.109c

1.09

0.593 ± 0.909°

27.1

lOi

Control

Female

5.530 ± 0.383f

100

1.790 ± 0.334h

100

15i

DEMC

tt

1.436 ± 0.274s

25.9

0.396 ± 0.04T

22.1

16i

DEM-TTZ

11

1.016 ± 0.290g

18.3

0.783 ± 0.1221

43.7

Group

li

°
b
c
d
e
f
g
h

%

Control

D ata represent Mean ± SD for n=3 rats.
Significantly different (p<0.05) from male DEMC and DEM-TTZ liver.
Significantly different (p<0.05) from male controlliver.
Significantly different (p<0.05) from male DEMC and DEM-TTZ lung.
Significantly different (p<0.05) from male control lung.
Significantly different (p<0.05) from female DEMC and DEM-TTZ liver.
Significantly different (p<0.05) from female control liver.
Significantly different (p<0.05) from female control lung.
For dosing protocol see Table 9.

Lung
GSH(um/g)

%
Control

TABLE 36
EFFECT OF N-ACETYL-L-CYSTEINE (NAC) ON RAT LIVER AND LUNG GLUTHATHIONE (GSH)
CONCENTRATIONS3.
Group

Treatm ent

Sex

Liver

No.
li

%

Lung

%

GSH(um/g)

Control

GSH(um/g)

Control

Control

Male

5.806 ± 0.679

100

2.186 ± 0.263

100

8i

NACC

it

9.186 ± 0.402b

158.2

2.120 ± 0.415

96.9

9i

NAC-TTZ

it

8.680 ± 0.222b

149.5

1.906 ± 0.197

87.2

lOi

Control

Female

5.530 ± 0.383

100

1.790 ± 0.330

100

Hi

NACC

ii

4.963 ± 1.447

89.8

0.793 ± 0.344°

43.3

12i

NAC-TTZ

ti

5.043 ± 0.479

91.2

0.593 ± 0.575°

33.1

a D ata represent Mean ± SD for n=3 rats.
b Significantly different (p<0.05) from control male liver.
c Significantly different (p<0.05) from control female lung.
For dosing protocol see Table 9.
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concentrations in liver and lung of male ra ts are shown in Figures 20 and
21 and the effects of these compounds on female ra t glutathione
concentrations are shown in Figures 22 and 23.

CONTROL

DEMC

DEMT

NACC

NACT

F igu re 20 . G lutahione co n cen tra tio n in th e liv e r o f m ale rats
exp osed to d ieth y lm a lea te (DEMC) ; d ieth y lm a leate +
TTZ (DEMT) ; N -aceytyl-L -cystein e (NACC) and
N -acetyl-L -cystein e + TTZ (NACT). F or d o sin g p rotocol
se e T able 9 . * = S ig n ifica n tly d ifferen t (p < 0.05) from
con trol.
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F igu re 21 . G lu tath ion e co n cen tra tio n in th e lu n g o f m ale rats
ex p o sed to d ieth y lm a leate (DEMC) ; d ieth y lm a lea te +
TTZ (DEMT) ; N -aceytyl-L -cysteine (NACC) and
N -acetyl-L -cysteine + TTZ (NACT). F or d o sin g p rotocol
se e T able 9 . * = S ig n ifica n tly d ifferen t (p < 0.05) from
con trol.
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CONTROL

DEMC

DEMT

NACC

NACT

F igu re 22 . G lu tath ion e co n cen tration in th e liv e r o f fem ale rats
exp osed to d ieth ylm alea te (DEMC) ; d ieth ylm aleate +
TTZ (DEMT) ; N -aceytyl-L -cysteine (NACC) and
N -acetyl-L -cysteine + TTZ (NACT). F or d osin g p rotocol
se e T able 9 . * = S ig n ifica n tly d ifferen t (p < 0.05) from
con trol.

UM NPSH/G LUNG
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1
CONTROL

I
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I
DEMT

I
NACC

NACT

F igu re 23 . G lu tathione co n cen tra tio n in th e lu n g o f fem ale rats
exp osed to d ieth y lm a lea te (DEMC) ; d ieth y lm a lea te +
TTZ (DEMT) ; N -aceytyl-L -cystein e (NACC) and
N -acetyl-L -cysteine + TTZ (NACT). F or d o sin g p rotocol
se e T able 9 . * = S ig n ifica n tly d ifferen t (p < 0.05) from
con trol.
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EXPERIMENT 5 - EFFECT OF GLUTATHIONE DEPLETION BY
DIETHYLMALEATE (DEM) AND L-BUTHIONINE-(SR)
SULFOXAMINE (BSO) ON TTZ TOXICITY IN RATS.

The toxicity of TTZ was markedly increased in male, female and im m ature
rats by diethylmaleate (DEM) pretreatm ent. DEM (485 mg/kg) itself did not
produce toxicity in male rats but when administered at 970 mg/kg produced
toxicity in 20% of the anim als tested (Table 37).

DEM (485 mg/kg)

pretreatm ent of adult male rats dosed with a sublethal dose of TTZ (1
mg/kg) produced 50% mortality.

Adult male rats pretreated with DEM

(970 mg/kg) and 1 mg TTZ/kg produced 88% mortality.

Previously, no

m ortality was observed a t 1 mg TTZ/mg ip. P retreatm ent of ra ts with DEM
(485 mg/kg) produced 100% m ortality in adult male ra ts dosed with TTZ (5
mg/kg). L-Buthionine-(SR)-sulfoxamine (inhibitor of glutathione synthesis)
pretreatm ent decreased the toxicity of TTZ in male ra ts and no m ortality
was observed (Table 38).

Pretreatm ent with DEM potentiated the toxicity of TTZ in adult female and
im m ature rats.

The combination treatm ent with DEM and TTZ caused

66% mortality a t 1 mg TTZ/kg; 83% m ortality a t 1.25 and 5mg TTZ/kg and
100% m ortality a t 2.5 and 10 mg TTZ/kg in female rats (Table 39). The
response of im m ature male rats to TTZ was also potentiated by DEM
pretreatm ent, whereby 90% m ortality was observed in both 30 and 40 day
old im m ature male ra ts after adm inistration of 10 mg TTZ/kg. Im m ature
female ra ts showed a sim ilar response, in which 60% m ortality was
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TABLE 37
EFFECT OF DIETHYLMALEATE (DEM) PRETREATMENT ON 2THIOTRIAZONE (TTZ) TOXICITY IN ADULT MALE RATS'1

Group
No.

DEM
(mg/kg)

TTZ
(mg/kg)

No. Dead/No. Tested

% Mortality

Ik

485

0

0/5

0

3k

II

1

5/10

50

4k

II

5

10/10

100

2k

970

0

1/5

20

5k

it

1

8/9

88

a All rats were administered DEM 0.5 h r prior to adm inistration of TTZ.
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TABLE 38
EFFECT OF DIETHYLMALEATE (DEM) AND L-BUTHIONINE-(SR)SULFOXAMINE (BSO) PRETREATMENT ON 2-THIOTRIAZONE (TTZ)
TOXICITY IN MALE RATS'*.

BSO°

DEMb
TTZ

Group

(mg/kg)

No. Dead

%

Group

No. Tested Mortality

No. Dead/

%

No. Tested

Mortality

1

3j

5/10

50

5j

0/3

0

5

4j

10/10

100

6j

0/3

0

a All rats were administered TTZ ip 0.5 hr after adm inistration of DEM
or BSO.
b DEM was administered ip (485) mg/kg).
c BSO was administered ip (1,786 mg/kg).
For dosing protocol see Table 10.
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TABLE 39
EFFECT OF DEM PRETREATMENT ON TTZ TOXICITY IN ADULT
FEMALE RATS'*.

Group

Sex

TTZ

No.

8k
9k

DEM

(mg/kg)

Female

0.5

No. Dead/No. Tested

485

% Mortality

0/6

0

m

1

4/6

66

10k

n

1.25

5/6

83

I lk

it

2.5

6/6

100

12k

ii

5

5/6

83

13k

it

10

6/6

100

All rats were administered DEM 0.5 hrs prior to adm inistration of
TTZ.
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observed in 30 day old female rats and 90% mortality was observed in
those 50 days of age (Table 40). Clinical signs of intoxication observed in
DEM + TTZ treated male, female and im m ature rats were the same as
signs observed in TTZ (10 mg/kg) dosed male rats. However, clinical signs
were more severe and occurred much faster (reached a maximum between
0.5-1 hour). Death usually occurred within 1-1.5 hours in both adult and
im m ature animals. Macroscopic lesions were also more severe (mottling of
the lungs, pulmonary edema, effusion and large swollen lungs th a t filled
the chest cavity).

Histopathologic evaluation of rats treated with DEM and TTZ combination
showed no hepatic structural alterations.

Diethylmaleate itself did not

cause any structural alterations in the lungs of male or female rats (Figures
24, 25). Histological changes observed in adult male ra ts pretreated with
DEM and subsequently dosed with TTZ (10 mg/kg ip) were the same as
responses observed in male rats exposed to TTZ (10 mg/kg) alone (Figure
26). Histological changes observed were severe perivascular and interstitial
edema.

Edema was located principally around blood vessels with slight

infiltration of neutrophils, macrophages and lymphocytes. This shows th at
DEM did not potentiate the toxic effects of TTZ in male rats.

However,

diethylmaleate (DEM) pretreatm ent did potentiate the effect of TTZ in adult
female rats, whereby histological examination of lung tissue of female rats
pretreated with DEM and subsequently dosed with TTZ (10 mg/kg) showed
the exact same response as male rats dosed with TTZ (10 mg/kg) alone.
Large areas of perivascular and peribronchial edema with some distension
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TABLE 40
EFFECT OF DEM PRETREATMENT ON TTZ TOXICITY IN
IMMATURE RATS0.

Group

Sex

No.

Age
(days)

14k

Male

15k

n

it

16k

it

40

17k

it

it

18k

30

Female 30

19k

n

it

20k

it

40

21k

ti

it

TTZ

DEM

(mg/kg)

1

No. Dead/
No. Tested

485

%
Mortality

0/10

0

10

it

9/10

90

1

M

0/10

0

10

it

9/10

90

0/10

0

1

485

10

ii

6/10

60

1

ii

0/10

0

10

ii

9/10

90

a All rats were administered DEM 0.5 hrs prior to adm inistration of
TTZ.
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F igu re 24 . P hotom icrograph o f a b ron ch ovascu lar bu n d le o f a m ale
rat after 1 h r ex p osu re to DEM (485 m g/kg),
a = bronchiole; b = artery; c = a lv eo li. S tain ed w ith
hem otoxylin -eosin ; x 112.

F igu re 25 . P h otom icrograp h o f a b ron ch ovascu lar b u n d le o f a
fem ale ra t a fter 1 h r exp osu re to DEM (485 m g/kg),
a = b ro n ch iole ; b = artery ; c = a lv eo li. S tain ed w ith
h em otoxylin -eosin ; x 113.
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F igu re 26 . P h otom icrograp h o f b ron ch ovascu lar b u n d le o f a m ale
ra t ex p o sed to DEM (485 m g/kg) , 0.5 h r p rior to
ad m in istration o f TTZ (10 m g/kg) , and 1 h r after
treatm en t w ith TTZ . a = b ron ch iole ; b = artery ;
c = p eriv a scu la r edem a ; d = in te r stitia l edem a.
S ta in ed w ith h em otoxylin -eosin ; x 83.
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into the alveoli (interstitial edema) and also mild interstitial inflammatory
response (infiltration of neutrophils, macrophages and lymphocytes) were
observed (Figure 27). These histopathological findings correlate well with
toxicity data for DEM and TTZ in combination.

Results show th a t the DEM and TTZ combination did not affect liver
weights and liver to body weight ratios in adult male and female rats but
did significantly increase liver weights in im m ature male rats (Table 41).
Liver to body weight ratios in im m ature rats were also significantly
increased from those of the control group. Lung weights and lung to body
weight ratios were significantly increased in male, female and im m ature
male rats after exposure to DEM and TTZ in combination (Table 42). In
all cases treated groups had significantly increased values compared to
controls.

Effect of DEM and BSO on Resistance in R ats:

Diethylmaleate pretreatm ent reversed the resistance obtained in adult male
rats by prior exposure to a sublethal dose of TTZ or survival from a toxic
dose (TTZ induced resistance). Diethylmaleate pretreatm ent caused TTZ (5
mg/kg) to be toxic to 100% of the resistant rats tested (Table 43).

L-

Buthionine-(SR)-sulfoxamine did not reverse the resistance and animals
remained non-susceptible to TTZ. The resistance produced by BNF in adult
male rats was also reversed by DEM pretreatm ent and subsequent dosing
of a toxic dose of TTZ (5 mg/kg), producing 100% m ortality in the BNF
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F igu re 27 . P hotom icrograph o f a bron ch ovascu lar bu n d le o f a
fem ale rat exp osed to DEM (485 m g/kg) , 0.5 h r p rior to
ad m in istration o f TTZ (10 m g/kg) , and 1 h r a fter the
treatm en t w ith TTZ. a = b ron ch iole ; b = artery ;
c = p erivascu lar edem a ; d = in te r stitia l edem a .
S tain ed w ith h em otoxylin -eosin ; x 83.

TABLE 41
LIVER WEIGHTS (g) AND LIVER TO BODY WEIGHT RATIOS FOR
RATS DOSED WITH DEM-TTZ COMBINATION®.

Group

Sex

Liver Wt.(g)

Liver to
Body Wt.Ratio

1L (DEM-Control)
1L (DEM-TTZ)
4L (DEM-Control)
4L (DEM-TTZ)
5L (DEM-Control)
6L (DEM-TTZ)

Male
ft

Female
tt

Im m ature
ft

11.47 ± 1.17°

3.34 ± 0.23

13.22 ± 1.71°

3.90 ± 0.33®

7.62 ± 0.80

2.92 ± 0.49

8.35 ± 0.93

3.18 ± 0.46

7.18 ± 0.69

4.02 ± 0.07

10.19 ± 1.90

5.34 ± 0.72b

® All rats were administered DEM (485 mg/kg) 0.5 h r prior to exposure
to TTZ (10 mg/kg). D ata represent Mean ± SD for n=6 animals.
b Significantly different (p<0.05) from male DEM-Control body to liver
wt. ratio.
c Significantly different (p<0.05) from im m ature male DEM-Control liver
to body wt. ratio.
d Significantly different (p<0.05) from im m ature and female liver
weights.
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TABLE 42
LUNG WEIGHT AND LUNG TO BODY WEIGHT RATIOS FOR RATS
DOSED WITH DEM-TTZ COMBINATION®.

Group

Sex

Lung Wt.(g)

Lung to
Body Wt. Ratio

1L (DEM-Control)
1L (DEM-TTZ)
4L (DEM-Control)
4L (DEM-TTZ)
5L (DEM-Control)
6L (DEM-TTZ)

Male
ii

Female
it

Im m ature
ii

2.02 ± 0.47

0.59 ± 0.15

5.19 ± 0.98b

1.53 ± 0.23c

1.66 ± 0.54

0.64 ± 0.24

3.95 ± 1.07d

1.49 ± 0.378

1.06 ± 0.13

0.59 ± 0.03

2.81 ± 0.71r

1.48 ± 0.33B

a All rats were administered DEM (485 mg/kg) 0.5 h r prior to dosing
with TTZ (10 mg/kg)ip. D ata represent Mean ± SD for n=6 animals.
b Significantly increased (p<0.05) from male DEM-Control weight .
0 Significantly increased (p<0.05) from male DEM-Control liver to body
wt. ratio.
d Significantly increased (p<0.05) from female DEM-Control weights.
8 Significantly increased (p<0.05) from female DEM-Control lung to body
weight ratios.
f Significantly increased (p<0.05) from im m ature DEM-Control weights.
B Significantly increased (p<0.05) from im m ature DEM-Control lung to
body weight ratios.
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TABLE 43
EFFECT OF DIETHYLMALEATE (DEM) AND L-BUTHIONINE-(SR)SULFOXAMINE (BSO) ON 2-THIOTRIAZONE (TTZ)8 INDUCED
RESISTANCE IN ADULT MALE RATS.

Group

Treatm ent

lk

DEMb

6/6

100

2k

BSO'

0/3

0

No. Dead/No. Tested

% M ortality

8 All rats were administered TTZ (5 mg/kg ip).
b Administered diethylmaleate (485 mg/kg ip).
c Administered L-Buthionine-(SR)-sulfoxamine (1,786 mg/kg ip).
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induced resistant rats tested (Table 44). BSO did not alter or effect the
BNF induced resistance in rats.

The route of exposure or adm inistration

of TTZ affected the toxicity of TTZ in BNF induced anim als (Table 45).
Oral adm inistration of TTZ produced 83% toxicity and ip adm inistration of
TTZ produced 100% m ortality (10% increase), which is consistent with
increased toxicity with ip adm inistration of TTZ.
observed with phenobarbital induced animals.

However, this was not

All PB induced rats died

with 30-45 m inutes when treated with DEM + TTZ.

Effect of DEM and TTZ in combination on hepatic microsomal enzymes and
enzyme activities in rats:

Diethylmaleate (DEM) and 2-thiotriazone (TTZ) combination did not
significantly affect hepatic microsomal cytochromes P-450 (Table 46) or b5
content (Table 47), NADH cytochrome-b5 (Table 48) and NADPH cytochromeC-reductase activities (Table 49), glutathione-S-transferase activity (Table 50)
and UDP-glucuronosyltransferase activity (Table 51) in non-induced female
and imm ature rats. However, cytochrome P-450 content was significantly
decreased in adult male rats (Table 46), whereas cytochrome b5 and all
other activities were not affected.

Both PB and BNF induced rats had

significantly higher P-450 content th an non-induced rats.

Cytochrome P-

450 content in PB induced ra ts administered both DEM and TTZ was
significantly lower than DEM controls (Table 46). Cytochrome P-450 content
in PB induced DEM control ra ts was also significantly higher than in BNF
induced anim als (Figure 28). Hepatic cytochrome b5 content in BNF induced
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TABLE 44
EFFECT OF DIETHYLMALEATE (DEM) AND L-BUTHIONINE (SR)SULFOXAMINE ON fi-NAPTHOFLAVONE (BNF) INDUCED RESISTANCE
TO 2-THIOTRIAZONE (TTZ) IN ADULT MALE RATS8.

Group

TTZ

DEM

BSO

BNF

(mg/kg)

3k

10

4k

10

No. Dead/
No. Tested

485
1786

%

Mortality

50

6/6

100

50

0/3

0

8 All rats were administered TTZ 24 hrs after BNF induction
and 0.5 h r after pretreatm ent with DEM or BSO

TABLE 45
EFFECT

OF DIETHYLMALEATE

(DEM) PRETREATMENT

ON

13-

NAPTHOFLAVONE (BNF) OR PHENOBARBETAL (PB) INDUCED ADULT
MALE RATS WHEN ADMINISTERED 2-THIOTRIAZONE (TTZ) EITHER
ORALLY OR INTRAPERITONEALLY (IP)0.

Enzvme Modifiers
PBC

BNFb
>

Route

Oral
it

IP
tt

TTZ

No. Dead/

%

No. Dead/

%

(mg/kg)

No. Tested

Mortality

No. Tested

Mortality

0

0/5

0

0/6

0

10

5/6

83

6/6

100

0

0/5

0

0/6

0

10

6/6

100

6/6

100

° All rats were administered TTZ 24 hrs after induction with BNF and 0.5
h r after pretreatm ent with DEM.
b 13-Napthoflavone (50 mg/kg) adm inistered via ip injection.
c Phenobarbital (60 mg/kg) administered via ip injection.
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TABLE 46
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) IN
COMBINATION ON HEPATIC CYTOCHROME P-450 CONTENT IN
INDUCED AND NON-INDUCED RATS'*.

Cytochrome P-450
(nmoles/mg microsomal protein)
Group

DEM-CONTROL

1L (Male)

0.572 ± 0.065

0.370 ± 0.234b

4L (Female)

0.575 ± 0.193

0.360 ± 0.106

5L (Immature Male)

0.541 ± 0.198

0.481 ± 0.105

2L (Male BNF Induced)

0.952 ± 0.323°

0.876 ± 0.327°

3L (Male PB Induced)

1.706 ± 0.184cd

1.075 ± 0.271°'

a

DEM-TTZ

D ata represent Mean ± SD for n=5 groups of 3 pooled livers per group.

b Significantly different (p<0.05) from male DEM-Controls.
c

Significantly different (p<0.05) from non-induced DEM-Controls.

d

Significantly different (p<0.05) from BNF induced DEM-Controls.

e Significantly different (p<0.05) from non-induced DEM-TTZ treated
animals.
f Significantly different (p<0.05) from male PB induced DEM-Controls.
For dosing protocol see Table 12.
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TABLE 47
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) IN
COMBINATION ON HEPATIC CYTOCHROME B5 CONTENT IN INDUCED
AND NON-INDUCED RATSa.
Cytochrome b5
(nmoles/mg microsomal protein)
Group

DEM-CONTROL

1L (Male)

0.219 ± 0.027

0.184 ± 0.040

4L (Female)

0.218 ± 0.061

0.190 ± 0.033

5L (Immature Male)

0.250 ± 0.088

0.189 ± 0.045

2L (Male BNF Induced)

0.329 ± 0.081b

0.293 ± 0.082b

3L (Male PB Induced)

0.243 ± 0.059

0.242 ± 0.057

DEM-TTZ

a Data represent Mean ± SD for n=5 groups of 3 pooled livers per group.
b Significantly different (p<0.05) from male DEM-Controls and all DEMTTZ treated animals.
For dosing protocol see Table 12.

TABLE 48
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) IN
COMBINATION ON HEPATIC MICROSOMAL NADH CYTOCHROME-B5REDUCTASE ACTIVITY IN INDUCED AND NON-INDUCED RATS°.
NADH cytochrome-b6-reductase
(nmoles cytochrome-b5 reduced
min/mg microsomal protein)
Group

DEM-CONTROL

DEM-TTZ

1L (Male)

468.366 ± 48.069

521.564 ± 279.899

4L (Female)

585.546 ± 115.481

499.968 ± 48.715

5L (Im mature Male)

478.700 ± 80.485

478.760 ± 275.233

2L (Male BNF Induced)

526.076 ± 93.426b

587.562 ± 199.962

3L (Male PB Induced)

234.958 ± 40.493bc

304.246 ± 91.634

a D ata represent Mean ± SD for n=5 groups of 3 pooled livers per group.
b Significantly different (p<0.05) from non-induced DEM-Controls and DEMTTZ treated animals.
c Significantly different (p<0.05) from BNF induced DEM-Controls and BNF
induced DEM-TTZ treated animals.
For dosing protocol see Table 12.

TABLE 49
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) IN
COMBINATION ON HEPATIC MICROSOMAL NADPH CYTOCHROME-CREDUCTASE ACTIVITY IN INDUCED AND NON-INDUCED RATS'1.

NADPH cytochrome-C-reductase
(nmoles cytochrome-C reduced
min/mg microsomal protein)
Group

DEM-CONTROL

DEM-TTZ

1L (Male)

128.194 ± 45.114

89.108 ± 17.501

4L (Female)

118.504 ± 40.582

83.152 ± 15.720

5L (Immature Male)

167.224 ± 128.862

102.213 ± 49.166

2L (Male BNF Induced)

142.868 ± 90.464

109.904 ± 61.908

3L (Male PB Induced)

285.888 ± 155.582b,c

118.164 ± 51.546

a D ata represent Mean ± SD for n=5 groups of 3 pooled livers per group.
b Significantly different (p<0.05) from non-induced DEM-Controls and DEMTTZ treated animals.
c Significantly different (p<0.05) from male BNF induced DEM-Controls and
BNF induced DEM-TTZ treated animals.
For dosing protocol see Table 12.
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TABLE 50
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) IN
COMBINATION

ON

HEPATIC

CYTOSOLIC

GLUTATHIONE-S-

TRANSFERASE ACTIVITY IN INDUCED AND NON-INDUCED RATSa.

Glutathione-S-transferase
(nmole l-chloro-2,4-dinitrobenzene
conjugated/min/mg microsomal protein)
Group

DEM-TTZ

DEM-CONTROL

1L (Male)

1643.186 ± 362.269

1638.380 ± 559.287

4L (Female)

1686.776 ± 543.289

1764.322 ± 375.091

5L (Immature Male)

2189.010 ± 564.719

2306.694 ± 753.281

2L (Male BNF Induced)

2003.072 ± 369.029

1903.526 ± 506.138

3L (Male PB Induced)

2599.830 ± 542.83l bc

1963.354 ± 428.114

a D ata represent Mean ± SD for n=5 groups of 3 pooled livers per group.
b Significantly different (p<0.05) from male DEM-Controls.
0 Significantly different (p<0.05) from female DEM-Controls.
For dosing protocol see Table 12.

TABLE 51
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THI0TRIAZ0NE (TTZ) IN
COMBINATION

ON

HEPATIC

MICROSOMAL

UDP-

GLUCURONOSYLTRANSFERASE ACTIVITY IN INDUCED AND NONINDUCED RATS".
UDP-glucuronosyltransferase
(nmoles p-nitrophenol
conjugated/min/mg microsomal protein)
Group

DEM-CONTROL

1L (Male)

0.987 ± 0.423

0.706 ± 0.591

4L (Female)

1.799 ± 1.732

1.230 ± 0.727

5L (Im mature Male)

2.202 ± 1.530

1.031 ± 1.528

2L (Male BNF Induced)

1.788 ± 1.544

1.479 ± 0.752

3L (Male PB Induced)

1.110 ± 0.689

1.089 ± 0.732

DEM-TTZ

" D ata represent Mean ± SD for n=5 groups of 3 pooled livers per group.
For dosing protocol see Table 12.

DEMC

DEMT BNFDC BNFDT PBDC

PBDT

F igu re 28 . E ffect o f d ieth ylm alea te (DEM) + TTZ in com b in ation
o n h ep atic m icrosom al cytochrom e P-450 co n ten t in
in d u ced and non*induced ra ts. DEMC = DEM -Control ;
DEMT = DEM + TTZ ; BNFDT = (i-napthoflavone
in d u ced + DEM ; PBDC = ph en ob arh ital in d u ced +
DEM ; PBDT = ph en ob arh ital in d u ced + DEM + TTZ .
F or d osin g p ro toco l se e T able 12 . * * S ig n ifica n tly
d ifferen t (p < 0.05) from DEM co n tro ls .
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male control rats was significantly higher than content in non-induced male,
female, im m ature and PB induced anim als (Table 47; Figure 29). NADH
cytochrome-bg-reductase activities in PB induced DEM control male rats
were significantly decreased from non-induced and BNF induced rats (Table
48; Figure 30), and NADPH cytochrome-C-reductase in PB induced DEM
controls were significantly increased from non-induced and BNF induced
rats (Table 49; Figure 31). Glutathione-S-transferase activity in PB induced
male rats was also significantly higher th an adult male and female noninduced rats (Table 50; Figure 32).

UDP-glucuronosyltransferase activity

was not affected by induction with PB or BNF (Figure 33).

Diethylmaleate and TTZ in combination did not significantly affect hepatic
aldrin epoxidase (Table 52), EROD (Table 53), or ECOD (Table 54) activities
in non-induced adult male and im m ature male rats. However, female rats
had significantly lower AE activity than non-induced (adult male and
im m ature male) and induced male rats.

Aldrin epoxidase, EROD and

ECOD activities in relation to cytochrome P-450 content was increased
approximately 2-fold in m ale (DEM-TTZ), female (Controls and DEM-TTZ),
and im m ature male (Controls and DEM-TTZ). These activities in relation
to cytochrome P-450 content was slightly higher in BNF and slightly lower
in PB induced male rats. In all cases where anim als were induced with
BNF or PB, activities were significantly higher th an activities in noninduced rats. An exception is th a t aldrin epoxidase activity in BNF induced
rats was significantly lower th an in non-induced male and im m ature male
rats. Aldrin epoxidase activity in PB induced rats was also significantly

NM

CYTOCHROME

B5/MG

PROTEIN
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DEMC

DEMT BNFDC BNFDT PBDC

PBDT

F igu re 29 . E ffect o f DEM + TTZ in com b in ation o n h ep a tic
m icrosom al cytoch rom e bs co n ten t in in d u ced an d nonin d u ced m ale ra ts . F or id en tifica tio n o f ab b reviation s
se e F ig u re 28 . F or d o sin g p ro tocol se e T able 12 .
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DEMC

DEMT BNFDC BNFDT PBDC

PBDT

F igu re 30 . E ffect o f DEM + TTZ in com b in ation on h ep a tic
m icrosom al NADH cytochrom e-bs-red u ctase a ctiv ity in
in d u ced and n on -in d u ced m ale ra ts . F or id en tifica tio n
o f ab b reviation s se e F igu re 28 . F or d o sin g p rotocol
se e T able 12 . * = S ig n ifica n tly d ifferen t (p < 0.05) from
DEM con trols.
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NM CYT. C REOUCED/MIN/MG

PROTEIN

400

A

300

200

100

0
DEMC

DEMT BNFDC BNFDT PBDC

PBDT

F igu re 31 . E ffect o f DEM + TTZ in com b in ation on h ep a tic
m icrosom al NADPH cytochrom e-C -reductase a c tiv ity in
in d u ced and n on -in d u ced m ale ra ts . F or id en tifica tio n
o f a b b reviation s se e F igu re 28 . F or d o sin g p rotocol
se e T able 12 . * = S ig n ifica n tly d ifferen t (p < 0.05) from
DEM con tro ls.

NM CDNB CONJUGATED/MIN/MG

PROTEIN
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DEMC

DEMT BNFDC BNFDT PBDC

PBDT

F igu re 32 . E ffect o f DEM + TTZ in com b in ation on h ep a tic
cy to so lic glu tath ion e-S -tran sferase a c tiv ity in in d u ced
an d n on -in d u ced m ale ra ts . F or id en tific a tio n o f
ab b reviation s se e F igu re 28 . F or d o sin g p rotocol see
T able 12 . * « S ig n ifica n tly d ifferen t (p < 0.05) from
DEM con tro ls.

DEMC

DEMT BNFDC BNFDT PBDC

PBDT

F igu re 33 . E ffect o f DEM + TTZ in com b in ation o n h ep a tic
m icrosom al U D P -glucuronosyltransferase a c tiv ity in
in d u ced and n on -in d u ced m ale rats . F or id en tifica tio n
o f ab b reviation s se e F igu re 28 . F or d o sin g p rotocol
s e e T able 12 .

TABLE 52
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL
ALDRIN EPOXIDASE ACTIVITY IN INDUCED AND NON-INDUCED RATS*.

Aldrin epoxidase
nmoles dieldrin formed/min/mg/microsomal protein
(nmoles dieldrin formed/min/nmole P-450)
DEM-CONTROL

DEM-TTZ

1L (Male)

1.728 ± 0.303
(3.099 ± 0.823)

1.129 ± 0.551
(3.227 ± 0.451)

4L (Female)

0.138 ± 0.146b
(0.320 ± 0.453)

0.149 ± 0.151'
(0.417 ± 0.539)

5L (Immature Male)

1.158 ± 0.401
(2.190 ± 0.476)

0.879 ± 0.228
(2.056 ± 0.605)

2L (Male BNF Induced)

0.755 ± 0.183d-*
(0.918 ± 0.474)

0.558 ± 0.2111-®
(0.737 ± 0.517)

3L (Male PB Induced)

5.339 ± 1.838w
(3.140 ± 1.155)

3.962 ± 1.256s*
(3.760 ± 1.208)

* Data represent Mean ± SD for n=5 groups of 3 pooled livers per group.
b Significantly lower (p<0.05) than male, immature male and induced (BNF or PB) male controls.
c Significantly lower (p<0.05) than male, immature male and induced male (BNFor PB) DEM-TTZ treated
animals.
d Significantly lower (p<0.05) than non-induced male and immature male DEM-Controls.
* Significantly higher (p<0.05) than non-induced female DEM-Controls.
' Significantly lower (p<0.05) than non-induced male, and immature male DEM-TTZ groups.
* Significantly higher (p<0.05) than non-induced female DEM-Controls.
h Significantly higher (p<0.05) than non-induced DEM-Controls.
1 Significantly higher (p<0.05) than BNF induced DEM-Controls.
j Significantly higher (p<0.05) than non-induced DEM-TTZ treated animals.
k Significantly higher (p<0.05) than BNF induced DEM-TTZ treated animals.
For dosing protocol see Table 12.

TABLE 53
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL
7-ETHOXYRESORUFIN-O-DEETHYLASE (EROD) ACTIVITY IN INDUCED AND NON-INDUCED
RATS*.

EROD
pmoles resorufin formed/min/mg/microsoinal protein
(pmoles resorufin formed/min/nmole P-450)

GROUP

DEM-CONTROL

DEM-TTZ

1L (Male)

117.662 ± 80.559
(66.460 ± 116.557)

85.698 ± 65.907
(238.500 ± 131.187)

4L (Female)

66.460 ± 37.981
(113.754 ± 44.545)

55.242 ± 27.887
(156.538 ± 78.338)

5L (Immature Male)

151.066 ± 159.478
(268.975 ± 234.054)

96.100 ± 106.880
(198.939 ± 208.725)

2L (Male BNF Induced)
3L (Male PB Induced)
*
b
*
d
*

5276.446 ± 1053.070b
(6399.681 ± 3329.304)

4416.738 ± 1646.205d
(5203.894 ± 1150.502)

544.762 ± 381.773“
(305.979 ± 196.115)

658.292 ± 424.978^
(631.609 ± 496.019)

Data represent Mean ± SD for n=5 groups of 3 pooled livers per group.
Significantly higher (p<0.05) than non-induced DEM-Controls.
Significantly lower (p<0.05) than BNF induced DEM Controls.
Significantly higher (p<0.05) than non-induced DEM-TTZ treated animals.
Significantly lower (p<0.05) than BNF induced DEM-TTZ treated animals.
For dosing protocol see Table 12.

TABLE 54
EFFECT OF DIETHYLMALEATE (DEM) AND 2-THIOTRIAZONE (TTZ) ON HEPATIC MICROSOMAL 7ETHOXYCOUMARIN'O-DEETHYLASE (ECOD) ACTIVITY IN INDUCED AND NON-INDUCED RATS*.

ECOD
nmoles 7-hydroxycoumarin formed/min/mg/microsomal protein
(nmoleB 7-hydroxycoumarin formed/min/nmole P-450)
GROUP

DEM-CONTROL

DEM-TTZ

1L (Male)

1.915 ± 1.201
(3.541 ± 2.466)

1.057 ± 0.369
(3.904 ± 2.123)

4L (Female)

1.240 ± 1.104
(2.017 ± 1.513)

0.810 ± 0.728
(2.214 ± 2.017)

5L (Immature Male)

2.514 ± 0.517
(5.119 ± 1.927)

1.952 ± 0.751
(4.706 ± 2.159)

15.214 ± 3.460"
(19.079 ± 11.983)

12.518 ± 3.757d
(15.616 ± 5.975)

5.572 ± 0.621"'
(3.310 ± 0.637)

4.142 ± 0.998'’*
(3.877 ± 0.514)

2L (Male BNF Induced)
3L (Male PB Induced)

* Data represent Mean ± SD for n=5 groups of 3 pooled livers per group.
" Significantly higher (p<0.05) than non-induced
DEM-Controls.
*Significantly lower (p<0.05) than BNF induced DEM-Controls.
d Significantly higher (p<0.05) than non-induced
DEM-TTZ treatedanimals.
*Significantly lower (p<0.05) than BNF induced DEM-TTZ treated animals.
For dosing protocol see Table 12.
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higher than activity in BNF induced anim als (Table 52; Figure 34). Both
EROD and ECOD activity in BNF induced anim als were significantly higher
th an activities in PB induced ra ts (Tables 53 and 54; Figures 35 and 36).
Phenobarhital induced rats

treated

with DEM

and TTZ also had

significantly lower ECOD activity th an PB induced DEM controls.

A comparison of the effects of TTZ and DEM + TTZ in combination on
organ weights is presented in Table 55. Lung weights in adult male and
female and im m ature male rats were significantly increased when exposed
to DEM and TTZ in combination compared to control and TTZ treated rats.
In fact, lungs of adult male ra ts adm inistered DEM and TTZ in combination
were 3 times as heavy as control r a t lungs and 2 times as heavy as lungs
from TTZ treated rats.

Female and im m ature male ra t lungs were

approximately 2 times as heavy as control and TTZ treated ra t lungs. Liver
weights were virtually the same in DEM+TTZ treated, DEM control, and
TTZ treated and control animals.

However, im m ature male ra t liver

weights in the DEM-TTZ treated group were significantly increased
compared to DEM controls, and TTZ treated and control livers.

Comparison of the effects of TTZ and DEM + TTZ in combination on organ
to body weight ratios is shown in Table 56. Lung to body weight ratios in
rats dosed with the DEM-TTZ combination followed the same pattern as
organ weights except all lung to body weight ratios in adult male and
female and im m ature male ra ts dosed with the combination were
approximately 3-fold higher th an controls and 2-fold higher th an TTZ

DEMC

DEMT BNFDC BNFDT PBDC

PBDT

F igu re 34 . E ffect o f DEM + TTZ in com b in ation on h ep a tic
m icrosom al ald rin ep ox id ase a c tiv ity in in d u ced and
n on -in d u ced m ale ra ts . F or id e n tific a tio n o f
ab b reviation s se e F igu re 28 . F or d o sin g p rotocol se e
T able 12 . * = S ig n ifica n tly d ifferen t (p < 0.05) from
DEM con trol.

DEMC

DEMT

BNFDC BNFDT

PBDC

PBDT

F igu re 35 . E ffect o f DEM + TTZ in com b in ation on h ep a tic
m icrosom al EROD a c tiv ity in in d u ced an d n on -in d u ced
m ale ra ts . F or id en tific a tio n o f ab b reviation s se e
F igu re 28 . F or d o sin g p rotocol se e T able 12 .
* c S ig n ifica n tly d ifferen t (p < 0.05) from DEM con trol.
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DEMC

DEMT BNFDC BNFDT PBDC

PBDT

F igu re 36 . E ffect o f DEM + TTZ in com b in ation o n h ep a tic
m icrosom al ECOD a c tiv ity in in d u ced an d n on -in d u ced
m ale ra ts . F or id e n tific a tio n o f ab b reviation s se e
F igu re 28 . F or d o sin g p rotocol se e T able 12 .
* s S ig n ifica n tly d ifferen t (p < 0.05) from DEM con trol.

TABLE 55
COMPARISON OF THE EFFECT OF TTZ AND DEM-TTZ IN COMBINATION ON ORGAN WEIGHTS.
TTZa

DEMb and TTZ

Sex

Organ

Control

Male

Lung
Liver

1.69 ± 0.27
13.12 ± 1.15

2.07 ± 0.28c
13.48 ± 1.06

2.02 ± 0.47
11.47 ± 1.17

5.19 ± 0.98d4’1
13.22 ± 1.71

Female

Lung
Liver

1.22 ± 0.11
8.92 ± 1.11

2.03 ± 0.39e
8.57 ± 0.83

1.66 ± 0.54
7.60 ± 0.80

3.95 ± 1.07fJjn
8.35 ± 0.93

Immature
(Male)

Lung
Liver

1.13 ± 0.07
8.46 ± 0.90

1.41 ± 0.14g
8.34 ± 0.49

1.06 ± 0.12
7.18 ± 0.69

2.80 ± 0.71h*n
10.19 ± 1.90°

a
b
c
d
e
f
g
h

TTZ

DEM-CONTROL

DEM-TTZ

TTZ (10 mg/kg) administered via ip injection. D ata represent Mean ± SD for n = 6 animals.
DEM (485 mg/kg) administered via ip injection 0.5 h r prior to TTZ exposure.
Significantly increased (p<0.05) from male control group.
Significantly increased (p<0.05) from male DEM-Control group.
Significantly increased (p<0.05) from female control group.
Significantly increased (p<0.05) from female DEM-Control group.
Significantly increased (p<0.05) from imm ature control group.
Significantly increased (p<0.05) from im m ature DEM-control group.
1
Significantly increased (p<0.05) from male control group.
j Significantly increased (p<0.05) from female control group.
k Significantly increased (p<0.05) from imm ature control group.
Significantly increased (p<0.05) from male TTZ group.
1
m Significantly increased (p<0.05) from female TTZ group.
n Significantly increased (p<0.05) from male TTZ group.
0
Significantly increased (p<0.05) from imm ature male control, TTZ treated, and DEM-Control group.
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DEM control groups (Table 56). Liver to body weight ratios were increased
in adult male rats treated with the DEM + TTZ combination, compared to
DEM controls. Liver to body weight ratios in im m ature ra ts treated with
the DEM + TTZ combination were significantly increased form DEM control,
TTZ treated and TTZ control groups.

The effects of TTZ and DEM + TTZ in combination are compared in this
study. Results show th at TTZ alone did not affect hepatic microsomal and
cytosolic enzymes in non-induced adult male rats (Table 57).

There was,

however, a significant decrease in cytochrome P-450 content in DEM + TTZ
treated male rats from control and TTZ treated rats.

Aldrin epoxidase,

EROD and ECOD activities were not affected by TTZ or DEM + TTZ in
adult male rats (Table 58).

The combination of DEM and TTZ did not

significantly affect hepatic microsomal and cytosolic enzymes in adult female
rats (Table 59).

However, cytochrome P-450 content was significantly

increased in female rats treated w ith TTZ, and UDP-glucuronosyltransferase
activity (UDPGT) in female controls was significantly higher th an TTZ
treated, DEM control and DEM + TTZ treated rats.

Aldrin epoxidase,

EROD and ECOD activity in female rats was unaffected by TTZ or DEM
+ TTZ in combination . But, in relation to cytochrome P-450 content aldrin
epoxidase, EROD and ECOD activities were all induced two-fold (Table 60).
This coincides with the increase in cytochrome P-450 content in female rats.
2-Thiotriazone alone did not affect hepatic microsomal and cytosolic enzymes
in im m ature male rats.

Contrariwise, glutathione-S-transferase (GST)

activity in TTZ treated im m ature male rats was significantly lower than

TABLE 56
COMPARISON OF THE EFFECT OF TTZ AND DEM-TTZ IN COMBINATION ON ORGAN TO BODY
WEIGHT RATIOS.
t

TTZa

DEMb and TTZ

Sex

Organ

Control

Male

Lung
Liver

0.51 ± 0.07
3.98 ± 0.23

0.61 ± 0.08c
3.98 ± 0.17

0.59 ± 0.15
3.34 ± 0.23

1.53 ± 0.23^
3.90 ± 0.33

Female

Lung
Liver

0.48 ± 0.05
3.47 ± 0.35

0.78 ± 0.14e
3.32 ± 0.32

0.64 ± 0.24
2.92 ± 0.49

1.49 ± 0.37f,k
3.18 ± 0.48

Im mature
(Male)

Lung
Liver

0.62 ± 0.05
4.50 ± 0.44

0.78 ± 0.078
4.46 ± 0.41

0.59 ± 0.03
4.02 ± 0.07

1.48 ± 0.33hJ
5.34 ± 0.721

a
b
c
d
e
f
8

h
1

j
k
1

TTZ

DEM-CONTROL

DEM+TTZ

TTZ (10 mg/kg) administered via ip injection. Data represent Mean ± SD for n = 6 animals.
DEM (485 mg/kg) administered via ip injection 0.5 h r prior to TTZ exposure.
Significantly increased (p<0.05) from male control group.
Significantly increased (p<0.05) from male DEM-Control group.
Significantly increased (p<0.05) from female control group.
Significantly increased (p<0.05) from female DEM-Control group.
Significantly increased (p<0.05) from im m ature control group.
Significantly increased (p<0.05) from im m ature male DEM-Control group.
Significantly increased (p<0.05) from im m ature male control and TTZ treated group.
Significantly increased (p<0.05) from male control and TTZ treated group.
Significantly increased (p<0.05) from female control and TTZ treated group.
Significantly increased (p<0.05) from imm ature male control and TTZ treated group.

TABLE 57
COMPARISON OP THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON HEPATIC
MICROSOMAL AND CYTOSOLIC ENZYMES IN ADULT MALE RATS.

DEM and TTZ

TTZ

Control
Cytochrome P-450*
Cytochrome b,*
NADH cytochrome-bs-reductase'
NADPH cytochrome-C-reductase*
Glutathione-S-transferase*
UDP-Glucuronosyltransferaser

0.672 ± 0.109
0.223 ± 0.049
512.030 * 54.643
119.432 ± 32.687
1701.066 ± 502.263
1.309 ± 0.871

TTZ

0.718 ± 0.170
0.236 ± 0.055
526.434 ± 139.838
129.481 ± 50.869
1783.790 ± 493.839
0.968 ± 0.542

Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.
* n mole P-450/mg microsomal protein
k n mole bjvag microsomal protein
* n mole cytochrome-b6-reduced/min/mg microsomal protein
* n mole cytochrome-C-reduced/min/mg microsomal protein
* n mole l-chloro-2,4-dinitrobenzene conjugated/min/mg microsomal protein
r n mole p-nitrophenol coigugated/min/rag microsomal protein
1 Significantly different (p<0.05) from TTZ treated group.

DEM-Control
0.572 ±
0.2191
468.366 ±
128.194 ±
1643.186 ±
0.987 ±

0.065
0.027
48.069
46.114
362.269
0.423

DEM+TTZ
0.370 ± 0.234*
0.184 ± 0.040
521.664 ± 279.899
89.108 * 17.601
1638.380 ± 559.287
0.706 ± 0.591

TABLE 58
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON SELECTED
HEPATIC MICROSOMAL ENZYME ACTTVITIES IN ADULT MALE RATS.

TTZ

DEM and TTZ
TTZ

Control

DEM-Control

DEM+TTZ

Aldrin epoxidase
(nmoles dieldrin/min/mg/protein
(nmoles dieldrin/min/nmole P-450)

1.609 ±
2.606 ±

0.965
1.956

1.414 ±
2.261 ±

0.926
1.860

1.728 ±
3.099 ±

0.303
0.823

1.129 ±
3.227 ±

0.551
0.451

7-Ethoxycoumarin-O-deethylase
(nmoles 7-OH coumarin/min/mg/
protein)
(nmoles 7-OH coumarin/min/
nmole P-450)

1.262 ±

0.234

1.312 ±

0.317

1.915 ±

1.201

1.053 ±

0.369

1.941 ±

0.596

1.916 ±

0.713

3.541 ±

2.466

3.904 ±

2.123

7-Ethoxyresorufin-O-deethylase
(pmoles resorufin/min/mg/
protein)
(pmoles reaorufin/min/nmole
P-450)

116.558 ± 63.918

142.334 ± 87.806

117.662 ± 80.559

85.698 ± 65.907

166.595 ± 76.932

184.884 ± 74.934

194.201 ± 116.557

238.500 ± 131.870

Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.

TABLE 59
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON HEPATIC
MICROSOMAL AND CYTOSOLIC ENZYMES IN ADULT FEMALE RATS.

TTZ

DEM and TTZ

Control
Cytochrome P-450*
Cytochrome b5*
NADH cytochrome-bu-reductase'
NADPH cytochrome-C-reductased
Glutathione-S-transferase*
UDP-Glucuronosyltransferaser

0.456 ±
0.214 *
533.526 ±
107.254 ±
1480.552 *
3.269 *

TTZ
0.113
0.069
167.126
38.119
707.729
1.118u

0.585 ±
0.228 *
617.310 ±
105.605 ±
1368.984 ±
1.727 ±

Data represents the Mean * SD for n=5 groups of 3 pooled livers per group.
* n mole P-450/mg microsomal protein
k n mole b^mg microsomal protein
* n mole cytochrome-bs-reduced/min/mg microsomal protein
* n mole cytochrome-C-reduced/min/mg microsomal protein
* n mole l*chloro-2,4-dinitrobenzene coryugated/min/mg microsomal protein
' n mole p-nitrophenol conjugated/min/mg microsomal protein
■ significantly different (p<0.05) from control group.
k significantly different (p<0.05) from DEM-Control group.
1 significantly different (p<0.05) from DEM-Control group.

0.044*
0.058
91.387
29.083
734.334
0.381*

DEM-Control
0.575 ±
0.248 ±
585.546 ±
118.504 ±
1686.776 ±
1.779 ±

0.193
0.061
115.481
40.582
543.289
1.732

DEM+TTZ
0.360 ±
0.190 ±
499.968 *
83.152*
1764.322 *
1.230 *

0.108
0.033
48.715
16.720
376.001
0.727

TABLE 60
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON SELECTED
HEPATIC MICROSOMAL ENZYME ACTIVITIES IN ADULT FEMALE RATS.

DEM and TTZ

TTZ

Control

DEM-Control

TTZ

DEM+TTZ

Aldrin epoxidase
(nmoles dieldrin/min/mg/protein
(nmoles dieldrin/min/nmole P-450)

0.241 ±
0.555 ±

0.287
0.574

0.238 ±
0.421 ±

0.234
0.446

0.138 ±
0.320 ±

0.146
0.453

0.149 ±
0.417 ±

0.151
0.539

7-Ethoxycoumarin-O-deethylase
(nmoles 7-OH coumarin/min/mg/
protein)
(nmoleB 7-OH coumarin/min/
nmole P-460)

0.949 ±

0.800

0.953 ±

0.798

1.240 ±

1.104

0.810 ±

0.728

1.890 ±

1.217

1.619 ±

1.346

2.017 ±

1.513

2.214 ±

2.017

7-Ethoxyre8orufin-0-deethylase
(pmoles resorufin/min/mg/
protein)
(pmoles resorufin/min/nmole
P-450)

72.870 ± 52.751

60.042 ± 33.922

66.460 ± 37.981

56.242 ± 27.887

148.511 ± 71.547

107.111 ± 56.903

113.764 ± 44.545

156.638 ± 78.338

Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.

177
GST activity in DEM control and DEM + TTZ treated anim als, and UDPGT
activity in TTZ treated im m ature male rats was also significantly decreased
from th at of control im m ature rats (Table 61). Aldrin epoxidase activity in
DEM control and DEM+TTZ treated im m ature ra ts was significantly lower
than AE activity in control and TTZ treated im m ature rats (Table 62). In
relation to cytochrome P-450 content aldrin epoxidase, EROD and ECOD
activities were induced approximately two-fold.
Neither TTZ or DEM+TTZ in combination affected hepatic microsomal and
cytosolic enzymes in BNF induced ra ts (Table 63). Aldrin epoxidase activity
in BNF induced male rats was not affected. EROD activity, however, was
significantly decreased from th a t of DEM control anim als and in TTZ
treated rats EROD activity was also significantly decreased from DEM
controls. The activity of ECOD in DEM+TTZ treated rats was significantly
decreased from th a t of DEM controls (Table 64).

Administration of TTZ

alone did not affect hepatic microsomal or cytosolic enzymes in PB induced
male rats. The combination of DEM and TTZ caused a significant decrease
in cytochrome P-450 in PB induced rats.

NADH cytochrome-b5-reductase

activity in DEM control anim als was significantly increased from controls,
DEM controls, and DEM + TTZ treated rats.

Glutathione-S-transferase

activity in DEM controls was significantly increased over th a t of TTZ
treated, TTZ control and DEM + TTZ treated animals.

Glutathione-S-

transferase activity in DEM + TTZ treated PB induced rats was also
significantly decreased from values for DEM control rats (Table 65). Aldrin
epoxidase activity in the DEM + TTZ group was significantly decreased from
TTZ control, TTZ, and DEM control groups (Table

6 6

).

TABLE 61
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON HEPATIC
MICROSOMAL AND CYTOSOLIC ENZYMES IN IMMATURE MALE RATS (40 DAY OLD).

TTZ

DEM and TTZ
TTZ

Control
Cytochrome P-4501
Cytochrome b6k
NADH cytochrome-b*-reducta8e*
NADPH cytochrome-C-reductase4
Glutathione-S-traneferase*
UDP-Glucuronosyltransferaser

0.562 ±
0.174 ±
373.318 ±
101.884 ±
1579.632 ±
1.469 ±

0.230
0.066
111.214
30.406
332.546
0.543

0.487 ±
0.160 ±
329.194 ±
94.336 ±
1370.162 ±
0.618 ±

Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.
* n mole cytochrome P-450/mg microsomal protein
k n mole b/mg microsomal protein
* n mole cytochrome-b,-reduced/min/mg microsomal protein
4 n mole cytochrome-C-reduced/min/mg microsomal protein
* n mole l-chloro-2,4-dinitrobenzene cor\jugated/min/mg microsomal protein
’ n mole p-nitrophenol coqjugated/min/mg microsomal protein
( Significantly different (p<0.05) from DEM-Control group.
k Significantly different (p<0.05) from DEM+TTZ group.

0.243
0.072
85.296
17.163
224.365**
0.533*

DEM-Control
0.541 ±
0.250 ±
478.700 ±
167.224 *
2189.010 ±
2.202 ±

0.198
0.088
80.485
128.862
664.719
1.630

DEM+TTZ
0.441 ±
0.189 ±
478.760 ±
102.213 ±
2306.694 ±
1.031 ±

0.105
0.045
275.233
49.166
763.280
1.628

TABLE 62
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON SELECTED
HEPATIC MICROSOMAL ENZYME ACTIVITIES IN IMMATURE MALE RATS (40 DAY OLD).

TTZ

DEM and TTZ
TTZ

Control

DEM-Control

DEM+TTZ

Aldrin epoxidase
(nmoles dieldrin/min/mg/protein
(nmoles dieldrin/min/nmole P-450)

1.933 ±
4.076 ±

0.352
2.233

1.994 ±
5.260 ±

0.819
3.923

1.158 ±
2.190 ±

0.401°
0.476

0.879 ±
2.056 ±

0.228°
0.605

7-Ethoxycoumarin-O-deethylase
(nmoles 7-OH coumarin/coin/mg/
protein)
(nmoles 7-OH courmarin/min/
nmole P-450)

2.361 ±

1.553

2.175 ±

1.924

2.514 ±

0.517

1.952 ±

0.751

4.016 ±

1.395

3.837 ±

1.946

5.119 ±

1.927

4.706 x

2.159

7-Ethoxyresorufin-O-deethylase
(pmoles resorufin/min/mg/
protein)
(pmoleB rB8orufin/min/nmole
P-450)

. 108.158 ± 60.252

84.022 * 55.498

151.066 * 159.478

96.100 ± 106.880

186.668 ± 40.687

162.257 ± 34.721

268.975 ± 234.054

198.939 ± 208.725

Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.
* significantly different (p<0.05) from control group
k significantly different (p<0.05) from TTZ treated group

TABLE 63
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON HEPATIC
MICROSOMAL AND CYTOSOLIC ENZYMES IN G-NAPTHOFLAVONE (BNF) INDUCED MALE RATS.

TTZ

DEM and TTZ
TTZ

Control
Cytochrome P-450*
Cytochrome b f
NADH ^ytochrome-bk-reductase*
NADPH cytochrome-C-reductase*
Glutathione-S-transferase*
UDP-Glucuronosyltransferase'

0.934 ±
0.319 ±
483.310 ±
85.022 *
1571.626 ±
1.573 ±

0.191
0.125
132.240
30.227
386.389
0.847

0.899 ±
0.268 ±
499.236 ±
89.224 ±
1724.722 ±
1.685 ±

Data represents the Mean ± SD for n={> groups of 3 pooled livers per group.
e n mole P-450/mg microsomal protein
* n mole b/mg microsomal protein
* n mole cytochrome-bg-reduced/min/mg microsomal protein
* n mole cytochrome-C-reduced/min/mg microsomal protein
* n mole l-chloro-2,4-dinitrobenzene coiyugated/min/mg microsomal protein
' n mole p-nitrophenol coryugated/min/mg microsomal protein

0.206
0.032
148.890
29.551
323.825
0.690

DEM-Control
0.952 *
0.329 ±
526.076 ±
142.868 *
2003.072 ±
1.788 ±

0.323
0.081
93.426
90.464
369.029
1.544

DEM+TTZ
0.876 *
0.293 ±
587.662 ±
109.904 *
1903.626 *
1.479 ±

0.327
0.082
199.962
61.908
506.138
0.762

TABLE 64
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON SELECTED
HEPATIC MICROSOMAL ENZYME ACTIVITIES IN P-NAPTHOFLAVONE (BNF) INDUCED MALE RATS.

TTZ

DEM and TTZ

Control
Aldrin epoxidase
(nmoles dieldrin/min/mg/protein
(nmoles dieldrin/min/nmole P-450)
7-Ethoxycoumarin-O-deethylase
(nmoles 7-OH coumarin/min/mg/
protein)
(nmoles 7-OH coumarin/min/
nmole P-450)
7-Ethoxyresorufin-O-deethylase
(pmoles resorufin/min/mg/
protein)
(pmoles resorufin/min/nmole
P-450)

TTZ

DEM-Control

DEM+TTZ

0.674 ±
0.746 ±

0.269
0.231

0.474 ±
0.538 ±

0.114
0.122

0.755 ±
0.918 ±

0.183
0.474

0.553 ±
0.737 ±

0.211
0.517

13.572 ±

1.628

12.524 ±

2.428*

15.214 ±

3.460

12.518 ±

3.757*

15.405 ±

3.094

14.289 ±

3.462

19.079 ±

11.983

15.616 ±

5.975

4738.238 ± 770.045

4726.094 ± 392.997

5276.446 ± 1053.070

4416.738 ± 1646.205*

5044.185 ± 891.752

5497.358 ± 1429.831

6399.681 ± 3329.304

5203.894 ± 1150.502

Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.
* Significantly different (p<0.05) from DEM-Controls

TABLE 65
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON
HEPATIC MICROSOMAL AND CYTOSOLIC ENZYMES IN PHENOBARBITAL (PB) INDUCED MALE RATS.

DEM and TTZ

TTZ
Control
Cytochrome P-450*
Cytochrome b,b
NADH cytochrome-bs-reductase‘
NADPH cytochrome-C-reductased
Glutathione-S-transferase*
UDP-Glucuronosyltransferaser

1.534 ±
0.268 ±
244.832 ±
149.046 ±
2105.576 ±
1.080 ±

TTZ
0.405
0.059
59.575
55.332
468.469
0.229

1.584 ±
0.281 ±
271.626 ±
210.522 ±
2141.044 ±
1.137 ±

0.338
0.033
86.491
104.363
702.964
0.304

DEM-Control
1.706 *
0.184
0.243 ±
0.059
234.958 ± 40.493
285.880 ± 155.582"
2599.830 ± 542.831*"
1.110 ±
0.689

DEM+TTZ
1.075 ±
0.242 *
304.246 ±
118.164 *
1963.354 *
1.089 *

0.271*"
0.057
91.634
51.546**
428.114“
0.732

Data represents the Mean ± SD for n=5 groups of 3 pooled livers per group.
* n mole P-450/mg microsomal protein.
b n mole b^mg microsomal protein.
c n mole cytochrome-C-reduced/min/mg microsomal protein
d n mole cytochrome-C-reduced/min/mg microsomal protein.
* n mole l-chloro-2,4-dinitrobenzene conjugated/min/mg microsomal protein.
' n mole p-nitrophenol conjugated/min/mg microsomal protein.
* Significantly different (p<0.05) from TTZ treated rats.
b Significantly different (p<0.05) from controls.
1 Significantly different (p<0.05) from DEM-Control group.
J Significantly different (p<0.05) from DEM+TTZ group.

CO

ro

TABLE 66
COMPARISON OF THE EFFECT OF 2-THIOTRIAZONE (TTZ) AND DIETHYLMALEATE (DEM) + TTZ TREATMENT ON SELECTED
HEPATIC MICROSOMAL ENZYME ACTIVITIES IN PHENOBARBITAL (PB) INDUCED RATS.

TTZ

DEM and TTZ
TTZ

Control

DEM-Control

DEM+TTZ

Aldrin epoxidase
(nmoles dieldrin/min/mg/protein
(nmoles dieldrin/min/nmole P-450)

5.854 ±
4.297 ±

1.399
2.187

6.308 ±
4.104 ±

1.109
1.037

5.339 ±
3.140 ±

1.838
1.155

3.962 ±
3.760 ±

1.256*
1.208

7-Ethoxycoumarin-O-deethylase
(nmoles 7-OH coumarin/min/mg/
protein)
(nmoles 7-OH coumarin/min/
nmole P-450)

5.158 ±

1.204

5.216 ±

0.931

5.572 ±

0.621

4.142 ±

0.998

3.538 ±

1.088

3.506 ±

1.327

3.310 ±

0.637

3.877 ±

0.614

7-Ethoxyresorufin-O-deethylase
(pmoles resorufin/min/mg/
protein)
(pmoles resorufin/min/nmole
P-450)

619.638 ± 464.583

518.750 ± 284.721

544.762 ± 381.773

658.292 ± 424.978

362.608 ± 220.852

315.209 ± 132.954

305.979 ± 196.115

631.609 ± 496.019

Data represents the Mean ± SD for n=5 groups of 3 pooled livere per group.
* Significantly different (p<0.05) from control, TTZ and DEM-Control groups.

CHAPTER 6
DISCUSSION
The goal of the present study was to characterize the toxicity of
2-thiotriazone (TTZ) and to determine its mechanism of action in Spraque
Dawley rats.

Since no previous toxicological research had been performed

with TTZ, acute toxicity testing in rats was the first step in characterizing
its toxicity.

TTZ was found to be an acute pulmonary toxicant in male

rats, producing severe pulmonary edema and effusion.

Interest in this

compound developed because of its m arked pulmonary toxicity in affected
rats a t very low doses (1.25-10 mg/kg).

The acute toxicity of TTZ closely

resembled th a t of a-napthylthiourea (ANTU).

Although there was a

marked resemblence between TTZ and ANTU, there were also considerable
differences between the two toxicants.

Description of toxicity

Alpha-napthylthiourea (ANTU) and other thioureas have been shown to
produce massive pulmonary edema with pleural effusion in susceptible
animals (Mackenzie and Mackenzie, 1943; Dieke and Richter, 1945; 1946;
Dieke et al., 1947; Richter, 1945;

1952; Me Closky and Smith, 1945;

Bohm,1966; Cunninham and Hurley, 1972; Meyrick et al., 1972). Marked
age and species differences in susceptibility have also been demonstrated
(Dieke and Richter, 1946).
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Acute toxicity testing with TTZ was performed on adult male, adult female
and im m ature Spraque-Dawley ra ts of both sexes to determine if there were
differences in susceptibility.

The acute single oral dose LDr, for TTZ in

male rats of 4.6 mg/kg and the acute intraperitoneal (ip) LDgo of 1.4 mg/kg
classifies it as a highly toxic compound (Buck et al., 1988).

The decreased

LDgo after ip compared to oral adm inistration is not unexpected.

This

could have resulted from incomplete absorption from the gastrointestinal
tract when TTZ was given orally, slower absorption of the parent compound,
or a shift from pathways of metabolic activation to deactivation.

An LD^

could not be determined for female rats dosed orally with TTZ, because a
maximum of only 40% mortality was produced a t all concentrations tested.
However, TTZ was not toxic to female rats after ip dosing and an LD5 0 of
>100 mg/kg was estimated. The reason for decreased m ortality observed in
females after ip adm inistration is not clear.

One possible explanation is

th a t the production of reactive metabolites in the female is rate-lim ited or
th a t ip adm inistration results in a greater proportion of the dose being
metabolized to inactive products.

TTZ was not lethal to im m ature rats

(30-40 days old) of either sex after either oral or ip dosing and the LD^, was
estim ated to be greater th an 1000 mg/kg. These results demonstrate th at
the toxicity of TTZ is both age and sex dependent.

Alpha-napthylthiourea (5mg/kg ip) treated rats developed pulmonary edema
and effusion within 2 hr, which reached a maximum by 4.5 h r (Cunningham
and Hurley, 1972).

These anim als usually died within 8-10 hrs, but in

survivors the edema and effusion were reabsorbed within 24-48 hr, leaving
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apparently normal lungs.

Administration of a larger dose of ANTU (20

mg/kg ip) resulted in rapid loss of 2-3% of body weight 5 h r after injection,
and animals were listless and did not eat or drink.

These anim als were

also severely dyspnoeic with m arked pulmonary edema and effusion.

They

subsequently died, but did not froth or hemorrhage from the nostrils.
However, TTZ treated anim als showed evidence of pulmonary edema and
effusion within 1 h r which appeared to reach a maximum within 2-3 hr.
The end result was death, although a few animals appeared to recover
completely.

Clinical signs of intoxication observed in TTZ affected animals

included respiratory distress, dyspnea, cyanosis, prostration or listlessness,
and ruffled fur. In male ra ts th a t subsequently died a white frothy nasal
dischage was observed.

The macroscopic lesions observed in TTZ affected

animals (mottling of the lungs, pulmonary edema and effusion) are
consistent with clinical signs of intoxication.

The rapid onset of toxicity

caused by TTZ in adult male rats could be due to TTZ itself exerting its
toxic effect before it is metabolized and excreted.

It is also possible th at

male rats do not adequately metabolize TTZ to an inactive metabolite before
it can exert its toxic effect. A third possibility is th a t male ra ts metabolize
TTZ to a toxic metabolite and the metabolite causes the toxic effect in the
lungs. W hether this metabolism could take place in the lungs is an open
question.

Alpha-napthylthiourea was tested in both male and female ra ts of a specific
pathogen free derived colony of the Carworth Farm strain of rats ( Ven Den
Brenk et al., 1976).

There was no resistance or decreased toxicity to
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ANTU in female rats, i.e., there were no sex related differences.

However,

decreased toxicity or resistance was observed in TTZ treated adult female
rats. Female rats were more resistant to TTZ th an male rats and only 40%
mortality was observed when rats were dosed orally.

Clinical signs of

intoxication observed in affected anim als were similar to those observed in
male rats. However, these signs lasted for longer periods of time (4-24 hrs).
This decreased toxic response to TTZ in female rats could suggest that: 1)
female rats metabolize TTZ to an inactive metabolite more rapidly than
males, 2) TTZ is activated to a toxic metabolite in both male and female
rats, but to a lesser extent in the latter, 3) female rats have a higher level
of protective enzyme activity against reactive metabolites than males, or 4)
the female lung is innately more resistant to damage caused by reactive
metabolites or the parent compound.

Im mature rats of neither sex showed toxic responses (mortality or clinical
signs of intoxication) to TTZ when dosed either orally or ip. This apparent
lack of response in im m ature rats could be due to im m aturity of specific
drug metabolizing enzyme systems, higher activities of protective enzyme
systems, or a decreased rate of absorption.

Im m ature rats may also have

the ability to completely metabolize TTZ to inactive products. Likewise, the
target cells in the lung may be more resistant to the effect of reactive
metabolites.

According to studies by Ven Den Brenk et al., (1976), histological changes
in the lung produced by ANTU typically consist of perivascular and
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peribronchial edematous cuffing and generalized interstitial edema of
alveolar walls. Intra-alveolar exudation is present but is rath er patchy in
distribution. Significant hemorrhage and cellular infiltration usually have
not been shown to occur (Ven Den Brenk et al., 1976).

No chronic or

delayed sequelae such as pulmonary fibrosis occurred in rats which were
allowed to recover after acute severe pulmonary edema and effusion (Ven
Den Brink et al., 1976).

Histopathologic evaluation of rats treated with TTZ showed no evidence of
hepatic structural alterations, which may rule out the liver as a possible
site of action or target organ. However, there is no evidence th a t TTZ is
not metabolized in the liver to a toxic metabolite th a t affects the lungs.
Marked histologic changes were observed in the lungs of affected rats.
Histopathological examination of adult male ra t lungs after 1 h r exposure
to TTZ (10 mg/kg ip) showed acute interstitial and perivascular edema. The
edema fluid was largely restricted to areas around the blood vessels.
Edema was also noted around the bronchioles with some sepage into the
alveoli, causing distension of perivascular and peribronchiolar spaces. There
was also substantially more fluid in the loose periarterial interstitum than
around airways within the perivascular bundles, and more edema was
observed around larger bundles. The extensive perivascular and interstitial
edema and pleural effusion found in the lungs of affected male animals
could restrict oxgen transport across the alveoli, thus reducing oxygenation
of hemoglobin.

The edema was also associated with a mild interstitial

inflammatory response, with minimal num bers of neutrophilic macrophages
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and lymphocytes, suggesting th a t the toxicity was not the result of an
inflammatory or allergic response. These results also suggest th a t the lung
is probably the target organ for TTZ induced toxicity.

In male rats the peak response to TTZ occurred within 1 h r and there were
no apparent differences between responses a t lh r and 2hr

post-dosing.

Because of massive pulmonary edema and pleural effusion within the lungs
of male rats the anim als usually died within the 2-3 hr post-dosing, and
relatively few recovered.

If anim als recovered there were no noticable

histopathologic changes observed after 24 hr, the lungs appearing normal.
Histopathologic changes observed in affected male rats were consistent with
clinical signs of intoxication (severe respiratory distress, dyspnea, cyanosis,
prostration or listlessness and a white frothy nasal discharge).

Histopathologic changes observed in affected female rats were similar to
changes observed in male rats lh r after exposure to TTZ.

However, the

overall effects of TTZ were milder. Female ra t lungs were less endematous
with relatively small quantities of perivascular edema. Peribronchial and
interstitial edema were not present. These observations are consistent with
the lower degree of toxicity of TTZ observed in female rats. In summary,
the histopathology of the lungs of females supports the lower mortality
observed.

However, the am ount of edema and effusion varied within

females whereby some anim als suffocated and others did not.
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Im mature rats of both sexes (under 45 days of age) did not show any
clinical signs of intoxication, and there were no macroscopic lesions.
However, lung weights and lung to body weight ratios 1 h r following
exposure to TTZ were significantly increased in im m ature (40 day old) rats
as well as adults. These increased weights and ratios suggest th a t edema
was present in all ra t lungs.

According to studies with ANTU by Ven Den Brenk et al., (1976), larger
effusions caused a greater reduction in the volume of air in the lungs by
displacement. Also, smaller increases in lung weight due to edema often
accompanied the transfer of fluid from the intrapulm onary compartment to
the pleural cavity in older rats with larger effusions. The degree of acute
respiratory em barrassm ent caused by ANTU was determined more by
displacement of air by pleural effusion th an by pulmonary edema, measured
as an increase in specific lung weight.

This is based on the fact th at

edema was present in all anim als dosed with T TZ, but m ortality was not
observed in all animals.

Acute respiratory em barrassm ent and m ortality

produced by TTZ could also be the result of displacement of air by pleural
effusion instead of pulmonary edema itself.
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Effect of diethvlmaleate (DEM) and L-buthionine-(SR)-sulfoxamine (BSO) on
TTZ toxicity

Diethylmaleate (DEM) is an <x,P-unsaturated carbonyl compound which
depletes glutathione from the liver of rats, mice and ham sters (Boyland and
Chasseaud, 1970; 1967; Plummer et al., 1981). The reaction between DEM
and glutathione is both spontaneous and catalyzed by a cytosolic
glutathione transferase.

DEM also depletes glutathione in erythrocytes,

kidney, lung and brain, but to a lesser extent than in liver (Boyland and
Chasseaud, 1967).

DEM has been widely used in toxicological studies to

investigate the possible role of glutathione-mediated reactions in the
metabolism of various drugs and chemicals, either in vivo or in isolated
hepatocytes (Mitchell et al., 1973; Jollow et al., 1974; Sultatos et al., 1982;
Youner and Siegers, 1981). However, DEM has many non-specific effects
in addition to depletion of glutathione. For example, it has been shown to
affect hepatic microsomal monooxygenase activities (Anders, 1978; Burk and
Correia, 1979; Chuang and Bresnick, 1978;

and Welling and De Vries

1985); to stimulate bile flow (B arnhart and Combes, 1978) and to im pair
glycogen metabolism (Krack et al., 1980).

Costa and M urphy (1986)

showed th a t DEM (lml/kg) inhibited protein synthesis in brain and liver
following adm inistration to mice.

O ther effects of DEM, such as lipid

peroxidation (Younes and Siegers, 1981; Stacey and Presley, 1978) or acute
ulcerogenesis (Boyd et al., 1981) may be a consequence of glutathione
depletion rath er than a seperate effect (Boyland and Chasseaud, 1967).
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L-Buthionine-(SR)-suIfoxamine (BSO) is a specific inhibitor of
gamma-glutamylcysteine

synthetase,

a

major enzyme in

glutathione

synthesis and has been shown to decrease hepatic and renal glutathione
without affecting other enzymes involved in xenobiotic biotransformation
(Drew and Miners, 1984; Sun et al., 1985). It has been suggested for use
as a preferable glutathione depletor in the investigation of mechanisms of
xenobiotic-induced toxicities (Costa and Murphy, 1986).

However, BSO

(1,786 mg/kg) has been shown not to affect pulmonary glutathione levels for
several hours after a single treatm ent in mice (Mizutani et al., 1987).

Even though DEM appears to have a large number of non-specific effects,
glutathione depletion caused by lower doses of DEM can be achieved
without seriously affecting other systems. Compared to BSO, DEM also has
a more rapid onset of action. Pretreatm ent with a single dose of DEM (485
mg/kg) 30 min prior to sacrificing the animal sufficiently depletes 80-90%
of lung and liver GSH levels. By comparison, a sigle dose of BSO (1,780
mg/kg) depletes hepatic GSH to about 40% of control levels between 2-4 h r
but it does not deplete GSH concentration in the lung after 6hr in mice.

In this study DEM was adm inistered a t a dose of 485 mg/kg, which is
one-half the dose th at has been shown to cause decreases in protein
synthesis. This dosage was used because DEM administered a t 970 mg/kg
was shown to be toxic to 20% of the anim als tested. Results in the present
study show th at DEM administered a t 485mg/kg depleted GSH levels by
80-90% in both the lung and liver of adult male and female rats.

193
Diethylmaleate pretreatm ent potentiated the toxicity of TTZ in male
rats, causing 50% m ortality a t lmg/kg ip whereas no toxicity was observed
a t this concentration previously.

BSO, however, was not as effective as

DEM in enhancing m ortality in rats. The reason for this difference could
be related to the time required for glutathione depletion in lung and liver.
Previous studies have shown th a t BSO depletes glutahione levels in the
liver 2-4 h r after injection while it takes DEM 30 m inutes. Therefore, GSH
levels were probably not depleted in the BSO pretreated anim als a t the
time th a t TTZ was administered.

This difference could also support the

contention th a t the toxic metabolite is produced in the lung, since BSO
would not have reduced glutathione concentrations in the lung a t all when
TTZ was administered.

Pretreatm ent with DEM potentiated the toxicity of TTZ in adult female
rats, causing 66% m ortality a t lm g TTZ/kg and 100% m ortality a t 2.5 and
10 mg TTZ/kg ip.

Previously, no mortality was observed in female rats

dosed ip with TTZ a t concentrations of 5-100mg/kg, although, 40 %
mortality was oberved in female rats when dosed orally a t 2.5-1000 mg
TTZ/kg. These results clearly suggest th a t GSH plays a protective role in
the metabolism of TTZ in female rats.

Diethylmaleate pretreatm ent also potentiated the effects of TTZ in im m ature
rats of both sexes, causing 90% m ortality in both 30 and 40 day old males,
60% m ortality in 30 day old females and 90% m ortality in 40 day old
females. These results also suggest th at glutathione played a protective role
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in the metabolism of TTZ. Previously, im m ature rats showed no response
to TTZ when dosed either orally or ip a t concentrations up to lOOOmg
TTZ/kg.

It has been shown th a t there are age and sex differences in glutathione
levels (Igarashi, et al., 1983). Male and female ra ts 7 weeks of age showed
no significant differences in GSH concentrations in the fiver.

However,

female rats (7 wk old) showed 1.7 fold higher activities of hepatic
y-glutamyltranspeptidase (y-GTP) than did males. These workers reported
th a t there were significant increases in cysteine content in females
compared to males a t 7 weeks of age, but not a t 12 weeks of age. GSH is
degraded to cysteine by two successive reactions involving y-GTP and
dipeptase.

Hepatic y-GTP and glutathione peroxidase activities were also

significantly higher in females th an males.
relative

resistance

to

TTZ

seen

in

This could account for the

female

rats

since

cysteine

(N-acetyl-L-cysteine) has been shown to be protective against glutathione
depletion by replenishing glutathione (Wong et al., 1986; Cotgreave et al.,
1987).

It has also been reported th at GSH resynthesis in hepatocytes from
neonatal mice is grater than in those from adult mice after DEM exposure
(Harman and Henry, 1987). Hepatocytes from young mice have a greater
capacity to resynthesize GSH after depletion with DEM. It is known th at
DEM rapidly alkylates GSH in the hepatocyte (Chauseaud, 1974). Since
GSH concentrations in the cell are controlled by a non-allosteric feedback
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mechanism (Richman and Meister, 1975), when GSH concentrations decrease
rapidly, the hepatocyte will attem pt to resynthesize more GSH.

Despite

deficiency of the GSH-transferase mediated reaction, the ability to rapidly
resynthesize GSH may explain why neonatal mice were less susceptible to
toxic electrophillic metabolites compared to adults. The rapid replenishment
of GSH stores could aid in the protection of vital nucleophilic sites from
electrophilic attack by reactive metabolites (Harmon and Henry, 1987).
Therefore, im m ature rats could also rapidly resynthesize GSH stores and in
so doing aid in protection against TTZ toxicity.

This could explain why

30-40 day old rats were resistant, although GSH repletion would have to
happen very rapidly in order to protect against TTZ induced lung damage.
When im m ature rats were pretreated with DEM, it apparently depleted
GSH stores and allowed TTZ to exert its toxic effect before anim als were
able to resynthesize enough glutathione to counteract the effect.

Clinical signs of intoxication (severe respiratory distress, dyspnea,
cyanosis, prostration or listlessness, and ruffled fur) were observed in adult
and im m ature rats of both sexes in rats treated with DEM. In rats th at
subsequently died, large am ounts of a white frothy discharge were expelled
from the nostrils. In previous studies with TTZ alone, im m ature rats did
not show any clinical signs of intoxication.

This observation

in itself

shows th a t DEM pretreatm ent potentiated the toxic effects of TTZ in
im m ature rats. Clinical signs of intoxication in the adult male and female
were more severe and occurred with a more rapid onset of action th an in
rats treated w ith TTZ alone. Death, however, usually occurred within 1-1.5
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h r in both adult and im m ature rats. Macrosocopic lesions were also more
severe (mottling of the lungs, pulmonary edema and effusion) than in rats
treated with TTZ alone.

Histopathologic evaluation of adult male rats treated with DEM and TTZ
in combination showed no hepatic structural alterations.

However,

histological changes observed in the lungs of male rats pretreated with
DEM+TTZ in combination included severe perivascular and interstitial
edema.

Edema was located principally around blood vessels with slight

infiltration of neutrophils, macrophages and lymphocytes. The changes seen
were the same as those observed in adult male rats dosed with TTZ alone.
These results show th a t the lung is the pricipal site of action or target
organ for TTZ toxicity.

Diethylmaleate pretreatm ent potentiated the effects of TTZ in adult female
rats.

Histological changes observed in the lungs of female rats were the

same as those observed in adult male rats dosed with a toxic dose of TTZ.
The pathology was

evidenced as

large

areas

of perivascular

and

peribronchiolar edema with some distension into the alveoli (interstitial
edema), and there also was a mild interstitial inflammatory response
(infiltration of neutrophils, macrophages and lymphocytes). Previously only
small areas of perivascular edema were observed when rats were dosed with
TTZ alone, and peribronchial and interstitial edema were not present.
These histological findings correlate well with the DEM-TTZ toxicity study
in female rats whereby DEM pretreatm ent increased m ortality caused by
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TTZ in female rats. These results also suggest th a t the lung is the target
organ for TTZ toxcity.

DEM+TTZ in combination did not affect liver weights and liver to body
weight ratios in adult male and female rats.

However, a significant

increase in liver weight and liver to body weight ratios was observed in
imm ature rats.

These livers were not subjected to histopathologic

examination, so the exact mechanism by which this occurs is not fully
understood.

Lung weights and lung to body weight ratios were increased

in adult male, adult female, and im m ature rats (40 day old) after exposure
to DEM and TTZ.

These weights and ratios were approximately 2 times

higher than lung weights and lung to body weight ratios from rats dosed
with TTZ alone.

In summary, DEM pretreatm ent potentiated the toxic

effects of TTZ in adult male, adult female and im m ature rats of both sexes.

Innate and TTZ induced resistance

Young or im m ature rats have been shown to be highly resistant to the toxic
effects of ANTU during the 3rd, and 4th weeks of life. However, toxicity
developed rapidly during the following 2 weeks (Dieke and Richter, 1945,
1946; Ven Den Brink et al., 1976). According to studies by Ven Den Brenk
et al, (1976), weanling 3-4 week-old female rats weighing from 50-80g were
very resistant to

ANTU; no significant pulmonary edema or effusion

developed after injection of 100 mg ANTU/kg body weight and there were
no deaths.

This innate resistance of weanlings to ANTU decreased
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relatively rapidly during postnatal development. By the time they were 6
weeks of age the maximal tolerated dose (MTD) of ANTU had decreased to
approximatly 5 mg/kg ip.

Im m ature rats of both sexes showed no toxic response to TTZ when dosed
either orally or ip.

No clinical signs of toxicity were observed up to 6

weeks (45 days) of age, but toxicity developed rapidly during the next two
weeks (50-55 days of age) in male rats.

Im m ature female rats however,

remained resistant through the 55th day.

This apparent resistance in

im m ature ra ts could be due to im m aturity of drug metabolizing enzyme
systems (Kato and Kam ataki, 1982; Chengelis, 1988).

Enzyme activities

(cytochrome P-450) are low in im m ature rats but increase with age. Kato
et al., noted as early as 1964 th a t age related differences in metabolism
may be responsible for age-related differences in toxicity. It is reasonable
to suggest th a t as male ra ts age the rate of metabolism of TTZ to a toxic
metabolite may increase and it is th a t metabolite th a t produces the
pulmonary toxicity. However, this is not observed to the same degree in
female rats.

Clear sex differences in the activites of drug metablolizing

ezyme systems are not observed until 30 days of age ( Kato et al., 1962b).
The activities of microsomal drug metabolizing enzymes are clearly increased
in male ra ts over those of female ra ts a t 50 days of age. This could explain
why female rats are still resistant a t 55 days of age and relatively resistant
(compared to males) as adults.

The prior treatm ent of susceptible, older anim als with small sub-lethal doses
of ANTU produced striking tolerance to subsequent adm inistration of larger
doses of ANTU (Me Closky and Smith, 1945; Ven Den Brenk et al., 1976;
Richter, 1946; Meyer and Sanders, 1949; Sabonya and Kleinerman, 1973).
Ven Den Brenk et al., (1976) found th a t tachyphylaxis to ANTU in 6 week
old rats was induced rapidly by 3 or 4 daily doses of 2 mg ANTU/kg. The
subsequent injection of lOOmg ANTU/kg caused no pulmonary edema or
pleural effusion.

The tachyphylaxis was dose-dependent and lasted for 3

weeks. The pretreatm ent of rats with sub-lethal doses of ANTU daily for
5 days decreased the activity of the lung mixed-function oxygenase enzyme
system th a t metabolized parathione and ANTU in vitro (Boyd and Neal,
1976). A similar effect was observed with CS2 (Bond and De Matteis, 1969),
and other thiono-sulfur compounds (Hunter and Neal, 1975) on ra t liver
mixed-function oxygenase activity. The pretreatm ent of ANTU also caused
a decrease in both covalent binding and pulmonary toxicity of “ S-ANTU in
vivo (Boyd and Neal, 1976).

This suggested th a t a decreased rate of

activation of ANTU in ANTU-pretreated rats might have been a t least
partially responsible for the development of tolerance.

Resistance to TTZ in adult male ra ts (8weeks or older) was produced after
either prior exposure to a single sublethal dose (lm g TTZ/kg) or in animals
th a t survived a toxic dose of TTZ (10 mg/kg).

This resistance was not

dose-dependent and lasted for 8 weeks in orally dosed animals. The fact
th a t TTZ-induced tolerance can be produced by a single sub-lethal dose of
lm g TTZ/kg is remarkable, and in this respect different from the
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tachyphylaxis produced by ANTU and other thioureas, including 4-ipomeanol
(another specific pulmonary toxicant).

Tolerance to normally lethal doses

of these compounds can also be produced by prior adm inistration of small,
non-lethal doses of the toxin itself, bu t several repeated doses appear to be
necessary.

For example, pretreatm ent of rats for 7 days with 7 mg/kg ip

of 4-ipomeanol increased the LD50 by nearly three-fold, and ANTU required
a t least 3 or 4 daily doses of 2 mg/kg for several weeks to produce
tachyphylaxis.

In all cases the covalent binding after a normally lethal

dose was decreased in the lungs and livers of tolerant rats.

According to Boyd, (1980) there are several possible mechanisms th a t may
account for the decreased covalent binding and toxicity of these compounds
in tolerant rats.

First, the am ount of reactive metabolite formed in the

lung after adm inistration of sub-lethal doses m ay have been sufficient to
destroy a portion of the enzyme system th a t m ediated its formation, but
insufficient to cause lethal pulmonary damage.

Therefore on subsequent

challenge with large doses of toxin there may not be sufficient enzyme
activity rem aining to form the

toxic metabolite required to cause

pathological changes seen in affected animals.

Secondly, the injury from

sub-lethal doses might lead to decreased activity of enzymes m ediating the
covalent binding because of a shift in residual cells to synthetic pathways
for repair rath er than mixed function oxidations.

Finally, tolerance

development could also have been due to induction of metabolic detoxication
pathways.

The exact mechanism of tolerance development to TTZ is not

clearly understood. The possibility th a t metabolism of a single
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sub-lethal dose of TTZ would produce a highly reactive metabolite in the
liver or lung th a t destroys a significant portion of the enzyme system th at
mediated its formation, thereby causing the enzyme system to rem ain
inactive for 8 weeks, is highly unlikely.

However, TTZ could delete

receptors, resulting in resistance, and their restoration would depend on
DNA-dependent RNA synthesis and post-transcriptional events leading to
protein synthesis.

Intraperitoneal adm inistration of TTZ was more toxic

th an oral dosing and the length of resistance was also decreased from 8 wks
to 6 wks. This difference could possibly be due to the three-fold increase
in toxicity when rats were dosed ip with TTZ, thereby causing decreased
resistance or increased response of anim als to a toxic dose.

Effect of sex steroids on TTZ toxicity

Female rats were shown to respond differently to TTZ when dosed on
different days of the week and m ortality ranged from 20-100%. This lead
to the development of a study testing the effects of changes in the estrous
cycle on TTZ toxicity.

Results showed th a t changes in

estrus did not

significantly affect TTZ toxicity and variable responses were observed for
each stage of the cycle ( proestrus, diestrus, estrus, and metestrus).
However, the highest m ortality was obtained a t 62.5 mg TTZ/kg, when rats
were in the proestrus stage.

Due to continued variation in response

observed in female rats, their relative resistance to TTZ, and resistance in
imm ature rats of both sexes, a study was designed to determine if sex
steroids had an effect on TTZ toxicity.

Sex steroids have been shown to
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regulate the concentrations of some enzymes, to including the flavoprotein
containing monooxygenases.

Therefore they could increase or decrease

metabolism of certain xenobiotics.

In this study, neither P-estradiol nor

testosterone significantly affected TTZ toxicity in adult male, adult female
or imm ature rats of either sex, suggesting th a t they do not influence the
toxic action of TTZ.

Effect of TTZ and DEM+TTZ in combination on hepatic microsomal and
cytosolic enzymes

At least two enzyme systems are known th a t m ight play a role in activating
toxic thioureas.

Cytochrome P-450 dependent oxygenases are known to

activate certain thionosulfur compounds (Dalvi et al., 1974; Kam ataki et al.,
1976; H unter and Neal, 1975; De M atteis, 1974; De M atteis and Seawright,
1973; Bond and De M atteis, 1969).

In vitro incubation with ANTU

inhibited the ability of ra t liver microsomes to metabolize parathion and
benzphetamine and brought about a decrease in the level of cytochrome
P-450 (Hollinger et al., 1974). ANTU and other thiono-sulfur-containing
compounds affected these param eters only when incubated with microsomes
in the presence of NADPH (Dalvi et al., 1974; H unter and Neal, 1975; De
M atteis and Seawright, 1973; De M atteis, 1974). These experiments showed
th a t metabolism of ANTU was required for it to produce its damaging effect
on mixed-function oxidase systems in vitro Cunningham and Hurley, (1972)
suggested th a t a metabolite of ANTU produced by the liver, rath er than
ANTU itself, reacts with the lung endothelium as the damaging agent
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because they could provide no explanation for the reason th a t the toxic
effects of ANTU were restricted to pulmonary vascular endothelium. They
postulated th a t such a metabolite could damage pulmonary endothelium and
be inactivated before it reached the systemic circultation.

Butler et al.,

(1970) have shown th a t a mechanism of this kind is responsible for the lung
lesions caused by oral adm inistration of the pyrrolizidine alkaloids.

Another mixed-function oxidase system th a t m ust be considered is the
flavoprotein enzyme described by Poulsen et al., (1974; 1979). This enzyme
system is capable of NADPH-dependent desulfuration of some thionocarbonyl
compounds, and it is reasonable to suspect th a t chemically reactive toxic
interm ediates could also be formed by this route. ANTU has been shown
to be a substrate for this system.

Effect on substrate metabolism

Glucuronidation is one of the major conjugation (phase II) reactions in the
conversion of both exogenous and endogenous compounds to polar, w ater
soluble

compounds.

There

are

several

distinct

forms

of

UDP-glucuronyltransferase (UDPGT). One form in particular (GTmc) has
been shown to be induced by ctochrome P-448 specific inducers such as
3-methylcholanthrene in the fiver (Bock et al., 1973). Metabolism studies
by Scheline et al., (1961) showed th a t the highly toxic compound,
phenylthiourea is metabolized in rats and rabbits by desulphuration to
phenylcyanamide, as well as hydroxylation to p-hydroxyphenylthiourea. This
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metabolite is metabolized mainly by conjugation with glucuronic acid and
sulphuric acid.

Because of the susceptibilty of certain glucuronides to

enzymatic and chemical degradation, glucuronides may serve to transport
potentially reactive compounds from the liver to the target tissues. W hether
or not this could occur in the lung would depend on the presence of
P-glucuronidase in th a t tissue.

Hepatic microsomal

UDPGT activity in

adult female and im m ature male ra ts was significantly decreased, while this
activity in adult male rats rem ained unaffected. These results could suggest
th at glucuronidation of TTZ was occurring in adult female and im m ature
male rats, and th a t TTZ was being excreted as a non-reactive glucuronide.
Likewise, the glucuronic acid conjugation of TTZ may occur to a lesser
extent in adult male rats. There is also the possibility th a t glucuronides
may transport a reactive metabolite of TTZ to the lungs.

Aldrin epoxidase, EROD and ECOD activities were not affected by TTZ.
However, aldrin epoxidase activity in female rats was lower th an activities
in adult and im m ature male rats.

These results show th a t the P-450

specific isozyme activity is very low in female rats.

Aldrin epoxidase,

EROD and ECOD activities, relative to cytochrome P-450 content, were
increased two-fold in both control and TTZ treated im m ature male and
female rats. In summary, cytochrome P-450 and cytochrome P-448 specific
activities remained stable in the presence of TTZ.

Diethylmaleate+TTZ in combination did not affect UDPGT activity in the
adult male, adult female or 40 day old rats and did not significantly affect
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cytochrome P-450 or P-448 specific activities such as aldrin epoxidase (AE),
EROD and ECOD in adult and im m ature male rats. However female rats
had lower AE activity compared to non-induced male, im m ature male and
induced male rats.

This is likely since female rats have very low

cytochrome P-450 specific isozyme activity.

Aldrin epoxidase, EROD and

ECOD activities in DEM+TTZ treated rats

relative to cytochrome P-450

content were also increased approximately two-fold, which is the same
response as observed in rats treated with TTZ alone. These results show
th a t these activities are stable even when DEM is adm inistered coincident
with TTZ, i.e. DEM had no effect and did not alter the effect of TTZ.

Effect on components of the hepatic microsomal monooxygenase system

Treatm ent with TTZ did not produce changes in the cytochrome P-450
complex in adult male or im m ature male rats. However, cytochrome P-450
content in adult female rats was increased.

Cytochrome b5 content and

NADPH cytochrome-C-reductase were unaffected . These latter two do not
exist as a family of isozymes, but they are im portant components of the
cytochrome P-450 electron transport system.

The fact th a t these

components were not affected suggests th a t they were available in sufficient
quantities in the liver for metabolism to take place even in the presence of
TTZ.

It also suggests th a t there was little or no damage to the

endoplasmic reticulum caused by the production of a reactive metabolite.
NADH cytochrome-b5

reductase

activity was

significantly lower in

imm ature ra ts than activity in adult male and female rats.

However,

206
NADH cytochrome b5 reductase activity was much higher th an NADPH
cytochrome-C-reductase activity, which is consistent with previous studies
by Chengelis (1988).

There were also m arked age and sex differences

associated with NADH cytochrome-b6-activity; however, the exact meaning
of the changes in term s of cytochrome b5 involvement in microsomal MFO
activity rem ains to be determined.

Although TTZ did not

affect the

components of the hepatic microsomal monooxygenase system in liver, these
components may be drastically reduced in lung microsomes. F urther studies
should be performed to determine the effects of TTZ on the microsomal
monooxygenase system in the lung.

DEM and TTZ in combination did not affect the hepatic microsomal
monooxygenase system components (cytochromes P-450 and b5 content,
NADPH cytochrome-C-reductase and NADH cytochrome b5 reductase
activities). However cytochrome P-450 content was decreased in adult male
rats.

These results show th a t TTZ may be affecting cytochrome P-450

concentration when glutathione stores have been depleted by DEM, or DEM
itself may be affecting the cytochrome P-450 monooxygenase system by
inhibiting protein synthesis through some non-specific effect.

Effect on glutathione-S-transferase and GSH concentrations

Glutathione, a tripeptide consisting of glutamic acid, cysteine, and glycine,
is a cellular thiol th a t participates in a wide range of protective and
maintenance processes.

Protective functions which receive continuing
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attention include conjugation with electrophillic toxins, reaction with
oxidants and scavenging of radicals, intracellular transport of amino acids,
thiol-disulfide exchange with proteins, and provision of coenzymes for several
biochemical reactions (maintenance functions) (Meister and Anderson, 1983;
Meister and Tate, 1976). Hepatic glutathione concentrations appear tightly
regulated by feedback inhibition of
glutathione itself,

y-glutamylcysteine synthetase by

and by limiting availability of the sulfur amino acid

precursor, L-cysteine (Kaplowitz et. al., 1985; Richman and Meister, 1975).

It is well known th a t glutathione-S-transferase (GST) is responsible for GSH
conjugation of the active metabolites formed via cytochrome P-450- coupled
monooxygenases.

The degree of hepatotoxicity caused by reactive

metabolites depends directly on the GST activity in liver (Igarashi et al.,
1983). According to studies by Mitchell et al., (1982), the toxicity of many
indirect hepatotoxins is modulated by the availability of glutathione: toxicity
is not generally manifested until after the glutathione is consumed in
reactions with

reactive metabolites.

Therefore,

the availabilty of

glutathione, not the activity of glutathione-S-transferase, may be a more
critical factor in determining sensitivity to hepatotoxins.

Glutathione-S-transferase activity in adult males and females and 40 day
old males was not affected by TTZ nor was it affected by DEM+TTZ in
combination, thus indicating th a t enzyme was available a t levels sufficient
for conjugation with metabolites of TTZ.

However, TTZ was shown to

produce a dose-dependent decrease in glutathione (GSH) or non-protein

208
sulfhydryls (NPSH) in the lungs of adult male rats.

Glutathione

concentration was also decreased in the lungs of female rats. However, no
dose-dependent relationship was observed. TTZ did not affect glutathione
concentrations in the liver of either adult male or female rats.

These

results suggest th a t glutathione probably plays a protective role in the
metabolism of TTZ in both male and female rats and th a t glutathione
concentration in the lung is very im portant in the detoxification of locally
produced reactive metabolites.

Evidence for GSH involvement in the protection of the ra t lung against the
deleterious effects of TTZ was produced by analyzing GSH levels following
diethylmaleate (DEM) treatm ent.

Diethylmaleate reacts with GSH and

depletes cytoplasmic stores (Anders, 1978; Meredith and Reed, 1982). The
depletion of hepatocyte glutathione by DEM never exceeds 90% to 95% of
total cell glutathione content. Hepatocytes thus depleted can rem ain viable
for several hours, eventually resynthesizing the orginal complement of GSH
(Reed and Fariss, 1984).

DEM has been shown to potentiate the hepatotoxic effects of allyl formate
in trout (Droy, 1988).

Hanson and Anders (1978) showed th a t DEM

pretreatm ent of rats exposed to normally sub-lethal doses of allyl alcohol
produced

100%

mortality.

DEM

pretreatm ent

also

potentiated

acetominophen-induced hepatic necrosis in mice (Mitchell et al., 1973).

Previous studies by Boyd and Neal (1976) with thioureas and ANTU
suggested th a t sulfhydryl compounds could modulate susceptibility to the
toxicitiy of thioureas.

DEM depleted the lung and liver GSH levels by

approximately 80%. Both pulmonary toxicity and in vivo covalent binding
after the adm inistration of ANTU were strikingly increased by DEM
pretreatm ent.

They assumed th a t GSH could detoxify reactive species

involved in the toxicity of thioureas, possibly by forming non-toxic
conjugates. The results of in vitro studies by Hollinger et al., (1976), using
lung slices, also appeared to be consistent with this hypothesis.

In vitro

binding of radioactivity from 14C thiourea to lung protein could be
antagonized either by cysteine or by reduced glutathione.

Conversely,

elevated binding of radioactivity was observed when 14C-thiourea was
incubated with lung slices obtained from anim als whose tissues were
previously depleted of GSH by pretreatm ent with DEM in vivo. This could
have been due to resynthesis of glutathione because the cytosolic pool of
glutathione is resynthesized within 2 h r after depletion and peak effects of
DEM are observed after about 30 min, and decrease thereafter.

DEM itself depleted glutathione stores in both liver (to 10.5% of control)
and lung (to 7.1% of control) and DEM-TTZ in combination depleted liver
GSH stores to 1.09% of control and lung GSH to 27.1% of control in adult
male rats.

DEM depleted female GSH in the liver to 25.9% of control and

lung GSH to 22.1% of control. GSH concentrations in females administered
DEM-TTZ were depleted to 18% of control in the liver and 43% of control
in the lungs. Although GSH concentrations in DEM-TTZ treated males and
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females were slightly lower in the liver and higher in the lungs, they were
not significantly different. This increase in GSH in the lungs may also be
due to subsiding effects of DEM, as resynthesis of GSH in the lung is faster
th an resynthesis in the liver.

Glutathione concentrations in the lung of

female rats were twice as high as those of males administered DEM+TTZ.
The fact th a t higher concentrations of GSH were present in the lungs of
female rats after depletion with DEM sugggests th a t more GSH was
available to deactivate reactive metabolites formed by metabolism of TTZ.
This could also explain why female rats were relatively resistant to TTZ.

Effect of enzyme induction and inhibition on TTZ toxicity

P retreatm ent of rats with other drugs has been shown to affect ANTU
toxicity (Ven Den Brenk et al., 1976). Pretreatm ent with 3-4 benzpyrene,
a cytochrome P-448 isozyme inducer, reduced the toxic effects of ANTU by
reducing pulmonary edema and effusion (Ven Den Brenk et al., 1976).
Pretreatm ent of rats with phenobarbital, a P-450 inducer, was much less
effective.

N either piperonyl butoxide or SKF-525A, which inhibit the

induction of microsomal enzymes in liver and other tissues (Conney,1967),
increased the toxicity of ANTU.
piperonyl

butoxide

actually

SKF-525A had no significant effect and

decreased

ANTU-induced

lung

damage.

Tachyphylaxis and/or resistance in ANTU treated anim als induced by
pretreatm ent with iodide and thiourea derivatives as well as by unrelated
agents such as 3-4 benzpyrene and barbiturates suggested th a t resistance
resulted from the induction of drug metabolizing enzymes in the animal

(Ven Den Brenk et al., 1976).

Cunningham and Hurley (1952) suggested

th a t a metabolite of ANTU of hepatic origin, rath er th an ANTU itself,
reacted

with

lung

endothelium

Pretreatm ent with thyroid

to

produce

the

damaging

event.

hormones also increased ANTU induced

pulmonary edema bu t thyroidectomy had no significant effect on the toxicity
of ANTU. It has also been reported th a t the sulfhydryl compounds, cysteine
(Dubois et al., 1946; Karel and Meyer, 1948), glutathione (Giri and Combs,
1979; Karel and Meyer, 1948) and 2-aminoethylisothiouronium bromide,
(Ven Den Brenk et al., 1976) protected rats against the lethal effects of
thiourea derivatives.

Giri and Combs, (1970) found th a t cysteine and

reduced glutathione inhibitied both the pulmonary endematogenic effect and
the hyperglycemic effect of phenylthiourea in rats. These results suggested
th a t sulfhydryl compounds could modulate susceptibility to the toxicity of
thioureas and th a t glutathione plays a protective role in the metabolism of
ANTU and other thioureas. Lung damage caused by ANTU has been shown
to be reduced by pretreatm ent w ith cysteine (Du Bois et al., 1946; Karel
and Mayer, 1948). However, this was accounted for by loss of fluid into the
peritoneal cavity due to the irritative effect of cysteine. Another sulfhydryl
agent, 2-aminoethylisothiouroniom bromide (AET), which did not cause
peritoneal reactions, greatly reduced the toxic effects of ANTU.

In this study pretreatm ent of rats with other drugs also affected the toxicity
of TTZ. P-Napthoflavone (BNF) induction of the microsomal mixed function
monooxygenase system (specifically, cytochrome P-448) in rats completely
protected adult male rats against the toxicity of TTZ.

BNF induced

cytochrome P-448 in the liver as well as the lungs.

BNF induced

protection against TTZ could have occurred because increased metabolism
of TTZ in the liver resulted in a decreased concentration of TTZ presented
to the lungs because of the first pass effect. Phenobarbital (PB) induction
of the cytochrome P-450 isozyme did not significantly affect TTZ toxicity in
male rats. This is expected since PB does not induce cytochrome P-450 in
the lung and TTZ is probably not being metabolized by the cytochrome
P-450

isozyme.

Neither a-napthoflavone (ANF), a cytochrome P-448

isozyme inhibitor, nor SKF-525A, a cytochrome P-450 isozyme inhibitor in
liver and other tissues (Coney, 1967; Jenner and Netter, 1972), reversed the
effects of BNF or PB induction on TTZ toxicity.

Specifically, ANF did not

reverse BNF induced protection against TTZ in adult male rats. This can
be explained by the fact th a t ANF would have blocked the cytochrome P-448
mediated metabolism of TTZ to a toxic metabolite in both liver and lung,
there could be no reversal to toxicity.

SKF-525A did not increase or

decrease the toxicity of TTZ in PB induced adult male rats because PB
induces the cytochrome P-450 isozyme and not P-448 isozyme.

If toxic

metabolites were produced by cytochrome P-448, PB induction could have
no effect.

In any event, SKF-525A could not have blocked PB induced

increases in cytochrome P-450 isozyme mediated metabolism in the lung,
because PB has been shown not to induce this isozyme in the lung of rats
(Parke and Ioannides, 1984). These results suggest th a t resistance in male
rats pretreated w ith BNF may be due to stimulation of cytochrome P-448
isozyme activity.

This phenomenon is of considerable importance in the

hepatic metabolism (activation) of m any drugs, bu t it also takes place in the
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lung and other organs (Conney, 1967). These results also suggest th a t the
cytochrome P-448 isozyme is responsible for metabolism of TTZ to a reactive
toxic metabolite.

All induced animals (BNF and PB) had significantly higher cytochrome
P-450 content than non-induced rats, which shows th a t induction did occur.
TTZ itself did not affect the components of the hepatic microsomal
monooxygenase system (cytochromes P-450 and b5, NADH cytochrome-b5 and
NADPH

cytochrome-C-reductases),

glutathione-S-transferase

UDP-glucuronosytransferase activiies in PB or BNF induced rats.
epoxidase , EROD and ECOD activities were also unaffected.

and
Aldrin

However,

cytochrome P-450 content in PB induced rats adm inistered DEM-TTZ in
combination was significantly decreased from DEM controls and cytochrome
P-420 content was also increased in DEM-TTZ treated animals. According
to studies by Magos and B utler (1972), Bond et al., (1969), and Magos et
al., (1973), in animals pretreated with phenobarbital, carbon disulfide (CS2)
causes greater fractional decreases in both drug metabolizing enzymes and
cytochrome P-450 levels.

This effect was aggravated by short-term

starvation. Starvation significantly decreased the urinary excretion of both
CS2 and its bivalent sulfur metabolites in exposed ra ts (Magos, 1972) and
starvation also contributed to the development of liver necrosis in
phenobarbital-pretreated anim als (Bond et al., 1962).

It has alo been

recorded th a t starvation caused glutathione depletion (Reed and Fariss,
1984). Because of this it was suggested th a t the effect of phenobarbital on
carbon disulphide induced hepatotoxicity might not be mediated through the
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formation of a more toxic metabolite as considered previously by Greim,
(1970).

However, Potter and Neal (1977) suggested th a t the decrease in

cytochrome P-450 levels and monooxygenase activity was due to covalent
binding to the sulfur atom released from parathion and carbon disulfide.
In phenobarbital induced DEM-TTZ treated rats, the decrease of cytochrome
P-450 levels and

monooxygenase activity may also be due to covalent

binding of P-450 to the sulfur atom of TTZ. Aldrin epoxidase and ECOD
activities were also decreased which could also be attrubuted to decreased
cytochrome P-450 specific monooxygenase content.

NADH cytochrome-b5-reductase activity in PB induced DEM control male
rats was decreased from non-induced and BNF induced rats.

NADPH

reductase activity in PB induced DEM controls was significantly increased
compared to non-induced rats, while NADH and NADPH reductase activities
in PB induced DEM-TTZ treated
non-induced

DEM

controls,

animals was not different from

BNF+DEM

controls,

and

TTZ

treated

non-induced and BNF induced animals. Since no differences were observed
in the DEM-TTZ treated groups from DEM controls, the exact reason for
the variation observed in the control group rem ains to be established.
However, NADH cytochrome b6 reductase is a cytochrome P-450 specific
activity and DEM may have decreased its activity through a non-specific
effect.

NADPH cytochrome-C-reductase activity was increased in PB

controls over th a t of all non-induced and BNF- induced DEM treated rats.
Although NADPH reductase activity in PB induced

DEM-TTZ rats was

lower than PB induced DEM controls the values were within the range of
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non-induced and BNF induced DEM treated animals. The exact reason for
this response rem ains to be established.

Glutathione-S-transferase (GST) activity in PB induced male rats was
significantly higher th an activity in adult male and female non-induced rats.
This was not unexpected since it is known th a t PB induces GST (Lee et al.,
1985).

However, GST activity in PB induced DEM+TTZ treated animals

was not different from PB induced DEM controls suggesting th a t this
activity was unaffected by DEM-TTZ.

Effect of N-acetvl-L-cvsteine on TTZ toxicity

N-acetyl-L-cysteine, a glutathione precursor, has been shown to
increase the rate of glutathione synthesis, resulting in prolonged elevation
of the hepatic glutathione pool (Wong et al., 1986). NAC has been shown
to be protective against diquat-induced cytotoxicity in isolated hepatocytes
Cotgreave et al., 1987) and it has been shown to protect the liver against
allyl formate induced toxicity (Droy, 1988). Additionally,it has been shown
to lower the cytotoxic effects of allyl and benzyl isothiocyanate in
hepatocytes (Bruggeman et al., 1986).

Pretreatm ent of rats with NAC

protected them against TTZ toxicity, which indicates th a t glutathione (GSH)
concentrations are im portant in preventing the toxicity of TTZ and th at
GSH could play a protective role in its toxicity. This again m ay indicate
th a t a reactive metabolite is produced via the cytochrome P-448 isozyme.
Further evidence supporting a major protective role of GSH was provided

by glutathione studies with NAC and TTZ.

NAC m aintained glutathione

concentrations significantly above control values in the liver of adult male
rats even in the presence of a toxic dose of TTZ. However, lung glutathione
concentrations were m aintained a t approximately control levels even in the
presence of TTZ (87.2% of control).

This could explain why NAC was

protective against TTZ toxicity in male rats. Glutathione concentrations in
the liver of adult female ra ts were m aintained a t approximately control
values when pretreated with NAC and also in the presence of a toxic dose
of TTZ (91.2% of control). Female GSH concentrations, compared to GSH
concentration in male rats, were not increased above control values
suggesting th a t NAC did not increase the rate of synthesis of GSH in the
liver of female rats.

These results also suggest th a t GSH synthesis in

females may be high enough to keep up with the depletion caused by TTZ.
It is also possible, of course, th a t NAC does not replenish GSH stores in
female rats.

Tateishi et al (1974) have shown th a t the concentration of

cysteine may lim it the overall rate of GSH synthesis and he also suggested
th a t hepatic GSH concentration may be regulated by the activities of y-GTP
rath er than the rate of glutathione synthesis. GSH concentrations in female
ra t lungs were significantly decreased from control values when pretreated
with NAC (43% of control), and were decreased even more when female rats
were pretreated with NAC and dosed with TTZ (33% of control). The exact
mechanism by which this sex related difference occurs is not understood.
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Effect of DEM and BSO on TTZ and BNF induced resistance

DEM pretreatm ent abolished the resistance in adult male rats obtained by
prior exposure to a sublethal dose of TTZ or survival from a toxic dose.
However, BSO did not affect TTZ induced resistance and rats
non-susceptible to TTZ toxicity.

remained

BNF induced resistance was also abolished

by DEM pretreatm ent but, BSO pretreatm ent did not affect BNF induced
resistance.

These results indicate th a t when glutahione concentration in

the lung of TTZ induced and BNF induced resistant anim als is reduced by
DEM they become susceptible to TTZ toxicity.

This again suggest th at

glutathione plays a protective role in the metabolism of TTZ.

Mechanisms of toxic action

According to studies by Boyd and Neal (1976), ANTU toxicity requires the
microsomal monooxygenase-catalyzed activation of the compound a t the
thiocarbonyl locus of the molecule. Tolerance to the lung toxicity of
ANTU may result from decreased monooxygenase activity produced by prior
dosing either with ANTU itself, or by dosing with 4-ipomeanol. Evidence
for the involvement of the cytochrome P-450 containing monooxygenase
system in this activation reaction comes from in vitro studies with other
thiono-sulfur-containing compounds (Dalvi et al., 1974; 1975; H unter and
Neal, 1975; DeMatteis and Seawright, 1973; Norman et al., 1974; Omura
and Sato, 1964; Norman and Neal, 1976; DeMatteis, 1974). Boyd and Neal
(1976) also considered the flavin-containing monooxygenase system described
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by Poulsen et al., (1974).

This system is capable of NADPH-dependent

desulfuration of some thionocarbonyl compounds, and it is reasonable to
suspect th a t chemically reactive interm ediates could also be produced via
this route. ANTU has also been shown to be a substrate for this enzyme
system.

According to studies by Parke and Ioannides (1984), the activation of toxic
chemicals and carcinogens into reactive metabolites involves oxygenation in
hindered positions of the molecule by cytochrome P-448 (LM4), flavoprotein
oxidoreductases, or transoxygenation during prostaglandin biosynthesis.
Cytochrome P-450 (LM2) does not oxygenate in hindered positions and
generally detoxicates carcinogens and toxic chemicals.

Vodicnik et al.,

(1981) demonstrated th a t a significant sex difference could be observed with
the P-448 isozyme. For example, in female ra ts cytochrome P-448 specific
activity, estim ated using ethoxyresorufin as a substrate, was much higher
th an activity in males. These results indicated th a t a P-448 isozyme exists
in female microsomes in higher quantities or activities th an in microsomes
from male rats.
substrate

for

Ethoxyresorufin has been reported to be a specific
P-448,

which

is

inducible

with

agents

such

as

3-methylcholanthrene (Burke and Mayer 1974; 1975; Burke et ad., 1977)
and BNF (Levin et al., 1977; Ioannides and Parke, 1987).

Cytochrome

P-448 is also found predominately in the neonatal ra t and decreases
postnatally, whereas P-450 is low in neonates and increases with age
(Ioannides and Parke, 1987).
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The results of the present study suggest th at TTZ may be metabolized to
a short-lived reactive toxic metabolite in the lung by the cytochrome P-448
isozyme.

Factors supporting this postulated mechanism include:

1)

P-napthoflavone (BNF) induction of the cytochrome P-448 isozyme obliterated
TTZ toxicity.

BNF induction could increase the rate of metabolism of TTZ

in the liver because of increased P-448 isozyme activity. Since oral or ip
adm inistration would result in a first-pass effect, the am ount of TTZ
presented to the lungs and the rate of production of a reactive metabolite
in the lung could be decreased, 2) Glutathione (GSH) concentrations were
decreased by TTZ in the lung but not in the liver and depletion of
glutathione stores in the liver and lung by DEM increases TTZ toxicity in
adult male, adult female and im m ature rats of both sexes. This suggests
th a t GSH probably plays a major protective role in the metabolism of TTZ.
Other evidence for glutathione involvement includes: a) L-buthionine-(SR)_
sulfoxamine did not increase TTZ toxicity and it probably did not deplete
GSH concentrations in the lungs; b) DEM reversed BNF and TTZ induced
resistance whereas BSO did not; c) DEM increased the toxicity of TTZ in
female and im m ature rats; and d) N-Acetyl-L-cysteine (NAC), which is a
glutathione replenisher, protected against TTZ toxicity in male rats. Since
GSH protects against electrophyllic metabolite damage,

an electrophyllic

metabolite was probably produced in the lung by the cytochrome P-448
isozyme.

Some questions concerning the toxicity and metabolism of TTZ in rats
remain. Im m ature rats were less susceptible to TTZ toxicity a t 30-40 days
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of age when they should have been more susceptible, since it is reported
th a t P-448 decreases as P-450 increases. However, many studies show th at
overall xenobiotic metabolism increases beyond 30-40 days of age in male
rats. It could be th a t cytochrome P-448 is also increased in males. This
could also relate to postnatal changes in monooxygenase activity in the lung.
Specifically, it is not known w hether the P-448 isozyme occurs in the lung
of im m ature rats i.e., it may not occur until 50-55 days of age. Also, there
could be enough GSH and glutathione transferase activity in the lung to
protect im m ature rats, or the reactive metabolite produced in the lung may
be less effective for some other reason related to the physiologic
development of the lung of im m ature rats. Male vs female differences could
be related to higher GSH concentrations in female liver and lung. However,
this is not a complete explanation since toxicity would seem to require the
production of a toxic metabolite in the lung. The lungs of female rats may
also have more limited amounts of cytochrome P-448 isozyme activities than
males.

Higher doses of TTZ definitely increased the concentration of GSH in the
lungs of female rats. This may be a self-induced protective effect. If this
is the case, then lower toxicity in females may relate to both low
cytochrome P-448 in the lung and increases in GSH concentration.

Intraperitoneal adm inistration of TTZ increased toxicity in males but
decreased toxicity in females. This is difficult to explain since the first
pass effect should have reduced the amount of TTZ entering the lungs of
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both males and females.

It is possible th a t the first-pass effect is

overwhelmed in the male ra ts and more gets to the lung to be metabolized
to a toxic metabolite.

In females, however, there may be a saturation

phenomenon in which an alternate detoxifying mechanism increases in
importance. This could also explain the finding th a t increasing oral doses
in the female produced no further increase in toxicity.

There is also the question of TTZ induced resistance. This was studied in
males only and showed th a t sublethal doses and potentially lethal doses of
TTZ provided protection against TTZ toxicity for 8 weeks.

This could

suggest th a t TTZ is a suicide substrate for P-448 which leads to a decrease
in the concentration of the cytochrome P-448 isozyme in the lung.

It could

also bind covalently to cytochrome P-448 in the lung, induce an alternate
pathway in the liver whereby cytochrome P-450 would metabolize it to a
non-reactive metabolite (which could be conjugated and excreted in the bile),
cause induction of GSH or glutathione-S-transferase in the lung, or produce
a self-limiting protective effect in the lung endothelium.

The possibility rem ains th a t TTZ could be metabolized to a toxic metabolite
in the liver and transported as such to the lung. However, if this occurs
the metabolite would have to be protected in some m anner during
translocation, or it would react before getting to the lung. Theoretically
TTZ could be conjugated in the liver and then deconjugated in the lung to
produce a toxic metabolite.
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The flavin containing monooxygenase syustem has been shown to activate
toxic thioureas, leading to the formation of chemically reactive
toxic intermediates ( Poulsen et al., 1979).

The experiments of these

authors demonstrated th a t the microsomal FAD-containing monoooxygenase
catalyzes the sequential S-oxygenation of thioureido compounds. Lipophilic
N-substituted thioureas are oxidized to formamidine sulfinic acids through
intermediate sulfenic acids and each step in the sequence is enzymatic. The
oxidation of thioureas to sulfinic acids may be an im portant pathway in
their activation to toxic metabolites. Rats exposed to airborne formamidine
sulfinic acid exhibited pathological changes sim ilar to those observed with
thioureas and the sulfinic acid was a t least 10-fold more toxic than
thiourea.

The microsomal flavin-containing monooxygenase activity is

exceptionally high in pigs and hum ans but is low in rats (Casarett and
Doull, 1986). However, it has also been characterized in lung microsomes
of pregnant rabbits (Williams et al., 1985). If the flavoprotein enzyme is
uncoupled in the lungs of rabbits and amines are concentrated in the lungs,
it could lead to the localized production of H202 or 02- radicals with
subsequent peroxidative damage. TTZ m ay be metabolized and activated to
a toxic metabolite by this system in the lung of rats, bu t this possibility
was not addressed in this study.

The flavin containing monooxygenase is not under the same regulatory
control as cytochrome P-450.

In fact, it is repressed rath er than induced

by both phenobarbital and 3-methylcholanthrene treatm ent (Casarette and
Doull, 1986). Additionally, it appears th a t the concentration of the enzyme
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is regulated by steroid sex hormones, with testosterone decreasing and
progesterone increasing activity.

This m itigates against its involvement,

since sex steroids did not affect TTZ toxicity.

In summary, it is possible

th a t this system is involved but little evidence was generated concerning its
involvement in the present study. Ultimately, the answer to this question
would only come from studies on the metabolism of TTZ in ra t lung.

CHAPTER 7
SUMMARY AND CONCLUSIONS

1.

The acute single oral dose LD50 for 2-thiotriazone (TTZ) in adult male
rats was determined to 4.6 mg/kg and the acute intraperitoneal LD50
was 1.4 mg/kg, which classifies it as a highly toxic compound.

2.

An LD50 could not be determined for female rats because the highest
m ortality produced a t concentrations of 2.5-1000 mg TTZ/kg was 40%.
At concentrations of 5-100 mg/kg it was not toxic to female rats when
dose ip and an acute ip LD50 was calculated to >100 mg/kg.

3.

TTZ did not produce m ortality in imm ature rats of either sex when
administered doses of 10-1000 mg/kg either orally or ip. An acute oral
and ip LD50 was estim ated to > 1000 mg TTZ/kg.

4.

Acute toxicity testing w ith TTZ adult and im m ature rats of both sexes
revealed th a t TTZ toxicity is both age and sex dependent.

5.

Clinical signs of intoxication observed in affected anim als included
severe respiratory distress, dyspnea, labored breathing, cyanosis,
prostration, ruffled fur and a white frothy nasal discharge th a t was
present in rate th a t subsequently died. In adult male rats these signs
reached a maximum within 2-3 h r and death usually ensued. Rats
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th a t did not die appeared to recover completely. These signs lasted
for longer periods of tim e in female rats (4-24 hr) and a higher
percentage of animals recovered. Im m ature rats did not exhibit any
signs of intoxication.

6.

Marked histologic changes were observed in the lungs of adult male
rats treated with a toxic dose of TTZ. Major changes included acute
interstitial and perivascular edema. Edem a was largely restricted to
the region around the blood vessels. Edema was also noted around
bronchioles with some sepage into the alveoli.

There was also

substantially more fluid in the loose periarterial interstitium than
around the airways within the perivascular bundles, and there was
more edema around the larger bundles. This edema was associated
with

mild

inflammatory

response

with

minimal

numbers

of

neutrophils, macrophages, and lymphocytes. These changes along with
macroscopic lesions (mottling of the lungs, pulmonary edema and
effusion) confirm the lung as the principal site of action or target
organ.

7.

Female ra t lungs were much less edematous than male ra t lungs.
Histologic examination revealed small quantities of perivascular
edema. There was no interstitial or peribronchial edema present and
no inflammatory response in female ra ts treated with TTZ.

8.

Lung weights and lung to body weight ratios were significantly
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increased in adult male, adult female, and 40-day old male rats
treated with TTZ.

However, liver weights and ratios were not

increased, again confirming the lung as the principal site of action.

9.

Toxicity of TTZ in male, female and im m ature male ra ts was markedly
potentiated by diethylmaleate (DEM) pretreatm ent, indicating th at
glutathione plays a protective role in the metabolism of TTZ.
However, L-buthionine-(SR)-sulfoxamine (BSO) pretreatm ent did not
affect TTZ toxicity in adult male rats because GSH stores were not
depleted by BSO.

10.

Clinical signs of intoxication in DEM-TTZ treated male, female and
im m ature rats of both sexes were the same as signs observed in TTZ
treated rats (severe respiratory distress, dyspnea, cyanosis, prostration
or listlessness, and ruffled fur). In rats th a t subsequently died, large
amounts of a white frothy discharge were expelled from the nostrils.
However, these signs were more severe and occurred with a more
rapid onset of action th an in rats treated with TTZ alone.

Death

usually ensued within 1-1.5 h r in both adult and im m ature male rats.

11.

Histologic changes observed in DEM-TTZ treated adult male and
female rats were the same as those observed in TTZ treated adult
male rats. These changes were potentiated in female rats since only
small amounts of perivascular edema were observed when exposed to
TTZ alone. There were no changes observed in the liver of DEM-TTZ

227
treated rats. Macroscopic lesions observed in DEM-TTZ treated rats
included mottling of the lungs, pulmonary edema, effusion, and large
swollen lungs th a t filled the chest cavity. These changes also indicate
th a t the lung is the site of action or target organ.

12.

Lung weights and lung to body weight ratios of DEM-TTZ treated rats
were 2 times (2x) higher th an those of TTZ treated animals. However,
like TTZ alone, DEM-TTZ in combination did not affect liver weights
and liver to body weight ratios.

13.

Im m ature rats of both sexes were resistant to TTZ up to 45 days of
age. Resistance began to diminish by 45 days of age in male rats and
by 55 days of age it was completely diminished. However, female rats
were still resistant up to 55 days of age.

14.

Resistance was produced in adult male rats by adm inistration of a
sublethal dose of TTZ (1 mg/kg) and in anim als th a t survived a toxic
dose of TTZ. This resistance lasted for 8 weeks in orally dosed rats
and for 6 weeks in ra ts dosed ip.

15.

Sex steroid (13-estradiol and testosterone) did not affect TTZ toxicity
in adult male, adult female and im m ature rats of both sexes,
indicating th a t they do not influence the toxic action of TTZ. Changes
in the estrous cycle also did not affect TTZ toxicity in female rats
indicating th a t changes in estrus do not influence the toxic action of
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TTZ in females.
16.

TTZ itself did not affect UDP-glucuronosyltransferase (UDPGT) activity
in adult male rats. However, UDPGT activity was decreased in adult
female and 40-day old male rats, indicating th a t TTZ may be
metabolized by glucuronidation and excreted as a non-reactive
glucuronide. Aldrin epoxidase, ECOD and EROD activities in male
and imm ature male rats were not affected. However, aldrin epoxidase
activity was significantly decreased in female rats which was
consistent with previous reports of low cytochrome P-450 isozyme
activity. Aldrin epoxidase, EROD and ECOD activities, in relation to
specific content of P-450, were increased two-fold in adult male, adult
female and 40-day old male rats.

Pretreatm ent with DEM did not

cause any TTZ related effect on UDPGT, aldrin epoxidase, EROD or
ECOD activities in male, female, and im m ature male rats.

These

results indicate th a t these activities are stable in the presence of TTZ
alone and even when anim als are pretreated with DEM and
administered TTZ, and th a t they are also present in sufficient
quantities to carry out metabolism in the liver.

17.

Treatm ent with TTZ did not produce changes in the cytochrome P450 complex in adult male rats. In contrast, the specific content of
cytochrome P-450 was increased in female rats. Cytochrome b5 specific
content and NADPH cytochrome-C-reductase activity were unaffected.
NADH cytochrome-b5 reductase activity was significantly lower in 40day old male rats th an in adults.

These results indicate th a t the
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components of the hepatic microsomal monooxygenase system are
available in sufficient quantities in the liver for metabolism to take
place, even in the presence of TTZ. DEM+TTZ in combination did not
affect the hepatic microsomal monooxygenase system components.
However, cytochrome P-450 specific content was decreased in adult
male rats indicating th a t TTZ may be affecting cytochrome P-450
when glutathione stores have been depleted with DEM or DEM itself
may be affecting the cytochrome P-450 monooxygenase system.

18.

Glutathione-S-transferase (GST) activity in adult and 40-day old male
rats was not affected by TTZ alone or by DEM-TTZ in combination,
indicating th a t GST was available a t levels sufficient for conjugation
with metabolites of TTZ.

19.

TTZ caused a dose-dependent decrease in glutathione (GSH) content
in the lung of adult male rats. It also decreased GSH concentration
in the lung of female rats in a dose-independent m anner, indicating
th at glutathione plays a protective role in the metabolism of TTZ in
both male and female rats and th a t glutathione concentration in the
lung is very im portant in the detoxification of cytochrome P-448
mediated metabolite production.

20.

Glutathione concentrations in the lungs of female rats administered
DEM+TTZ in combination were twice as high as th a t of males
suggesting th a t more GSH was available to deactivate reactive
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metabolites formed by metabolism of TTZ.
21.

B-Napthoflavone induction of the hepatic microsomal monooxygenase
system (specifically P-448) completely protected against TTZ toxicity
in male rats.

Phenobarbital induction of the cytochrome P-450

isozyme did not significantly affect TTZ toxicity in male rats. Neither
alpha-napthoflavone nor SKF-525A reversed the effects of BNF and PB
induction on TTZ toxicity. These results indicate th a t the cytochrome
P-450 isozyme is not responsible for the metabolism of TTZ, but th at
the P-448 isozyme could be involved.

22.

All induced anim als (BNF and PB) had significantly higher cytochrome
P-450 specific content than non-induced rats, which shows th at
induction did occur.

TTZ itself did not affect components of the

hepatic microsomal monooxygenase system (cytochromes P-450 and b5,
NADPH cytochrome-C and NADH cytochrome-b5 reductases), and it
did not affect glutathione-S-transferase in PB and BNF induced rats.
There were also no changes in substrate metabolism (UDPGT, EROD,
ECOD and AE activities) attributed to TTZ treatm ent.

However,

cytochrome P-450 specific content in PB induced adult male rats
administered DEM+TTZ was significantly decreased and cytochrome
P-450 may be covalently bound with the sulfur atom of TTZ. Aldrin
epoxidase and EROD activities in PB induced, DEM-TTZ treated rats
were also decreased, which could be attributed
cytochrome P-450 content.

NADPH

to decreased

cytochrome-C-and NADH

cytochrome b5 reductase activities were not affected. Glutathione-S-
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transferase activity was not affected in PB induced DEM-TTZ treated
animals.

23.

N-acetyl-L-cysteine, a glutathione precursor and replenisher, protected
male rats against TTZ toxicity, indicating th a t GSH plays a protective
role in the metabolism of TTZ.

24.

N-acetyl-L-cysteine (NAC) alone increased GSH in the liver of male
rats to 158% of control values and m aintained GSH concentrations in
the lung a t 96.9% of control values. It also m aintained GSH in the
liver of female rats a t 89.8% of control, and lung GSH was decreased
to 43.3% of control. These results indicate th a t NAC increased GSH
in the liver and m aintained it in the lung of male rats.

GSH was

m aintained in the liver of female rats but not in the lungs, suggesting
th a t NAC actually decreased GSH stores in female rats.

25.

GSH in the liver of adult male rats treated w ith NAC-TTZ was
increased to 140.5% of control values and was m aintained a t 87.2% of
control in the lung.

GSH in NAC-TTZ treated female rats was

m aintained in the liver a t 91.2% of control values, but it was
decreased in the lung to 33.1% of the control, showing th a t NAC
decreased GSH concentrations in the lung.

26.

DEM pretreatm ent reversed or abolished TTZ induced resistance and
BNF induced resistance in male rats, indicating th a t glutathione plays

a protective role in the metabolism of TTZ.

However, BSO, an

inhibitor of glutathione synthesis, did not affect TTZ induced
resistance or BNF induced resistance in male rats. This can probably
be attributed to inadequate depletion of GSH by BSO.

Evidence is presented for the involvement of the cytochrome P-448
isozyme of the pulmonary monooxygenase system in the production of
a reactive metabolite which produces the lesions observed with TTZinduced toxicity.

The involvement of a non-cytochrome flavin

containing monooxygenase system, however, cannot be ruled out.
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